Cover Page
Cover Page - shares | 6 Months Ended | |
Jun. 30, 2020 | Aug. 04, 2020 | |
Cover [Abstract] | ||
Document Type | 10-Q | |
Document Quarterly Report | true | |
Document Period End Date | Jun. 30, 2020 | |
Document Transition Report | false | |
Entity File Number | 0-17071 | |
Entity Registrant Name | FIRST MERCHANTS CORP | |
Entity Incorporation, State or Country Code | IN | |
Entity Tax Identification Number | 35-1544218 | |
Entity Address, Address Line One | 200 East Jackson Street | |
Entity Address, City or Town | Muncie | |
Entity Address, State or Province | IN | |
Entity Address, Postal Zip Code | 47305-2814 | |
City Area Code | 765 | |
Local Phone Number | 747-1500 | |
Title of 12(b) Security | Common Stock, $0.125 stated value per share | |
Trading Symbol | FRME | |
Security Exchange Name | NASDAQ | |
Entity Current Reporting Status | Yes | |
Entity Interactive Data Current | Yes | |
Entity Filer Category | Large Accelerated Filer | |
Entity Small Business | false | |
Entity Emerging Growth Company | false | |
Entity Shell Company | false | |
Entity Common Stock, Shares Outstanding | 54,124,467 | |
Entity Central Index Key | 0000712534 | |
Current Fiscal Year End Date | --12-31 | |
Document Fiscal Year Focus | 2020 | |
Document Fiscal Period Focus | Q2 | |
Amendment Flag | false |
CONSOLIDATED CONDENSED BALANCE
CONSOLIDATED CONDENSED BALANCE SHEETS - USD ($) $ in Thousands | Jun. 30, 2020 | Dec. 31, 2019 |
ASSETS | ||
Cash and cash equivalents | $ 229,759 | $ 177,201 |
Interest-bearing time deposits | 380,021 | 118,263 |
Investment securities available for sale | 1,890,593 | 1,790,025 |
Investment securities held to maturity (fair value of $941,426 and $827,566) | 898,786 | 806,038 |
Loans held for sale | 901 | 9,037 |
Loans, net of allowance for loan losses of $121,119 and $80,284 | 9,177,422 | 8,379,026 |
Premises and equipment | 112,548 | 113,055 |
Federal Home Loan Bank stock | 28,736 | 28,736 |
Interest receivable | 57,063 | 48,901 |
Goodwill | 543,918 | 543,918 |
Other intangibles | 31,937 | 34,962 |
Cash surrender value of life insurance | 290,715 | 288,206 |
Other real estate owned | 7,367 | 7,527 |
Tax asset, deferred and receivable | 13,126 | 12,165 |
Other assets | 156,486 | 100,194 |
TOTAL ASSETS | 13,819,378 | 12,457,254 |
Deposits: | ||
Noninterest-bearing | 2,260,351 | 1,736,396 |
Interest-bearing | 8,705,637 | 8,103,560 |
Total Deposits | 10,965,988 | 9,839,956 |
Borrowings: | ||
Federal funds purchased | 0 | 55,000 |
Securities sold under repurchase agreements | 181,150 | 187,946 |
Federal Home Loan Bank advances | 400,817 | 351,072 |
Subordinated debentures and other borrowings | 285,197 | 138,685 |
Total Borrowings | 867,164 | 732,703 |
Interest payable | 5,587 | 6,754 |
Other liabilities | 171,544 | 91,404 |
Total Liabilities | 12,010,283 | 10,670,817 |
COMMITMENTS AND CONTINGENT LIABILITIES | ||
STOCKHOLDERS' EQUITY | ||
Cumulative Preferred Stock, $1,000 par value, $1,000 liquidation value: Authorized - 600 shares; Issued and outstanding - 125 shares | 125 | 125 |
Common Stock, $.125 stated value: Authorized - 100,000,000 shares; Issued and outstanding - 53,795,000 and 55,368,482 shares | 6,724 | 6,921 |
Additional paid-in capital | 1,002,962 | 1,054,997 |
Retained earnings | 735,439 | 696,520 |
Accumulated other comprehensive income | 63,845 | 27,874 |
Total Stockholders' Equity | 1,809,095 | 1,786,437 |
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY | $ 13,819,378 | $ 12,457,254 |
CONSOLIDATED CONDENSED BALANC_2
CONSOLIDATED CONDENSED BALANCE SHEETS (Parenthetical) - USD ($) $ in Thousands | Jun. 30, 2020 | Dec. 31, 2019 |
Statement of Financial Position [Abstract] | ||
Investment securities held to maturity - fair value | $ 941,426 | $ 827,566 |
Loans - allowance for loan losses | $ 121,119 | $ 80,284 |
Preferred Stock, par value (in dollars per share) | $ 1,000 | $ 1,000 |
Preferred Stock, liquidation value per share (in dollars per share) | $ 1,000 | $ 1,000 |
Preferred Stock, authorized (in shares) | 600 | 600 |
Preferred Stock, issued (in shares) | 125 | 125 |
Preferred Stock, outstanding (in shares) | 125 | 125 |
Common Stock, stated value (in dollars per share) | $ 0.125 | $ 0.125 |
Common Stock, authorized (in shares) | 100,000,000 | 100,000,000 |
Common Stock, issued (in shares) | 53,795,500 | 55,368,482 |
Common Stock, outstanding (in shares) | 53,795,500 | 55,368,482 |
CONSOLIDATED CONDENSED STATEMEN
CONSOLIDATED CONDENSED STATEMENTS OF INCOME (Unaudited) - USD ($) $ in Thousands | 3 Months Ended | 6 Months Ended | ||
Jun. 30, 2020 | Jun. 30, 2019 | Jun. 30, 2020 | Jun. 30, 2019 | |
Loans receivable: | ||||
Taxable | $ 87,312 | $ 92,824 | $ 183,964 | $ 183,305 |
Tax exempt | 5,359 | 4,244 | 10,674 | 8,397 |
Investment securities: | ||||
Taxable | 6,147 | 6,998 | 13,778 | 13,093 |
Tax exempt | 10,019 | 7,454 | 19,354 | 14,325 |
Deposits with financial institutions | 134 | 784 | 709 | 1,659 |
Federal Home Loan Bank stock | 281 | 335 | 580 | 673 |
Total Interest Income | 109,252 | 112,639 | 229,059 | 221,452 |
INTEREST EXPENSE | ||||
Deposits | 12,707 | 23,087 | 34,455 | 42,681 |
Federal funds purchased | 2 | 117 | 113 | 210 |
Securities sold under repurchase agreements | 92 | 342 | 444 | 672 |
Federal Home Loan Bank advances | 1,794 | 1,692 | 3,568 | 3,506 |
Subordinated debentures and other borrowings | 1,639 | 2,123 | 3,584 | 4,239 |
Total Interest Expense | 16,234 | 27,361 | 42,164 | 51,308 |
NET INTEREST INCOME | 93,018 | 85,278 | 186,895 | 170,144 |
Provision for loan losses | 21,895 | 500 | 41,647 | 1,700 |
NET INTEREST INCOME AFTER PROVISION FOR LOAN LOSSES | 71,123 | 84,778 | 145,248 | 168,444 |
OTHER INCOME | ||||
Net gains and fees on sales of loans | 3,674 | 1,736 | 7,037 | 3,031 |
Increase in cash surrender value of life insurance | 1,231 | 927 | 2,591 | 1,916 |
Gains on life insurance benefits | 95 | 19 | 95 | 19 |
Net realized gains on sales of available for sale securities | 3,068 | 1,843 | 7,680 | 2,983 |
Other income | 1,028 | 1,064 | 1,293 | 1,394 |
Total Other Income | 26,481 | 21,614 | 56,280 | 40,327 |
OTHER EXPENSES | ||||
Salaries and employee benefits | 35,698 | 32,709 | 74,941 | 65,737 |
Net occupancy | 5,447 | 4,469 | 11,248 | 9,496 |
Equipment | 4,489 | 4,117 | 8,833 | 7,759 |
Marketing | 2,092 | 2,752 | 3,535 | 3,826 |
Outside data processing fees | 2,618 | 3,929 | 6,817 | 7,613 |
Printing and office supplies | 279 | 334 | 666 | 649 |
Intangible asset amortization | 1,511 | 1,520 | 3,025 | 3,048 |
FDIC assessments | 1,472 | 678 | 2,995 | 1,385 |
Other real estate owned and foreclosure expenses | 684 | 903 | 1,189 | 2,068 |
Professional and other outside services | 1,553 | 2,376 | 3,811 | 4,260 |
Other expenses | 4,146 | 3,800 | 9,100 | 8,367 |
Total Other Expenses | 59,989 | 57,587 | 126,160 | 114,208 |
INCOME BEFORE INCOME TAX | 37,615 | 48,805 | 75,368 | 94,563 |
Income tax expense | 4,623 | 7,749 | 8,113 | 14,690 |
NET INCOME AVAILABLE TO COMMON STOCKHOLDERS | $ 32,992 | $ 41,056 | $ 67,255 | $ 79,873 |
Per Share Data: | ||||
Basic Net Income Available to Common Stockholders (in dollars per share) | $ 0.62 | $ 0.83 | $ 1.24 | $ 1.62 |
Diluted Net Income Available to Common Stockholders (in dollars per share) | 0.62 | 0.83 | 1.24 | 1.61 |
Cash Dividends Paid (in dollars per share) | $ 0.26 | $ 0.26 | $ 0.52 | $ 0.48 |
Average Diluted Shares Outstanding (in shares) | 53,942,567 | 49,549,887 | 54,429,519 | 49,545,152 |
Service charges on deposit accounts | ||||
OTHER INCOME | ||||
Other income | $ 4,312 | $ 5,437 | $ 10,282 | $ 10,532 |
Fiduciary and wealth management fees | ||||
OTHER INCOME | ||||
Other income | 5,601 | 3,931 | 11,586 | 7,749 |
Card payment fees | ||||
OTHER INCOME | ||||
Other income | 6,097 | 4,829 | 12,004 | 9,655 |
Derivative hedge fees | ||||
OTHER INCOME | ||||
Other income | 1,042 | 1,487 | 2,981 | 2,268 |
Other customer fees | ||||
OTHER INCOME | ||||
Other income | $ 333 | $ 341 | $ 731 | $ 780 |
CONSOLIDATED CONDENSED STATEM_2
CONSOLIDATED CONDENSED STATEMENTS OF COMPREHENSIVE INCOME (Unaudited) - USD ($) $ in Thousands | 3 Months Ended | 6 Months Ended | ||
Jun. 30, 2020 | Jun. 30, 2019 | Jun. 30, 2020 | Jun. 30, 2019 | |
Statement of Comprehensive Income [Abstract] | ||||
Net income | $ 32,992 | $ 41,056 | $ 67,255 | $ 79,873 |
Other comprehensive income (loss), net of tax: | ||||
Unrealized holding gain (loss) on securities available for sale arising during the period, net of tax of $3,335, $4,822, $11,406, and $10,402 | 12,545 | 18,140 | 42,909 | 39,130 |
Unrealized gain (loss) on cash flow hedges arising during the period, net of tax of $31, $148, $306, and $230 | (114) | (553) | (1,153) | (862) |
Reclassification adjustment for net gains included in net income, net of tax of $595, $369, $1,538, and $596 | (2,242) | (1,390) | (5,785) | (2,244) |
Total other comprehensive income, net of tax | 10,189 | 16,197 | 35,971 | 36,024 |
Comprehensive income | $ 43,181 | $ 57,253 | $ 103,226 | $ 115,897 |
CONSOLIDATED CONDENSED STATEM_3
CONSOLIDATED CONDENSED STATEMENTS OF COMPREHENSIVE INCOME (Unaudited) (Parenthetical) - USD ($) $ in Thousands | 3 Months Ended | 6 Months Ended | ||
Jun. 30, 2020 | Jun. 30, 2019 | Jun. 30, 2020 | Jun. 30, 2019 | |
Statement of Comprehensive Income [Abstract] | ||||
Unrealized holding gain (loss) on securities available for sale arising during the period, tax | $ 3,335 | $ 4,822 | $ 11,406 | $ 10,402 |
Unrealized gain (loss) on cash flow hedges arising during the period, tax | (31) | (148) | (306) | (230) |
Reclassification adjustment for net losses (gains) included in net income, tax | $ 595 | $ 369 | $ 1,538 | $ 596 |
CONSOLIDATED CONDENSED STATEM_4
CONSOLIDATED CONDENSED STATEMENTS OF STOCKHOLDERS' EQUITY (Unaudited) - USD ($) $ in Thousands | Total | Preferred | Common Stock | Additional Paid in Capital | Retained Earnings | Accumulated Other Comprehensive Income (Loss) |
Beginning balance (in shares) at Dec. 31, 2018 | 125 | 49,349,800 | ||||
Beginning balance at Dec. 31, 2018 | $ 1,408,260 | $ 125 | $ 6,169 | $ 840,052 | $ 583,336 | $ (21,422) |
Comprehensive income: | ||||||
Net income | 79,873 | 79,873 | ||||
Other comprehensive income (loss), net of tax | 36,024 | 36,024 | ||||
Cash dividends on common stock | (23,847) | (23,847) | ||||
Share-based compensation (in shares) | 108,638 | |||||
Share-based compensation | 1,825 | $ 14 | 1,811 | |||
Stock issued under employee benefit plans (in shares) | 11,247 | |||||
Stock issued under employee benefit plans | 362 | $ 1 | 361 | |||
Stock issued under dividend reinvestment and stock purchase plan (in shares) | 18,686 | |||||
Stock issued under dividend reinvestment and stock purchase plan | 709 | $ 2 | 707 | |||
Stock options exercised (in shares) | 11,200 | |||||
Stock options exercised | 105 | $ 1 | 104 | |||
Stock redeemed (in shares) | (42,977) | |||||
Restricted shares withheld for taxes | (1,675) | $ (5) | (1,670) | |||
Ending balance (in shares) at Jun. 30, 2019 | 125 | 49,456,594 | ||||
Ending balance at Jun. 30, 2019 | 1,501,636 | $ 125 | $ 6,182 | 841,365 | 639,362 | 14,602 |
Beginning balance (in shares) at Mar. 31, 2019 | 125 | 49,428,468 | ||||
Beginning balance at Mar. 31, 2019 | 1,455,848 | $ 125 | $ 6,179 | 839,919 | 611,220 | (1,595) |
Comprehensive income: | ||||||
Net income | 41,056 | 41,056 | ||||
Other comprehensive income (loss), net of tax | 16,197 | 16,197 | ||||
Cash dividends on common stock | (12,914) | (12,914) | ||||
Share-based compensation (in shares) | 4,978 | |||||
Share-based compensation | 844 | $ 1 | 843 | |||
Stock issued under employee benefit plans (in shares) | 5,908 | |||||
Stock issued under employee benefit plans | 188 | 188 | ||||
Stock issued under dividend reinvestment and stock purchase plan (in shares) | 10,178 | |||||
Stock issued under dividend reinvestment and stock purchase plan | 369 | $ 1 | 368 | |||
Stock options exercised (in shares) | 7,500 | |||||
Stock options exercised | 65 | $ 1 | 64 | |||
Stock redeemed (in shares) | (438) | |||||
Restricted shares withheld for taxes | (17) | (17) | ||||
Ending balance (in shares) at Jun. 30, 2019 | 125 | 49,456,594 | ||||
Ending balance at Jun. 30, 2019 | 1,501,636 | $ 125 | $ 6,182 | 841,365 | 639,362 | 14,602 |
Beginning balance (in shares) at Dec. 31, 2019 | 125 | 55,368,482 | ||||
Beginning balance at Dec. 31, 2019 | 1,786,437 | $ 125 | $ 6,921 | 1,054,997 | 696,520 | 27,874 |
Comprehensive income: | ||||||
Net income | 67,255 | 67,255 | ||||
Other comprehensive income (loss), net of tax | 35,971 | 35,971 | ||||
Cash dividends on common stock | (28,336) | (28,336) | ||||
Repurchase of common stock (in shares) | (1,634,437) | |||||
Repurchases of common stock | (55,912) | $ (204) | (55,708) | |||
Share-based compensation (in shares) | 8,591 | |||||
Share-based compensation | 2,433 | $ 1 | 2,432 | |||
Stock issued under employee benefit plans (in shares) | 11,511 | |||||
Stock issued under employee benefit plans | 309 | $ 1 | 308 | |||
Stock issued under dividend reinvestment and stock purchase plan (in shares) | 31,607 | |||||
Stock issued under dividend reinvestment and stock purchase plan | $ 863 | $ 4 | 859 | |||
Stock options exercised (in shares) | 10,050 | 10,050 | ||||
Stock options exercised | $ 83 | $ 1 | 82 | |||
Stock redeemed (in shares) | (304) | |||||
Restricted shares withheld for taxes | (8) | (8) | ||||
Ending balance (in shares) at Jun. 30, 2020 | 125 | 53,795,500 | ||||
Ending balance at Jun. 30, 2020 | 1,809,095 | $ 125 | $ 6,724 | 1,002,962 | 735,439 | 63,845 |
Beginning balance (in shares) at Mar. 31, 2020 | 125 | 53,754,137 | ||||
Beginning balance at Mar. 31, 2020 | 1,777,960 | $ 125 | $ 6,719 | 1,000,942 | 716,518 | 53,656 |
Comprehensive income: | ||||||
Net income | 32,992 | 32,992 | ||||
Other comprehensive income (loss), net of tax | 10,189 | 10,189 | ||||
Cash dividends on common stock | (14,071) | (14,071) | ||||
Share-based compensation (in shares) | 5,259 | |||||
Share-based compensation | 1,213 | $ 1 | 1,212 | |||
Stock issued under employee benefit plans (in shares) | 11,511 | |||||
Stock issued under employee benefit plans | 309 | $ 1 | 308 | |||
Stock issued under dividend reinvestment and stock purchase plan (in shares) | 15,897 | |||||
Stock issued under dividend reinvestment and stock purchase plan | 435 | $ 2 | 433 | |||
Stock options exercised (in shares) | 9,000 | |||||
Stock options exercised | 76 | $ 1 | 75 | |||
Stock redeemed (in shares) | (304) | |||||
Restricted shares withheld for taxes | (8) | (8) | ||||
Ending balance (in shares) at Jun. 30, 2020 | 125 | 53,795,500 | ||||
Ending balance at Jun. 30, 2020 | $ 1,809,095 | $ 125 | $ 6,724 | $ 1,002,962 | $ 735,439 | $ 63,845 |
CONSOLIDATED CONDENSED STATEM_5
CONSOLIDATED CONDENSED STATEMENT OF STOCKHOLDERS' EQUITY (Unaudited) (Parenthetical) - $ / shares | 3 Months Ended | 6 Months Ended | ||
Jun. 30, 2020 | Jun. 30, 2019 | Jun. 30, 2020 | Jun. 30, 2019 | |
Statement of Stockholders' Equity [Abstract] | ||||
Cash dividends on common stock (in dollars per share) | $ 0.26 | $ 0.26 | $ 0.52 | $ 0.48 |
CONSOLIDATED CONDENSED STATEM_6
CONSOLIDATED CONDENSED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($) $ in Thousands | 6 Months Ended | |
Jun. 30, 2020 | Jun. 30, 2019 | |
Cash Flow From Operating Activities: | ||
Net income | $ 67,255 | $ 79,873 |
Adjustments to reconcile net income to net cash provided by operating activities: | ||
Provision for loan losses | 41,647 | 1,700 |
Depreciation and amortization | 5,435 | 4,379 |
Change in deferred taxes | (18,509) | (398) |
Share-based compensation | 2,433 | 1,825 |
Loans originated for sale | (322,288) | (183,498) |
Proceeds from sales of loans held for sale | 336,583 | 184,667 |
Gains on sales of loans held for sale | (6,159) | (2,245) |
Gains on sales of securities available for sale | (7,680) | (2,983) |
Increase in cash surrender of life insurance | (2,591) | (1,916) |
Gains on life insurance benefits | 95 | 19 |
Change in interest receivable | (8,162) | (4,269) |
Change in interest payable | (1,167) | 1,133 |
Other adjustments | 28,006 | 4,759 |
Net cash provided by operating activities | 114,708 | 83,008 |
Cash Flows from Investing Activities: | ||
Net change in interest-bearing deposits | (261,758) | (92,651) |
Purchases of: | ||
Securities available for sale | (341,116) | (306,291) |
Securities held to maturity | (221,711) | (238,559) |
Proceeds from sales of securities available for sale | 167,390 | 82,052 |
Proceeds from maturities of: | ||
Securities available for sale | 135,398 | 53,910 |
Securities held to maturity | 127,380 | 35,185 |
Net change in loans | (840,804) | (288,195) |
Proceeds from the sale of other real estate owned | 592 | 827 |
Proceeds from life insurance benefits | 177 | 633 |
Other adjustments | (5,190) | (3,691) |
Net cash used in investing activities | (1,239,642) | (756,780) |
Net change in : | ||
Demand and savings deposits | 1,419,771 | 400,314 |
Certificates of deposit and other time deposits | (293,739) | 164,421 |
Borrowings | 467,056 | 533,010 |
Repayment of borrowings | (332,595) | (410,689) |
Cash dividends on common stock | (28,336) | (23,847) |
Stock issued under employee benefit plans | 309 | 362 |
Stock issued under dividend reinvestment and stock purchase plans | 863 | 709 |
Stock options exercised | 83 | 105 |
Restricted shares withheld for taxes | (8) | (1,675) |
Repurchase of common stock | (55,912) | 0 |
Net cash provided by financing activities | 1,177,492 | 662,710 |
Net Change in Cash and Cash Equivalents | 52,558 | (11,062) |
Cash and Cash Equivalents, January 1 | 177,201 | 139,247 |
Cash and Cash Equivalents, June 30 | 229,759 | 128,185 |
Additional cash flow information: | ||
Interest paid | 43,331 | 50,175 |
Income tax paid (refunded) | (300) | 11,499 |
Loans transferred to other real estate owned | 761 | 314 |
Fixed assets transferred to other real estate owned | 262 | 965 |
Non-cash investing activities using trade date accounting | 13,115 | 40,618 |
ROU assets obtained in exchange for new operating lease liabilities | $ 1,398 | $ 23,384 |
General
General | 6 Months Ended |
Jun. 30, 2020 | |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |
General | GENERAL Financial Statement Preparation The significant accounting policies followed by the Corporation and its wholly-owned subsidiaries for interim financial reporting are consistent with the accounting policies followed for annual financial reporting. All adjustments, which are of a normal recurring nature and are in the opinion of management necessary for a fair statement of the results for the periods reported, have been included in the accompanying Consolidated Condensed Financial Statements. The Consolidated Condensed Balance Sheet of the Corporation as of December 31, 2019 , has been derived from the audited consolidated balance sheet of the Corporation as of that date. Certain information and note disclosures normally included in the Corporation’s annual financial statements, prepared in accordance with accounting principles generally accepted in the United States of America, have been condensed or omitted. These consolidated condensed financial statements should be read in conjunction with the consolidated financial statements and notes thereto included in the Corporation’s Annual Report on Form 10-K for the year ended December 31, 2019 filed with the Securities and Exchange Commission. The results of operations for the three and six months ended June 30, 2020 , are not necessarily indicative of the results to be expected for the year. Reclassifications have been made to prior financial statements to conform to the current financial statement presentation. These reclassifications had no effect on net income. Material estimates that are particularly susceptible to significant change relate to the determination of the allowance for loan losses and fair value of financial instruments. The uncertainties related to the coronavirus disease 2019 ("COVID-19") could cause significant changes to these estimates compared to what was known at the time these financial statements were prepared. Impact of COVID-19 On January 30, 2020, the World Health Organization (“WHO”) announced that the outbreak of COVID-19 constituted a public health emergency of international concern. On March 11, 2020, WHO declared COVID-19 to be a global pandemic and, on March 13, 2020, the President of the United States declared the COVID-19 outbreak a national emergency. The health concerns relating to the COVID-19 outbreak and related governmental actions taken to reduce the spread of the virus have significantly impacted the global economy (including the states and local economies in which the Corporation operates), disrupted supply chains, lowered equity market valuations, and created significant volatility and disruption in financial markets. The outbreak has resulted in authorities implementing numerous measures to try to contain the virus, such as travel bans and restrictions, quarantines, shelter in place or total lock-down orders and business limitations and shutdowns. As a result of the shelter in place mandates in effect early in the second quarter of 2020, commercial activity throughout our geographic footprint, as well as nationally, decreased significantly. Most states have reopened, albeit under limited capacities and under other social distancing restrictions; however, commercial activity has not returned to the levels existing prior to the outbreak of the pandemic. Such measures have significantly contributed to rising unemployment and negatively impacted consumer and business spending. As a result, the demand for the Corporation’s products and services has been, and will continue to be, significantly impacted. Recent Accounting Changes Adopted in 2020 FASB Accounting Standards Updates No. 2018-15 - Intangibles - Goodwill and Other - Internal-Use Software (Subtopic 350-40): Customer's Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That Is a Service Contract Summary - The FASB issued Accounting Standards Update (ASU) No. 2018-15, Intangibles-Goodwill and Other-Internal-Use Software (Subtopic 350-40): Customer’s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That Is a Service Contract, which reduces complexity for the accounting for costs of implementing a cloud computing service arrangement. This standard aligns the accounting for implementation costs of hosting arrangements, regardless of whether they convey a license to the hosted software. The ASU aligns the following requirements for capitalizing implementation costs: • Those incurred in a hosting arrangement that is a service contract, and • Those incurred to develop or obtain internal-use software (and hosting arrangements that include an internal-use software license). For calendar-year public companies, the changes were effective for fiscal years ending after December 15, 2019. The Corporation adopted the standard in the first quarter of 2020 and adoption of the standard did not have a significant effect on the Corporation’s consolidated financial statements. FASB Accounting Standards Updates No. 2018-14 - Compensation - Retirement Benefits - Defined Benefit Plans - General (Subtopic 715-20): Disclosure Framework - Changes to the Disclosure Requirements for Defined Benefit Plans Summary - The FASB issued ASU No. 2018-14, Compensation - Retirement Benefits - Defined Benefit Plans - General (Subtopic 715-20): Disclosure Framework - Changes to the Disclosure Requirements for Defined Benefit Plans, that applies to all employers that sponsor defined benefit pension or other postretirement plans. The amendments modify the disclosure requirements for employers that sponsor defined benefit pension or other postretirement plans. Disclosure Requirements Deleted • The amounts in accumulated other comprehensive income expected to be recognized as components of net periodic benefit cost over the next fiscal year. • The amount and timing of plan assets expected to be returned to the employer. • Related party disclosures about the amount of future annual benefits covered by insurance and annuity contracts and significant transactions between the employer or related parties and the plan. • For public entities, the effects of a one-percentage-point change in assumed health care cost trend rates on the (a) aggregate of the service and interest cost components of net periodic benefit costs and (b) benefit obligation for postretirement health care benefits. Disclosure Requirements Added • An explanation of the reasons for significant gains and losses related to changes in the benefit obligation for the period. The amendments also clarify the disclosure requirements in paragraph 715-20-50-3, which state that the following information for defined benefit pension plans should be disclosed: • The projected benefit obligation (PBO) and fair value of plan assets for plans with PBOs in excess of plan assets, and • The accumulated benefit obligation (ABO) and fair value of plan assets for plans with ABOs in excess of plan assets. ASU No. 2018-14 is effective for fiscal years ending after December 15, 2020, for public business entities and for fiscal years ending after December 15, 2021, for all other entities. Early adoption is permitted for all entities. The Corporation adopted the standard in the first quarter of 2020 and adoption of the standard did not have a significant effect on the Corporation’s disclosures. FASB Accounting Standards Updates No. 2018-13 - Fair Value Measurement (Topic 820): Disclosure Framework - Changes to the Disclosure Requirements for Fair Value Measurement Summary - The FASB issued ASU No. 2018-13, Fair Value Measurement (Topic 820): Disclosure Framework - Changes to the Disclosure Requirements for Fair Value Measurement. ASU No. 2018-13 modifies the disclosure requirements on fair value measurements in Topic 820. Certain disclosure requirements related to transfers between Level 1 and Level 2 of the fair value hierarchy and Level 3 valuation process were removed from Topic 820. Disclosures were also added to Topic 820 for changes in unrealized gains and losses for the period included in other comprehensive income for recurring Level 3 fair value measurements held at the end of the reporting period and the range and weighted average of significant unobservable inputs used to develop Level 3 fair value measurements. In addition, the amendments eliminate "at a minimum" from the phrase “an entity shall disclose at a minimum” to promote the appropriate exercise of discretion by entities when considering fair value measurement disclosures and to clarify that materiality is an appropriate consideration of entities and their auditors when evaluating disclosure requirements. The amendments in ASU No. 2018-13 were effective for all entities for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2019. The amendments on changes in unrealized gains and losses, the range and weighted average of significant unobservable inputs used to develop Level 3 fair value measurements, and the narrative description of measurement uncertainty were applied prospectively for only the most recent interim or annual period presented in the initial fiscal year of adoption. All other amendments were applied retrospectively to all periods presented upon their effective date. Early adoption was permitted. An entity was permitted to early adopt any removed or modified disclosures upon issuance of ASU No. 2018-13 and delay adoption of the additional disclosures until their effective date. The Corporation adopted the standard in the first quarter of 2020 and adoption of the standard did not have a significant effect on the Corporation’s disclosures. FASB Accounting Standards Updates No. 2017-04 - Intangibles - Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment. Summary - The FASB issued ASU No. 2017-04, Intangibles-Goodwill and Other (Topic 350): Simplifying the Test for Goodwill, which simplifies how an entity is required to test goodwill for impairment. To simplify the subsequent measurement of goodwill, the ASU eliminates Step 2 from the goodwill impairment test. The annual, or interim, goodwill impairment test is performed by comparing the fair value of a reporting unit with its carrying amount. An impairment charge should be recognized for the amount by which the carrying amount exceeds the reporting unit's fair value; however, the loss recognized should not exceed the total amount of goodwill allocated to that reporting unit. In addition, the income tax effects of tax deductible goodwill on the carrying amount of the reporting unit should be considered when measuring the goodwill impairment loss, if applicable. The amendments also eliminate the requirements for any reporting unit with a zero or negative carrying amount to perform Step 2 of the goodwill impairment test. An entity still has the option to perform the qualitative assessment for a reporting unit to determine if the qualitative impairment test is necessary. The amendments were applied on a prospective basis. The Corporation adopted ASU No. 2017-04, Intangibles-Goodwill and Other (Topic 350): Simplifying the Test for Goodwill, January 1, 2020 and assessed the recent economic impact and market conditions from the COVID-19 pandemic. Based upon factors considered in the assessment and the general uncertainty as to the full extent of the COVID-19 pandemic and its effect on economic recovery, the Corporation has determined that it is not more likely than not that the fair value of the Corporation is less than the carrying value. Therefore, the Corporation concluded goodwill was not impaired at June 30, 2020, the details of which are included in NOTE 6. GOODWILL of these Notes to Consolidated Condensed Financial Statements. Guidance on Non-TDR Loan Modifications due to COVID-19 On March 22, 2020, a statement was issued by the Bank's banking regulators and titled the “Interagency Statement on Loan Modifications and Reporting for Financial Institutions Working with Customers Affected by the Coronavirus” (the "Interagency Statement") that encourages financial institutions to work prudently with borrowers who are or may be unable to meet their contractual payment obligations due to the effects of COVID-19. Additionally, Section 4013 of the CARES Act further provides that a qualified loan modification is exempt by law from classification as a TDR as defined by GAAP, from the period beginning March 1, 2020 until the earlier of December 31, 2020 or the date that is 60 days after the date on which the national emergency concerning the COVID-19 outbreak under the National Emergencies Act (50 U.S.C. 1601 et seq.) terminates. The Interagency Statement was subsequently revised on April 7, 2020 to clarify the interaction of the original guidance with Section 4013 of the CARES Act, as well as setting forth the banking regulators’ views on consumer protection considerations. In accordance with such guidance, the Bank is offering short-term modifications made in response to COVID-19 to borrowers who are current and otherwise not past due. These include short-term, 180 days or less, modifications in the form of payment deferrals, fee waivers, extensions of repayment terms, or other delays in payment that are insignificant. During the six months ended June 30, 2020, modifications were completed on loans having a total aggregate balance of approximately $1.1 billion , or 12.1 percent of the loan portfolio. Details of the modifications are included in NOTE 4. LOANS AND ALLOWANCE of these Notes to Consolidated Condensed Financial Statements. New Accounting Pronouncements Not Yet Adopted The Corporation continually monitors potential accounting changes and pronouncements. The following pronouncements have been deemed to have the most applicability to the Corporation's financial statements: FASB Accounting Standards Update No. 2016-13, Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments Summary - The FASB issued Accounting Standards Update (ASU) No. 2016-13, Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments . This new guidance was issued to address concerns that current generally accepted accounting principles (GAAP) restricts the ability to record credit losses that are expected, but do not yet meet the “probable” threshold by replacing the current “incurred loss” model for recognizing credit losses with an “expected life of loan loss” model referred to as the Current Expected Credit Loss (CECL) model. Under the CECL model, certain financial assets carried at amortized cost, such as loans held for investment and held-to-maturity debt securities, are required to be presented at the net amount expected to be collected. The measurement of expected credit losses is to be based on information about past events, including historical experience, current conditions, and reasonable and supportable forecasts that affect the collectability of the reported amount. This measurement will take place at the time the financial asset is first added to the balance sheet and periodically thereafter. This differs significantly from the “incurred loss” model required under current GAAP, which delays recognition until it is probable a loss has been incurred. The change could materially affect how the allowance for loan losses is determined and cause a charge/credit to earnings through the provision for loan losses. Such could create volatility in earnings and could adversely affect the financial condition of the Corporation. The ASU is effective for SEC filers for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2019. Pursuant to the CARES Act and the related joint statement of federal banking regulators (which also became effective as of March 27, 2020), and consistent with guidance from the SEC and FASB, the Corporation has elected to delay implementation of ASU No. 2016-13, which would have become effective for the Corporation as of January 1, 2020. As discussed above, ASU No. 2016-13 provides for the replacement of the incurred loss model for recording the allowance for loan losses with CECL. However, as a result of the Corporation’s election, its second quarter 2020 financial statements have been prepared under the existing incurred loss model. The temporary relief applicable to the Corporation’s compliance with CECL ends on the earlier of: (1) the termination date of the national emergency concerning the COVID-19 outbreak, declared by the President of the United States on March 13, 2020, under the National Emergencies Act; or (2) December 31, 2020. The Corporation has developed models that satisfy the requirements of the new standard which will be governed by a system of internal controls and a cross-functional working group consisting of accounting, finance, and credit administration personnel. The loan portfolio was pooled into ten loan segments with similar risk characteristics for which the probability of default/loss given default methodology will be applied. The Corporation intends to utilize a one-year economic forecast period then revert to historical macroeconomic levels for the remaining life of the portfolio. A baseline macroeconomic scenario, along with other scenarios, will be used to develop a range of estimated credit losses for which to determine the best estimate within. The Corporation will record a one-time cumulative-effect adjustment to retained earnings, net of income taxes, on the consolidated balance sheet as of the beginning of the adoption period. If adopted with retrospective measurement to January 1, 2020, the allowance will increase by 55 - 65 percent from December 31, 2019 because it will cover expected credit losses over the life of the loan portfolio, which approximates four years , and it includes all purchased loans that were previously excluded from the allowance for loan losses calculation. CECL also requires the establishment of a reserve for potential losses from unfunded commitments that is recorded in other liabilities, separate from allowance for credit losses, which is estimated to be approximately $18 million . FASB Accounting Standards Update No. 2019-11 - Codification Improvements to (Topic 326): Financial Instruments - Credit Losses Summary - The FASB issued ASU No. 2019-11, Codification Improvements to Topic 326, Financial Instruments - Credit Losses in order to address issues raised by stakeholders during the implementation of ASU No. 2016-13 , Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses of Financial Instruments. Among other narrow-scope improvements, the new ASU clarifies guidance around how to report expected recoveries. “Expected recoveries” describes a situation in which an organization recognizes a full or partial write-off of the amortized cost basis of a financial asset, but then later determines that the amount written off, or a portion of that amount, will in fact be recovered. While applying the credit losses standard, stakeholders questioned whether expected recoveries were permitted on assets that had already shown credit deterioration at the time of purchase (also known as PCD assets). In response to this question, the ASU permits organizations to record expected recoveries on PCD assets. In addition to other narrow technical improvements, the ASU also reinforces existing guidance that prohibits organizations from recording negative allowances for available-for-sale debt securities. The ASU includes effective dates and transition requirements that vary depending on whether or not an entity has already adopted ASU No. 2016-13. As discussed above, pursuant to the CARES Act, the Corporation elected to defer the adoption of CECL. The temporary relief applicable to the Corporation’s compliance with CECL ends on the earlier of: (1) the termination date of the national emergency concerning the COVID-19 outbreak, declared by the President of the United States on March 13, 2020, under the National Emergencies Act; or (2) December 31, 2020. FASB Accounting Standards Updates - No. 2020-04 - Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting Summary - The FASB issued ASU No. 2020-04 to provide temporary optional guidance to ease the potential burden in accounting for reference rate reform. LIBOR and other interbank offered rates are widely used benchmarks or reference rates in the United States and globally. Trillions of dollars in loans, derivatives, and other financial contracts reference LIBOR, the benchmark interest rate banks use to make short-term loans to each other. With global capital markets expected to move away from LIBOR and other interbank offered rates toward rates that are more observable or transaction based and less susceptible to manipulation, the FASB launched a broad project in late 2018 to address potential accounting challenges expected to arise from the transition. The new guidance provides optional expedients and exceptions for applying generally accepted accounting principles to contract modifications and hedging relationships, subject to meeting certain criteria, that reference LIBOR or another reference rate expected to be discontinued. The ASU is intended to help stakeholders during the global market-wide reference rate transition period. Entities may apply this ASU as of the beginning of an interim period that includes the March 12, 2020 issuance date of the ASU, through December 31, 2022. The Corporation expects to adopt the practical expedients included in the ASU prior to December 31, 2022. The Corporation is implementing a transition plan to identify and modify its loans and other financial instruments with attributes that are either directly or indirectly influenced by LIBOR. The Corporation is assessing ASU 2020-04 and its impact on the Corporation's transition away from LIBOR for its loans and other financial instruments. |
Acquisition
Acquisition | 6 Months Ended |
Jun. 30, 2020 | |
Business Combinations [Abstract] | |
Acquisition | ACQUISITION MBT Financial Corp. On September 1, 2019, the Corporation acquired 100 percent of MBT. MBT, a Michigan corporation, merged with and into the Corporation, whereupon the separate corporate existence of MBT ceased and the Corporation survived. Immediately following the merger, MBT's wholly-owned subsidiary, Monroe Bank & Trust, merged with and into the Bank, with the Bank continuing as the surviving bank. MBT was headquartered in Monroe, Michigan and had 20 banking centers serving the Monroe market. Pursuant to the merger agreement, each MBT shareholder received 0.275 shares of the Corporation's common stock for each outstanding share of MBT common stock held. The Corporation issued approximately 6.4 million shares of common stock, which was valued at approximately $229.9 million . The Corporation engaged in this transaction with the expectation that it would be accretive to income and add a new market area in Michigan that has a demographic profile consistent with many of the current Indiana and Ohio markets served by the Bank. Goodwill resulted from this transaction due to the expected synergies and economies of scale. Under the acquisition method of accounting, the total purchase price is allocated to net tangible and intangible assets based on their current estimated fair values on the date of the acquisition. Based on preliminary valuations of the fair value of tangible and intangible assets acquired and liabilities assumed, which are based on assumptions that are subject to change based on the timing of the transaction, the purchase price for the MBT acquisition is detailed in the following table. If, prior to the end of the one-year measurement period for finalizing the purchase price allocation, information becomes available about facts and circumstances that existed as of the acquisition date, which would indicate adjustments are required to the purchase price allocation, such adjustments will be included in the purchase price allocation retrospectively. Fair Value Cash and cash equivalents $ 10,222 Interest-bearing time deposits 281,228 Investment securities 212,235 Loans 732,578 Premises and equipment 21,664 Federal Home Loan Bank stock 4,148 Interest receivable 3,361 Cash surrender value of life insurance 59,545 Tax asset, deferred and receivable 5,205 Other assets 6,011 Deposits (1,105,926 ) Securities sold under repurchase agreements (94,760 ) Federal Home Loan Bank advances (10,853 ) Other liabilities (9,807 ) Net tangible assets acquired 114,851 Core deposit intangible 16,527 Goodwill 98,563 Purchase price $ 229,941 Of the total purchase price, $16,527,000 was allocated to a core deposit intangible, which will be amortized over its estimated life of 10 years . The remaining purchase price was allocated to goodwill, which is not deductible for tax purposes. Acquired loan data for MBT is included in the following table: Fair Value of Acquired Loans at Acquisition Date Gross Contractual Amounts Receivable at Acquisition Date Best Estimate at Acquisition Date of Contractual Cash Flows Not Expected to be Collected Acquired receivables subject to ASC 310-30 $ 3,531 $ 6,840 $ 2,733 Acquired receivables not subject to ASC 310-30 $ 729,047 $ 907,210 $ 14,722 Purchased loans with evidence of credit deterioration since origination and for which it is probable at the date of acquisition that the acquirer will not collect all contractually required principal and interest payments are accounted for under ASC 310-30, Loans Acquired with Deteriorated Credit Quality . The difference between contractually required payments and the cash flows expected to be collected at acquisition is referred to as the nonaccretable difference. The accretable portion of the fair value discount or premium is the difference between the expected cash flows and the net present value of expected cash flows, with such difference accreted into earnings over the term of the loans. Pro Forma Financial Information The results of operations of MBT have been included in the Corporation's consolidated financial statements since the acquisition date. The following table includes pro forma results for the year ended December 31, 2019 as if the MBT acquisition occurred as of the beginning of the period presented. 2019 Total revenue (net interest income plus other income) $ 474,891 Net income available to common shareholders $ 161,228 Earnings per share: Basic $ 2.89 Diluted $ 2.88 The pro forma information includes adjustments for interest income on loans and investments, interest expense on deposits and borrowings, premises expense for banking centers acquired and amortization of intangibles arising from the transaction and the related income tax effects. The pro forma information for the year ended December 31, 2019 includes operating revenue from MBT of $19.7 million since the date of acquisition. Additionally $19.7 million , net of tax, of non-recurring expenses directly attributable to the MBT acquisition were included in the year ended December 31, 2019 pro forma information. The pro forma information is presented for informational purposes only and is not indicative of the results of operations that actually would have been achieved had the acquisition been consummated as of that time, or intended to be a projection of future results. |
Investment Securities
Investment Securities | 6 Months Ended |
Jun. 30, 2020 | |
Investments, Debt and Equity Securities [Abstract] | |
Investment Securities | INVESTMENT SECURITIES The amortized cost, gross unrealized gains, gross unrealized losses and approximate market value of the Corporation's investment securities at the dates indicated were: Amortized Gross Gross Fair Available for sale at June 30, 2020 U.S. Treasury $ 598 $ 2 $ — $ 600 U.S. Government-sponsored agency securities 2,385 68 — 2,453 State and municipal 1,026,917 67,439 138 1,094,218 U.S. Government-sponsored mortgage-backed securities 761,391 28,870 27 790,234 Corporate obligations 3,031 57 — 3,088 Total available for sale 1,794,322 96,436 165 1,890,593 Held to maturity at June 30, 2020 U.S. Government-sponsored agency securities 10,100 3 — 10,103 State and municipal 374,214 23,779 43 397,950 U.S. Government-sponsored mortgage-backed securities 512,972 18,932 31 531,873 Foreign investment 1,500 — — 1,500 Total held to maturity 898,786 42,714 74 941,426 Total Investment Securities $ 2,693,108 $ 139,150 $ 239 $ 2,832,019 Amortized Gross Gross Fair Available for sale at December 31, 2019 U.S. Government-sponsored agency securities $ 38,529 $ 346 $ — $ 38,875 State and municipal 859,511 41,092 807 899,796 U.S. Government-sponsored mortgage-backed securities 842,349 10,378 1,404 851,323 Corporate obligations 31 — — 31 Total available for sale 1,740,420 51,816 2,211 1,790,025 Held to maturity at December 31, 2019 U.S. Government-sponsored agency securities 15,619 1 37 15,583 State and municipal 354,115 15,151 107 369,159 U.S. Government-sponsored mortgage-backed securities 434,804 6,921 401 441,324 Foreign investment 1,500 — — 1,500 Total held to maturity 806,038 22,073 545 827,566 Total Investment Securities $ 2,546,458 $ 73,889 $ 2,756 $ 2,617,591 The increase in unrealized gains from December 31, 2019 to June 30, 2020 is primarily due to interest rate declines. The longer term points on the yield curve have declined since year-end which increases the fair value of securities in the portfolio. The amortized cost and fair value of available for sale and held to maturity securities at June 30, 2020 and December 31, 2019 , by contractual maturity, are shown below. Expected maturities will differ from contractual maturities because issuers may have the right to call or prepay obligations with or without call or prepayment penalties. Available for Sale Held to Maturity Amortized Cost Fair Value Amortized Cost Fair Value Maturity Distribution at June 30,2020: Due in one year or less $ 1,947 $ 1,961 $ 12,191 $ 12,217 Due after one through five years 4,589 4,718 23,639 24,224 Due after five through ten years 49,425 52,485 95,694 101,354 Due after ten years 976,970 1,041,195 254,290 271,758 1,032,931 1,100,359 385,814 409,553 U.S. Government-sponsored mortgage-backed securities 761,391 790,234 512,972 531,873 Total Investment Securities $ 1,794,322 $ 1,890,593 $ 898,786 $ 941,426 Available for Sale Held to Maturity Amortized Cost Fair Value Amortized Cost Fair Value Maturity Distribution at December 31, 2019 Due in one year or less $ 1,134 $ 1,136 $ 9,920 $ 10,105 Due after one through five years 5,031 5,141 45,197 45,654 Due after five through ten years 74,745 76,920 84,153 88,844 Due after ten years 817,161 855,505 231,964 241,639 898,071 938,702 371,234 386,242 U.S. Government-sponsored mortgage-backed securities 842,349 851,323 434,804 441,324 Total Investment Securities $ 1,740,420 $ 1,790,025 $ 806,038 $ 827,566 The carrying value of securities pledged as collateral, to secure borrowings and for other purposes, was $1,100,278,000 at June 30, 2020 , and $503,427,000 at December 31, 2019 . In order to facilitate the funding of PPP loans, the Bank pledged securities to the Discount Window at the Federal Reserve Bank resulting in the increase in pledged securities at June 30, 2020 compared to December 31, 2019. The book value of securities sold under agreements to repurchase amounted to $171,346,000 at June 30, 2020 , and $182,856,000 at December 31, 2019 . Gross gains on the sales and redemptions of available for sale securities for the three and six months ended June 30, 2020 and 2019 are shown below. Three Months Ended Six Months Ended 2020 2019 2020 2019 Sales and Redemptions of Available for Sale Securities: Gross gains $ 3,068 $ 1,843 $ 7,680 $ 2,983 Gross losses — — — — The following tables show the Corporation’s gross unrealized losses and fair value, aggregated by investment category and length of time the individual securities have been in a continuous unrealized loss position at June 30, 2020 , and December 31, 2019 : Less than 12 Months Total Fair Gross Fair Gross Fair Gross Temporarily Impaired Available for Sale Securities at June 30, 2020 State and municipal $ 23,745 $ 138 $ — $ — $ 23,745 $ 138 U.S. Government-sponsored mortgage-backed securities 15,239 27 — — 15,239 27 Total Temporarily Impaired Available for Sale Securities 38,984 165 — — 38,984 165 Temporarily Impaired Held to Maturity Securities at June 30,2020 State and municipal 2,633 43 — — 2,633 43 U.S. Government-sponsored mortgage-backed securities 10,198 31 — — 10,198 31 Total Temporarily Impaired Held to Maturity Securities 12,831 74 — — 12,831 74 Total Temporarily Impaired Investment Securities $ 51,815 $ 239 $ — $ — $ 51,815 $ 239 Less than 12 Months Total Fair Gross Fair Gross Fair Gross Temporarily Impaired Available for Sale Securities at December 31, 2019 State and municipal $ 76,273 $ 807 $ — $ — $ 76,273 $ 807 U.S. Government-sponsored mortgage-backed securities 127,673 1,326 20,796 78 148,469 1,404 Total Temporarily Impaired Available for Sale Securities 203,946 2,133 20,796 78 224,742 2,211 Temporarily Impaired Held to Maturity Securities at December 31, 2019 U.S. Government-sponsored agency securities 3,016 4 12,467 33 15,483 37 State and municipal 22,947 107 — — 22,947 107 U.S. Government-sponsored mortgage-backed securities 124,253 364 7,991 37 132,244 401 Total Temporarily Impaired Held to Maturity Securities 150,216 475 20,458 70 170,674 545 Total Temporarily Impaired Investment Securities $ 354,162 $ 2,608 $ 41,254 $ 148 $ 395,416 $ 2,756 Certain investments in debt and equity securities are reported in the financial statements at an amount less than their historical cost as indicated in the table below. June 30, 2020 December 31, 2019 Investments reported at less than historical cost: Historical cost $ 52,054 $ 398,172 Fair value 51,815 395,416 Gross unrealized losses $ 239 $ 2,756 Percent of the Corporation's investment portfolio 1.9 % 15.2 % The Corporation's management believes the decline in fair value for these securities was temporary. Should the impairment of any of these securities become other-than-temporary, the cost basis of the investment will be reduced and the resulting loss recognized in net income during the period the other-than-temporary-impairment ("OTTI") is identified. The Corporation’s management has evaluated all securities with unrealized losses for OTTI and concluded no OTTI existed at June 30, 2020 . In determining the fair value of the investment securities portfolio, the Corporation utilizes a third party for portfolio accounting services, including market value input, for those securities classified as Level 1 and Level 2 in the fair value hierarchy. The Corporation has obtained an understanding of what inputs are being used by the vendor in pricing the portfolio and how the vendor classified these securities based upon these inputs. From these discussions, the Corporation’s management is comfortable that the classifications are proper. The Corporation has gained trust in the data for two reasons: (a) independent spot testing of the data is conducted by the Corporation through obtaining market quotes from various brokers on a periodic basis; and (b) actual gains or loss resulting from the sale of certain securities has proven the data to be accurate over time. Fair value of securities classified as Level 3 in the valuation hierarchy was determined using a discounted cash flow model that incorporated market estimates of interest rates and volatility in markets that have not been active. State and Municipal Securities The unrealized losses on the Corporation's investments in securities of state and political subdivisions were caused by interest rate changes. The contractual terms of those investments do not permit the issuer to settle the securities at a price less than the amortized cost basis of the investments. Because the Corporation does not intend to sell the investments and it is not more likely than not that the Corporation will be required to sell the investments before recovery of their amortized cost basis, which may be maturity, the Corporation does not consider those investments to be other-than-temporarily impaired at June 30, 2020 . The state and municipal securities portfolio contains unrealized losses of $138,000 on thirteen securities and $43,000 on two securities in the available for sale and held to maturity portfolios, respectively. At June 30, 2020, the Corporation had little to no exposure to municipal bonds related to entertainment receipts, student housing, parking facilities, airports, nursing homes or public transit. U.S. Government-Sponsored Mortgage-Backed Securities The unrealized losses on the Corporation's investment in mortgage-backed securities were a result of interest rate changes. The Corporation expects to recover the amortized cost basis over the term of the securities. Because the decline in market value is attributable to changes in interest rates and not credit quality, and because the Corporation does not intend to sell the investments and it is not more likely than not that the Corporation will be required to sell the investments before recovery of their amortized cost basis, which may be maturity, the Corporation does not consider those investments to be other-than-temporarily impaired at June 30, 2020 . The mortgage-backed securities portfolio contains unrealized losses of $27,000 on one security in the available for sale portfolio and $31,000 on three securities in the held to maturity portfolio. All these securities are issued by a U.S. government-sponsored entity and have an implicit or explicit government guarantee. The slowing of prepayments and the forbearance programs resulting from the financial impacts of COVID-19 could increase bond duration and potentially improve market values on these securities. |
Loans and Allowance
Loans and Allowance | 6 Months Ended |
Jun. 30, 2020 | |
Receivables [Abstract] | |
Loans and Allowance | LOANS AND ALLOWANCE Loans are stated at the amount of unpaid principal, reduced by deferred income (net of costs). Interest on loans is recognized using the simple interest method on the daily balances of the principal amounts outstanding. Loan origination fees, net of direct loan origination costs, and commitment fees are deferred and amortized as an adjustment to yield over the life of the loan, or over the commitment period, as applicable. The Corporation’s primary lending focus is small business and middle market commercial, commercial real estate and residential real estate, which results in portfolio diversification. The following tables show the composition of the loan portfolio, the allowance for loan losses and credit quality characteristics by collateral classification, excluding loans held for sale. Loans held for sale as of June 30, 2020 , and December 31, 2019 , were $901,000 and $9,037,000 , respectively. The following table illustrates the composition of the Corporation’s loan portfolio by loan class for the periods indicated: June 30, 2020 December 31, 2019 Commercial and industrial loans $ 2,898,329 $ 2,109,879 Agricultural production financing and other loans to farmers 93,838 93,861 Real estate loans: Construction 640,560 787,568 Commercial and farmland 3,239,998 3,052,698 Residential 1,145,187 1,143,217 Home equity 532,314 588,984 Individuals' loans for household and other personal expenditures 123,611 135,989 Public finance and other commercial loans 624,704 547,114 Loans 9,298,541 8,459,310 Allowance for loan losses (121,119 ) (80,284 ) Net Loans $ 9,177,422 $ 8,379,026 On March 27, 2020, the Coronavirus Aid, Relief and Economic Security Act (the “CARES Act”) was signed into law, providing an approximately $2 trillion stimulus package that includes direct payments to individual taxpayers, economic stimulus to significantly impacted industry sectors, emergency funding for hospitals and providers, small business loans, increased unemployment benefits, and a variety of tax incentives. For small businesses, eligible nonprofits and certain others, the CARES Act established a Paycheck Protection Program (“PPP”), which is administered by the Small Business Administration (“SBA”). On April 24, 2020, the Paycheck Protection Program and Health Care Enhancement Act was enacted. Among other things, this legislation amends the initial CARES Act program by raising the appropriation level for PPP loans from $349 billion to $670 billion. The PPP was further modified on June 5, 2020 with the adoption of the Paycheck Protection Program Flexibility Act (the Flexibility Act), which extended the maturity date for PPP loans from two years to five years for loans disbursed on or after the date of enactment of the Flexibility Act. For PPP loans disbursed prior to such enactment, the Flexibility Act permits the borrower and lender to mutually agree to extend the term of the loan to five years. The Bank has actively participated in assisting its customers with applications for resources through the program. PPP loans earn interest at a fixed rate of 1 percent and primarily have a two year term. The Bank anticipates that the majority of these loans will ultimately be forgiven, in whole or in part, by the SBA in accordance with the terms of the program. As of June 30, 2020, the Bank had funded over 5,000 PPP loans representing $882.9 million , which is net of deferred processing fees and costs of $24.6 million , and is primarily included in the commercial and industrial loan class. Under the terms of the PPP, the loans are fully guaranteed by the U.S. government. The Bank borrowed from the Paycheck Protection Program Liquidity Facility ("PPPL Facility") to supplement liquidity to fund the PPP loans. The outstanding balance of the PPPL Facility borrowings at June 30, 2020 was $166.9 million . Details of the borrowings from the PPPL Facility are included in the "LIQUIDITY" section of this Management's Discussion and Analysis of Financial Condition and Results of Operations on this Form 10-Q. Allowance, Credit Quality and Loan Portfolio The original implementation date of the Current Expected Credit Loss (CECL) model for calculating the Allowance for Credit Losses guided by FASB Accounting Standards Update No. 2016-13, Financial Instruments - Credit Losses (Topic 326): Measurement of Credit losses on Financial Instruments was January 1, 2020. Pursuant to the CARES Act and the related joint statement of federal banking regulators (which also became effective as of March 27, 2020), and consistent with guidance from the SEC and FASB, the Corporation elected to delay implementation of ASU No. 2016-13. As discussed below, ASU No. 2016-13, provides for the replacement of the incurred loss model for recording the allowance for loan losses with CECL. However, as a result of the Corporation’s election, its 2020 financial statements have been prepared under the existing incurred loss model. The temporary relief applicable to the Corporation’s compliance with CECL ends on the earlier of: (1) the termination date of the national emergency concerning the COVID-19 outbreak, declared by the President of the United States on March 13, 2020, under the National Emergencies Act; or (2) December 31, 2020. The Corporation maintains an allowance for loan losses to cover probable credit losses identified during its loan review process. Management believes the allowance for loan losses is adequate to cover probable losses inherent in the loan portfolio at June 30, 2020 . The process for determining the adequacy of the allowance for loan losses is critical to the Corporation’s financial results. It requires management to make difficult, subjective and complex judgments to estimate the effect of uncertain matters. The allowance for loan losses considers current factors, including economic conditions and ongoing internal and external examinations, and will increase or decrease as deemed necessary to ensure it remains adequate. In addition, the allowance as a percentage of charge-offs and nonperforming loans will change at different points in time based on credit performance, portfolio mix and collateral values. The allowance for loan losses is maintained through the provision for loan losses, which is a charge against earnings. The allowance is increased by provision expense and decreased by charge-offs less recoveries. All charge-offs are approved by the Bank's senior credit officers and in accordance with established policies. The Bank charges off a loan when a determination is made that all or a portion of the loan is uncollectable. The amount provided for loan losses in a given period may be greater than or less than net loan losses experienced during the period, and is based on management’s judgment as to the appropriate level of the allowance for loan losses. The determination of the provision amount is based on management’s ongoing review and evaluation of the loan portfolio, including an internally administered loan "watch" list and independent loan reviews. The evaluation takes into consideration identified credit problems, the possibility of losses inherent in the loan portfolio that are not specifically identified and management’s judgment as to the impact of the current environment and economic conditions on the portfolio. The allowance consists of specific impairment reserves as required by ASC 310-10-35, a component for historical losses in accordance with ASC 450 and the consideration of current environmental factors in accordance with ASC 450. A loan is deemed impaired when, based on current information or events, it is probable that all amounts due of principal and interest according to the contractual terms of the loan agreement will not be collected. The historical loss allocation for loans not deemed impaired according to ASC 450 is the product of the volume of loans within the non-impaired criticized and non-criticized risk grade classifications, each segmented by call code, and the historical loss factor for each respective classification and call code segment. The historical loss factors are based upon actual loss experience within each risk and call code classification. The historical look back period for non-criticized loans looks to the most recent rolling-four-quarter average and aligns with the look back period for non-impaired criticized loans. Each of the rolling four quarter periods used to obtain the average, include all charge-offs for the previous twelve-month period, therefore the historical look back period includes seven quarters. The resulting allocation is reflective of current conditions. Criticized loans are grouped based on the risk grade assigned to the loan. Loans with a special mention grade but not impaired are assigned a loss factor, and loans with a classified grade but not impaired are assigned a separate loss factor. The loss factor computation for this allocation includes a segmented historical loss migration analysis of risk grades to charge-off. In addition to the specific reserves and historical loss components of the allowance, consideration is given to various environmental factors to ensure that losses inherent in the portfolio are reflected in the allowance for loan losses. The environmental component adjusts the historical loss allocations for non-impaired loans to reflect relevant current conditions that, in management's opinion, have an impact on loss recognition. Environmental factors that management reviews in the analysis include: national and local economic trends and conditions; trends in growth in the loan portfolio and growth in higher risk areas; levels of, and trends in, delinquencies and non-accruals; experience and depth of lending management and staff; adequacy of, and adherence to, lending policies and procedures including those for underwriting; industry concentrations of credit; and adequacy of risk identification systems and controls through the internal loan review and internal audit processes. In conformance with ASC 805 and ASC 820, purchased loans are recorded at the acquisition date fair value. Such loans are included in the allowance to the extent a specific impairment is identified that exceeds the fair value adjustment on an impaired loan or the historical loss and environmental factor analysis indicates losses inherent in a purchased portfolio exceeds the fair value adjustment on the portion of the purchased portfolio not deemed impaired. The following tables summarize changes in the allowance for loan losses by loan segment for the three and six months ended June 30, 2020 and June 30, 2019 : Three Months Ended June 30, 2020 Commercial Commercial Consumer Residential Total Allowance for loan losses: Balances, March 31, 2020 $ 38,431 $ 37,907 $ 5,752 $ 17,364 $ 99,454 Provision for losses 6,240 8,945 2,783 3,927 21,895 Recoveries on loans 106 107 56 48 317 Loans charged off (99 ) (41 ) (146 ) (261 ) (547 ) Balances, June 30, 2020 $ 44,678 $ 46,918 $ 8,445 $ 21,078 $ 121,119 Six Months Ended June 30, 2020 Commercial Commercial Consumer Residential Total Allowance for loan losses: Balances, December 31, 2019 $ 32,902 $ 28,778 $ 4,035 $ 14,569 $ 80,284 Provision for losses 11,941 18,139 4,707 6,860 41,647 Recoveries on loans 549 225 98 118 990 Loans charged off (714 ) (224 ) (395 ) (469 ) (1,802 ) Balances, June 30, 2020 $ 44,678 $ 46,918 $ 8,445 $ 21,078 $ 121,119 Three Months Ended June 30, 2019 Commercial Commercial Consumer Residential Total Allowance for loan losses: Balances, March 31, 2019 $ 33,069 $ 29,434 $ 4,026 $ 14,373 $ 80,902 Provision for losses 100 320 36 44 500 Recoveries on loans 344 778 100 212 1,434 Loans charged off (311 ) (1,001 ) (92 ) (158 ) (1,562 ) Balances, June 30, 2019 $ 33,202 $ 29,531 $ 4,070 $ 14,471 $ 81,274 Six Months Ended June 30, 2019 Commercial Commercial Consumer Residential Total Allowance for loan losses: Balances, December 31, 2018 $ 32,657 $ 29,609 $ 3,964 $ 14,322 $ 80,552 Provision for losses 336 1,089 141 134 1,700 Recoveries on loans 886 1,023 218 312 2,439 Loans charged off (677 ) (2,190 ) (253 ) (297 ) (3,417 ) Balances, June 30, 2019 $ 33,202 $ 29,531 $ 4,070 $ 14,471 $ 81,274 The tables below show the Corporation’s allowance for loan losses and loan portfolio by loan segment as of the periods indicated. June 30, 2020 Commercial Commercial Consumer Residential Total Allowance Balances: Individually evaluated for impairment $ 7,466 $ 4,943 $ — $ 590 $ 12,999 Collectively evaluated for impairment 37,212 41,975 8,445 20,488 108,120 Total Allowance for Loan Losses $ 44,678 $ 46,918 $ 8,445 $ 21,078 $ 121,119 Loan Balances: Individually evaluated for impairment $ 15,312 $ 26,512 $ 3 $ 3,453 $ 45,280 Collectively evaluated for impairment 3,600,395 3,847,884 123,608 1,673,093 9,244,980 Loans acquired with deteriorated credit quality 1,164 6,162 — 955 8,281 Loans $ 3,616,871 $ 3,880,558 $ 123,611 $ 1,677,501 $ 9,298,541 December 31, 2019 Commercial Commercial Consumer Residential Total Allowance Balances: Individually evaluated for impairment $ — $ 231 $ — $ 458 $ 689 Collectively evaluated for impairment 32,902 28,547 4,035 14,111 79,595 Total Allowance for Loan Losses $ 32,902 $ 28,778 $ 4,035 $ 14,569 $ 80,284 Loan Balances: Individually evaluated for impairment $ 457 $ 8,728 $ 4 $ 2,520 $ 11,709 Collectively evaluated for impairment 2,748,681 3,821,660 135,985 1,727,966 8,434,292 Loans acquired with deteriorated credit quality 1,716 9,878 — 1,715 13,309 Loans $ 2,750,854 $ 3,840,266 $ 135,989 $ 1,732,201 $ 8,459,310 Loans individually evaluated for impairment are comprised of commercial and consumer loans deemed impaired in accordance with ASC 310-10. This includes loans acquired with deteriorated credit quality totaling $3,783,000 with $192,000 of related allowance for loan losses at June 30, 2020 and $2,819,000 with $124,000 related allowance for loan losses at December 31, 2019. The risk characteristics of the Corporation’s material portfolio segments are as follows: Commercial Commercial lending is primarily based on the identified cash flows of the borrower and secondarily on the underlying collateral provided by the borrower. The cash flows of borrowers, however, may not be as expected and the collateral securing these loans may fluctuate in value. Most commercial loans are secured by the tangible assets being financed such as equipment or real estate or other business assets such as accounts receivable or inventory and may incorporate a personal guarantee. Other loans may be unsecured, secured but under-collateralized or otherwise made on the basis of the enterprise value of an organization. In the case of loans secured by accounts receivable, the availability of funds for the repayment of these loans may be substantially dependent on the ability of the borrower to collect amounts due from its customers. Commercial real estate These loans are viewed primarily as cash flow loans and secondarily as loans secured by real estate. Commercial real estate lending typically involves higher loan principal amounts and the repayment of these loans is generally dependent on the successful operation of the property securing the loan or the business conducted on the property securing the loan. Commercial real estate loans may be more adversely affected by conditions in the real estate markets or in the general economy. Management monitors and evaluates commercial real estate loans based on collateral and risk grade criteria. In addition, management tracks the level of owner-occupied commercial real estate loans versus non-owner occupied loans. Consumer and Residential With respect to residential loans that are secured by 1-4 family residences and are typically owner occupied, the Corporation generally establishes a maximum loan-to-value ratio and requires private mortgage insurance if that ratio is exceeded. Home equity loans are secured by a subordinate interest in 1-4 family residences, and consumer loans are secured by consumer assets such as automobiles or recreational vehicles. Some consumer loans are unsecured such as small installment loans and certain lines of credit. Repayment of these loans is primarily dependent on the personal income and credit rating of the borrowers, which can be impacted by economic conditions in their market areas such as unemployment levels. Repayment on loans secured by 1-4 family residences can be impacted by changes in property values. Risk is mitigated by the fact that the loans are of smaller individual amounts and spread over a large number of borrowers. Loans are reclassified to a non-accruing status when, in management’s judgment, the collateral value and financial condition of the borrower do not justify accruing i n terest. When the interest accrual is discontinued, all unpaid accrued interest is reversed against earnings when considered uncollectable. Payments subsequently received on non-accrual loans are applied to principal. A loan is returned to accrual status when principal and interest are no longer past due and collectability is probable, typically after a minimum of six consecutive months of performance. Payments received on impaired accruing or delinquent loans are applied to interest income as accrued. The following table summarizes the Corporation’s non-accrual loans by loan class as of the periods indicated: June 30, 2020 December 31, 2019 Commercial and industrial loans $ 16,354 $ 1,255 Agriculture production financing and other loans to farmers — 183 Real estate loans: Construction 119 977 Commercial and farmland 25,405 7,007 Residential 5,773 5,062 Home equity 2,376 1,421 Individuals' loans for household and other personal expenditures 75 44 Total $ 50,102 $ 15,949 Non-accrual loans increased $34.2 million from December 31, 2019, primarily due to three relationships that were moved to non-accrual during the second quarter of 2020. Two relationships totaling $17.0 million are in the senior living sector. The third relationship totaling $14.4 million is in the university logo apparel sports industry. Impaired loans include loans deemed impaired according to the guidance set forth in ASC 310-10. Commercial loans under $500,000 and consumer loans, with the exception of troubled debt restructures, are not individually evaluated for impairment. Allowable methods for determining the amount of impairment include estimating fair value using the fair value of the collateral for collateral dependent loans. If the impaired loan is identified as collateral dependent, then the fair value method for measuring the amount of impairment is utilized. This method requires obtaining a current independent appraisal of the collateral and applying a discount factor, which includes selling costs if applicable, to the value. The fair value of real estate is generally based on appraisals by qualified licensed appraisers. The appraisers typically determine the value of the real estate by utilizing an income or market valuation approach. If an appraisal is not available, the fair value may be determined by using a cash flow analysis. Fair value on other collateral such as business assets is typically ascertained by assessing, either singularly or some combination of, asset appraisals, accounts receivable aging reports, inventory listings and or customer financial statements. Both appraised values and values based on borrower’s financial information are discounted as considered appropriate based on age and quality of the information and current market conditions. The following tables show the composition of the Corporation’s impaired loans, related allowance and interest income recognized while impaired by loan class as of the periods indicated: June 30, 2020 Unpaid Recorded Related Impaired loans with no related allowance: Commercial and industrial loans $ 5,024 $ 5,008 $ — Real estate Loans: Commercial and farmland 9,675 7,602 — Residential 75 59 — Individuals' loans for household and other personal expenditures 3 3 — Total $ 14,777 $ 12,672 $ — Impaired loans with related allowance: Commercial and industrial loans $ 10,342 $ 10,304 $ 7,466 Real estate Loans: Commercial and farmland 19,650 18,910 4,943 Residential 3,134 3,009 520 Home equity 401 385 70 Total $ 33,527 $ 32,608 $ 12,999 Total Impaired Loans $ 48,304 $ 45,280 $ 12,999 December 31, 2019 Unpaid Recorded Related Impaired loans with no related allowance: Commercial and industrial loans $ 320 $ 320 $ — Agriculture production financing and other loans to farmers 299 137 — Real estate Loans: Construction 1,206 970 — Commercial and farmland 8,037 5,849 — Residential 93 76 — Total $ 9,955 $ 7,352 $ — Impaired loans with related allowance: Real estate Loans: Commercial and farmland $ 2,648 $ 1,909 $ 231 Residential 2,070 2,044 383 Home equity 417 400 75 Individuals' loans for household and other personal expenditures 4 4 — Total $ 5,139 $ 4,357 $ 689 Total Impaired Loans $ 15,094 $ 11,709 $ 689 Three Months Ended June 30, 2020 Six Months Ended June 30, 2020 Average Interest Average Interest Impaired loans with no related allowance: Commercial and industrial loans $ 5,008 $ — $ 5,008 $ — Real estate Loans: Commercial and farmland 7,637 37 7,910 75 Residential 59 1 59 2 Individuals' loans for household and other personal expenditures 3 — 3 — Total $ 12,707 $ 38 $ 12,980 $ 77 Impaired loans with related allowance: Commercial and industrial loans $ 10,304 $ — $ 10,304 $ — Real estate Loans: Commercial and farmland 18,910 — 19,156 — Residential 3,020 19 3,032 38 Home equity 387 3 390 6 Total $ 32,621 $ 22 $ 32,882 $ 44 Total Impaired Loans $ 45,328 $ 60 $ 45,862 $ 121 Three Months Ended June 30, 2019 Six Months Ended June 30, 2019 Average Interest Average Interest Impaired loans with no related allowance: Commercial and industrial loans $ 1,013 $ — $ 1,021 $ — Agriculture production financing and other loans to farmers 668 — 672 — Real estate Loans: Construction 7,314 — 7,792 — Commercial and farmland 7,998 39 8,187 78 Residential 38 1 38 2 Home equity 49 — 49 — Public finance and other commercial loans 353 — 353 — Total $ 17,433 $ 40 $ 18,112 $ 80 Impaired loans with related allowance: Commercial and industrial loans $ 940 $ — $ 940 $ — Agriculture production financing and other loans to farmers 2,117 — 2,134 — Real estate Loans: Commercial and farmland 157 — 164 — Residential 2,021 16 2,029 32 Home equity 351 3 352 6 Individuals' loans for household and other personal expenditures 14 — 15 — Total $ 5,600 $ 19 $ 5,634 $ 38 Total Impaired Loans $ 23,033 $ 59 $ 23,746 $ 118 Impaired loans in the above tables do not include loans accounted for under ASC 310-30, or any other loan, unless deemed impaired in accordance with ASC 310-10. As part of the ongoing monitoring of the credit quality of the Corporation's loan portfolio, management tracks certain credit quality indicators including trends related to: (i) the level of criticized commercial loans, (ii) net charge-offs, (iii) non-performing loans, (iv) covenant failures and (v) the general national and local economic conditions. The Corporation utilizes a risk grading of pass, special mention, substandard, doubtful and loss to assess the overall credit quality of large commercial loans. All large commercial credit grades are reviewed at a minimum of once a year for pass grade loans. Loans with grades below pass are reviewed more frequently depending on the grade. A description of the general characteristics of these grades is as follows: • Pass - Loans that are considered to be of acceptable credit quality. • Special Mention - Loans which possess some credit deficiency or potential weakness, which deserves close attention. If left uncorrected, these potential weaknesses may result in deterioration of the repayment prospects for the asset or in the Corporation's credit position at some future date. Special mention assets are not adversely classified and do not expose the Corporation to sufficient risk to warrant adverse classification. The key distinctions of this category's classification are that it is indicative of an unwarranted level of risk; and weaknesses are considered “potential”, not “defined”, impairments to the primary source of repayment. Examples include businesses that may be suffering from inadequate management, loss of key personnel or significant customer or litigation. • Substandard - A substandard loan is inadequately protected by the current net worth and paying capacity of the obligor or of the collateral pledged, if any. Assets so classified have a well-defined weakness that jeopardizes the liquidation of the debt. They are characterized by the distinct possibility that the Corporation will sustain some loss if the deficiencies are not corrected. Other characteristics may include: o the likelihood that a loan will be paid from the primary source of repayment is uncertain or financial deterioration is underway and very close attention is warranted to ensure that the loan is collected without loss, o the primary source of repayment is gone, and the Corporation is forced to rely on a secondary source of repayment, such as collateral liquidation or guarantees, o loans have a distinct possibility that the Corporation will sustain some loss if deficiencies are not corrected, o unusual courses of action are needed to maintain a high probability of repayment, o the borrower is not generating enough cash flow to repay loan principal; however, it continues to make interest payments, o the Corporation is forced into a subordinated or unsecured position due to flaws in documentation, o loans have been restructured so that payment schedules, terms and collateral represent concessions to the borrower when compared to the normal loan terms, o the Corporation is seriously contemplating foreclosure or legal action due to the apparent deterioration of the loan, and o there is significant deterioration in market conditions to which the borrower is highly vulnerable. • Doubtful - Loans that have all of the weaknesses of those classified as Substandard. However, based on currently existing facts, conditions and values, these weaknesses make full collection of principal highly questionable and improbable. Other credit characteristics may include considerable doubt as to the quality of the secondary sources of repayment. The possibility of loss is high, but because of certain important pending factors that may strengthen the loan, loss classification is deferred until the exact status of repayment is known. • Loss – Loans that are considered uncollectable and of such little value that continuing to carry them as an asset is not warranted. Loans will be classified as Loss when it is neither practical not desirable to defer writing off or reserving all or a portion of a basically worthless asset, even though partial recovery may be possible at some time in the future. The following tables summarize the credit quality of the Corporation’s loan portfolio, by loan class for the periods indicated. Consumer non-performing loans include accruing consumer loans 90-days or more delinquent and consumer non-accrual loans. The entire balance of a loan is considered delinquent if the minimum payment contractually required to be made is not received by the specified date. Loans that evidenced deterioration of credit quality since origination and it was probable, at acquisition, that all contractually required payments would not be collected are included in the applicable categories below. June 30, 2020 Commercial Commercial Commercial Substandard Commercial Commercial Loss Consumer Performing Consumer Total Commercial and industrial loans $ 2,722,071 $ 87,069 $ 89,189 $ — $ — $ — $ — $ 2,898,329 Agriculture production financing and other loans to farmers 78,645 6,082 9,111 — — — — 93,838 Real estate Loans: Construction 590,889 791 20,229 — — 28,536 115 640,560 Commercial and farmland 3,035,363 103,921 99,330 — — 1,384 — 3,239,998 Residential 189,053 1,637 6,684 — — 943,222 4,591 1,145,187 Home equity 20,214 — 1,342 — — 508,457 2,301 532,314 Individuals' loans for household and other personal expenditures — — — — — 123,524 87 123,611 Public finance and other commercial loans 624,655 49 — — — — — 624,704 Loans $ 7,260,890 $ 199,549 $ 225,885 $ — $ — $ 1,605,123 $ 7,094 $ 9,298,541 December 31, 2019 Commercial Commercial Commercial Substandard Commercial Commercial Loss Consumer Performing Consumer Total Commercial and industrial loans $ 1,956,985 $ 81,179 $ 71,715 $ — $ — $ — $ — $ 2,109,879 Agriculture production financing and other loans to farmers 78,558 5,626 9,677 — — — — 93,861 Real estate Loans: Construction 749,249 1,613 1,634 — — 35,072 — 787,568 Commercial and farmland 2,894,366 57,776 98,575 — — 1,981 — 3,052,698 Residential 196,710 877 8,075 — — 932,743 4,812 1,143,217 Home equity 24,211 257 682 — — 562,507 1,327 588,984 Individuals' loans for household and other personal expenditures — — — — — 135,944 45 135,989 Public finance and other commercial loans 547,114 — — — — — — 547,114 Loans $ 6,447,193 $ 147,328 $ 190,358 $ — $ — $ 1,668,247 $ 6,184 $ 8,459,310 The tables below show a past due aging of the Corporation’s loan portfolio, by loan class, as of June 30, 2020 , and December 31, 2019 : June 30, 2020 Current 30-59 Days 60-89 Days Loans 90 Days or More Past Due And Accruing Non-Accrual Total Past Due Total Commercial and industrial loans $ 2,871,366 $ 9,435 $ 1,038 $ 136 $ 16,354 $ 26,963 $ 2,898,329 Agriculture production financing and other loans to farmers 92,735 1,103 — — — 1,103 93,838 Real estate loans: Construction 634,706 5,235 500 — 119 5,854 640,560 Commercial and farmland 3,172,688 18,948 18,458 4,499 25,405 67,310 3,239,998 Residential 1,136,131 2,679 329 275 5,773 9,056 1,145,187 Home equity 526,096 2,110 1,673 59 2,376 6,218 532,314 Individuals' loans for household and other personal expenditures 123,126 227 171 12 75 485 123,611 Public finance and other commercial loans 624,704 — — — — — 624,704 Loans $ 9,181,552 $ 39,737 $ 22,169 $ 4,981 $ 50,102 $ 116,989 $ 9,298,541 December 31, 2019 Current 30-59 Days 60-89 Days Loans 90 Days or More Past Due And Accruing Non-Accrual Total Past Due Total Commercial and industrial loans $ 2,105,445 $ 3,039 $ 136 $ 4 $ 1,255 $ 4,434 $ 2,109,879 Agriculture production financing and other loans to farmers 93,678 — — — 183 183 93,861 Real estate loans: Construction 784,961 1,630 — — 977 2,607 787,568 Commercial and farmland 3,043,318 2,324 49 — 7,007 9,380 3,052,698 Residential 1,133,476 4,290 367 22 5,062 9,741 1,143,217 Home equity 584,023 2,960 538 42 1,421 4,961 588,984 Individuals' loans for household and other personal expenditures 135,399 440 105 1 44 590 135,989 Public finance and other commercial loans 547,114 — — — — — 547,114 Loans $ 8,427,414 $ 14,683 $ 1,195 $ 69 $ 15,949 $ 31,896 $ 8,459,310 As shown in the tables above, the level of loan delinquencies increased in the 30-59, 60-89 and 90 days or more past due categories during the first six months of 2020. Four relationships totaling $28.6 million , which matured in May 2020 and were in the process of renewal at June 30, 2020, were included in the $25.1 million increase in the 30-59 days past due. Three real estate secured loans, totaling $17.8 million , accounted for 69 percent of the increase in the 60-89 days and 90 days or more past due categories. These loans were either well secured, in the process of collection, or under review for a deferral. On occasion, borrowers experience declines in income and cash flow. As a result, these borrowers seek to reduce contractual cash outlays including debt payments. Concurrently, in an effort to preserve and protect its earning assets, specifically troubled loans, the Corporation works to maintain its relationship with certain customers who are experiencing financial difficulty by contractually modifying the borrower's debt agreement with the Corporation. On March 22, 2020, a statement was issued by the Bank's banking regulators and titled the “Interagency Statement on Loan Modifications and Reporting for Financial Institutions Working with Customers Affected by the Coronavirus” (the "Interagency Statement") that encourages financial institutions to work prudently with borrowers who are or may be unable to meet their contractual payment obligations due to the effects of COVID-19. Additionally, Section 4013 of the CARES Act further provides that a qualified loan modification is exempt by law from classification as a TDR as defined by GAAP, from the period beginning March 1, 2020 until the earlier of December 31, 2020 or the date that is 60 days after the date on which the national emergency concerning the COVID-19 outbreak under the National Emergencies Act (50 U.S |
Purchased Credit Impaired Loans
Purchased Credit Impaired Loans | 6 Months Ended |
Jun. 30, 2020 | |
Receivables [Abstract] | |
Purchased Credit Impaired Loans | PURCHASED CREDIT IMPAIRED LOANS Purchased Credit Impaired Loans are included in NOTE 4. LOANS AND ALLOWANCE of these Notes to Consolidated Condensed Financial Statements. As described in NOTE 4, purchased loans are recorded at the acquisition date fair value, which could result in a fair value discount or premium. Purchased loans with evidence of credit deterioration since origination and for which it is probable at the date of acquisition that the acquirer will not collect all contractually required principal and interest payments are accounted for under ASC 310-30, Loans Acquired with Deteriorated Credit Quality . The difference between contractually required payments and the cash flows expected to be collected at acquisition is referred to as the nonaccretable difference. The accretable portion of the fair value discount or premium is the difference between the expected cash flows and the net present value of expected cash flows, with such difference accreted into earnings over the term of the loans. The carrying amount of Purchased Credit Impaired Loans as of June 30, 2020 was $12.1 million with allowance for loan loss of $192,000 . The carrying amount of Purchased Credit Impaired Loans as of December 31, 2019 was $16.1 million with $124,000 of related allowance for loan losses. As customer cash flow expectations improve, nonaccretable yield can be reclassified to accretable yield. The accretable yield, or income expected to be collected, and reclassifications from nonaccretable, are identified in the table below. Three Months Ended June 30, 2020 Six Months Ended June 30, 2020 Accretable yield beginning balance $ 1,926 $ 2,132 Additions — $ — Accretion (1,033 ) (1,418 ) Reclassification from nonaccretable 653 839 Disposals — (7 ) Accretable yield ending balance $ 1,546 $ 1,546 Three Months Ended June 30, 2019 Six Months Ended June 30, 2019 Accretable yield beginning balance $ 2,064 $ 2,143 Additions — — Accretion (638 ) (1,218 ) Reclassification from nonaccretable 488 989 Disposals — — Accretable yield ending balance $ 1,914 $ 1,914 There were no loans acquired during the six months ended June 30, 2020 and 2019, for which it was probable that all contractually required payments would not be collected. |
Goodwill
Goodwill | 6 Months Ended |
Jun. 30, 2020 | |
Goodwill and Intangible Assets Disclosure [Abstract] | |
Goodwill | GOODWILL Goodwill is recorded on the acquisition date of an entity. During the one-year measurement period, the Corporation may record subsequent adjustments to goodwill for provisional amounts recorded at the acquisition date. The MBT acquisition on September, 1, 2019 resulted in $98,563,000 of goodwill, which includes a measurement period adjustment of $719,000 . Details regarding the MBT acquisition are discussed in NOTE 2. ACQUISITION of these Notes to Consolidated Condensed Financial Statements. There have been no changes in goodwill since December 31, 2019, resulting in a goodwill balance of $543,918,000 as of June 30, 2020. 2019 Balance, January 1 $ 445,355 Goodwill acquired 97,844 Measurement period adjustment 719 Balance, December 31 $ 543,918 The Corporation adopted ASU No. 2017-04, Intangibles-Goodwill and Other (Topic 350): Simplifying the Test for Goodwill, |
Core Deposit Intangibles
Core Deposit Intangibles | 6 Months Ended |
Jun. 30, 2020 | |
Goodwill and Intangible Assets Disclosure [Abstract] | |
Core Deposit Intangibles | CORE DEPOSIT INTANGIBLES Core deposit intangibles are recorded on the acquisition date of an entity. During the one-year measurement period, the Corporation may record subsequent adjustments to these intangibles for provisional amounts recorded at the acquisition date. The MBT acquisition on September 1, 2019 resulted in a core deposit intangible of $16,527,000 . Details regarding the MBT acquisition are discussed in NOTE 2. ACQUISITION of these Notes to Consolidated Condensed Financial Statements. The carrying basis and accumulated amortization of recognized core deposit intangibles are noted below. June 30, 2020 December 31, 2019 Gross carrying amount $ 102,396 $ 85,869 Core deposit intangibles acquired — 16,527 Accumulated amortization (70,459 ) (67,434 ) Total core deposit intangibles $ 31,937 $ 34,962 The core deposit intangibles are being amortized primarily on an accelerated basis over their estimated useful lives, generally over a period of ten years . Intangible asset amortization expense for the three and six months ended June 30, 2020 was $1,511,000 and $3,025,000 , respectively, compared to $1,520,000 and $3,048,000 , respectively, for the three and six months ended June 30, 2019 . Estimated future amortization expense is summarized as follows: Amortization Expense 2020 $ 2,962 2021 5,429 2022 5,027 2023 4,827 2024 4,241 After 2024 9,451 $ 31,937 |
Derivative Financial Instrument
Derivative Financial Instruments | 6 Months Ended |
Jun. 30, 2020 | |
Derivative Instruments and Hedging Activities Disclosure [Abstract] | |
Derivative Financial Instruments | DERIVATIVE FINANCIAL INSTRUMENTS Risk Management Objective of Using Derivatives The Corporation is exposed to certain risks arising from both its business operations and economic conditions. The Corporation principally manages its exposures to a wide variety of business and operational risks through management of its core business activities. The Corporation manages economic risks, including interest rate, liquidity, and credit risk, primarily by managing the amount, sources, and duration of its assets and liabilities and through the use of derivative financial instruments. Specifically, the Corporation enters into derivative financial instruments to manage exposures that arise from business activities that result in the receipt or payment of future known and uncertain cash amounts, the value of which are determined by interest rates. The Corporation’s derivative financial instruments are used to manage differences in the amount, timing, and duration of the Corporation’s known or expected cash payments principally related to certain variable-rate liabilities. The Corporation also has derivatives that are a result of a service the Corporation provides to certain qualifying customers, and, therefore, are not used to manage interest rate risk in the Corporation’s assets or liabilities. The Corporation manages a matched book with respect to its derivative instruments offered as a part of this service to its customers in order to minimize its net risk exposure resulting from such transactions. Cash Flow Hedges of Interest Rate Risk The Corporation’s objectives in using interest rate derivatives are to add stability to interest expense and to manage its exposure to interest rate movements. To accomplish these objectives, the Corporation primarily uses interest rate swaps and interest rate caps as part of its interest rate risk management strategy. Interest rate swaps designated as cash flow hedges involve the payment of fixed amounts to a counterparty in exchange for the Corporation receiving variable payments over the life of the agreements without exchange of the underlying notional amount. Interest rate caps designated as cash flow hedges involve the receipt of variable amounts from a counterparty if interest rates rise above the strike rate on the contract in exchange for an up-front premium. As of June 30, 2020 and December 31, 2019 , the Corporation had four interest rate swaps with a notional amount of $46.0 million that were designated as cash flow hedges. The effective portion of changes in the fair value of derivatives designated and that qualify as cash flow hedges is recorded in accumulated other comprehensive income and is subsequently reclassified into earnings in the period that the hedged forecasted transaction affects earnings. During 2020 , $26.0 million of the interest rate swaps were used to hedge the variable cash outflows (LIBOR-based) associated with existing trust preferred securities when the outflows converted from a fixed rate to variable rate in September of 2012. In addition, the remaining $20.0 million of interest rate swaps were used to hedge the variable cash outflows (LIBOR-based) associated with two Federal Home Loan Bank advances. During the three and six months ended June 30, 2020 and 2019 , the Corporation did not recognize any ineffectiveness. Amounts reported in accumulated other comprehensive income related to derivatives will be reclassified to interest expense as interest payments are made on the Corporation's variable-rate liabilities. During the next twelve months, the Corporation expects to reclassify $1,046,000 from accumulated other comprehensive income to interest expense. Non-designated Hedges The Corporation does not use derivatives for trading or speculative purposes. Derivatives not designated as hedges are not speculative and result from a service the Corporation provides to certain customers. The Corporation executes interest rate swaps with commercial banking customers to facilitate their respective risk management strategies. Those interest rate swaps are simultaneously hedged by offsetting interest rate swaps that the Corporation executes with a third party, such that the Corporation minimizes its net risk exposure resulting from such transactions. As the interest rate swaps associated with this program do not meet the strict hedge accounting requirements, changes in the fair value of both the customer swaps and the offsetting swaps are recognized directly in earnings. As of June 30, 2020 and December 31, 2019 , the notional amount of customer-facing swaps was approximately $817,463,000 and $692,287,000 , respectively. These amounts are offset with third party counterparties, as described above. Fair Values of Derivative Instruments on the Balance Sheet The table below presents the fair value of the Corporation’s derivative financial instruments, as well as their classification on the Balance Sheet, as of June 30, 2020 , and December 31, 2019 . Asset Derivatives Liability Derivatives June 30, 2020 December 31, 2019 June 30, 2020 December 31, 2019 Balance Fair Balance Fair Balance Fair Balance Fair Derivatives designated as hedging instruments: Interest rate contracts Other Assets $ — Other Assets $ — Other Liabilities $ 2,547 Other Liabilities $ 1,444 Derivatives not designated as hedging instruments: Interest rate contracts Other Assets $ 84,658 Other Assets $ 27,855 Other Liabilities $ 84,658 Other Liabilities $ 27,855 The Corporation's derivative asset and derivative liability relating to interest rate contracts increased $56.8 million and $57.9 million , respectively, from December 31, 2019. The increases are primarily due to a $125.2 million increase in the related outstanding notional balance. Additionally, yield curve rates used for valuation purposes were lower at each term point as of June 30, 2020 compared to December 31, 2019. This was primarily the result of investors seeking the safety of U.S. Treasuries as containment efforts related to the COVID-19 outbreak began to significantly reduce economic activity. The amount of gain (loss) recognized in other comprehensive income is included in the table below for the periods indicated. Derivatives in Cash Flow Hedging Relationships Amount of Gain (Loss) Recognized in Other Comprehensive Income on Derivative Three Months Ended Six Months Ended June 30, 2020 June 30, 2019 June 30, 2020 June 30, 2019 Interest Rate Products $ (145 ) $ (701 ) $ (1,459 ) $ (1,092 ) Effect of Derivative Instruments on the Income Statement The Corporation did not recognize any gains or losses from derivative financial instruments in the Consolidated Condensed Statements of Income for the three and six months ended June 30, 2020 and 2019 . The amount of gain (loss) reclassified from other comprehensive income into income is included in the table below for the periods indicated. Derivatives Designated as Location of Gain (Loss) Amount of Gain (Loss) Reclassed from Other Comprehensive Income into Income (Effective Portion) Three Months Ended Three Months Ended Interest rate contracts Interest Expense $ (231 ) $ (84 ) Derivatives Designated as Location of Gain (Loss) Amount of Gain (Loss) Reclassed from Other Comprehensive Income into Income (Effective Portion) Six Months Ended Six Months Ended Interest rate contracts Interest Expense $ (357 ) $ (143 ) The Corporation’s exposure to credit risk occurs because of nonperformance by its counterparties. The counterparties approved by the Corporation are usually financial institutions, which are well capitalized and have credit ratings through Moody’s and/or Standard & Poor’s at or above investment grade. The Corporation’s control of such risk is through quarterly financial reviews, comparing mark-to-market values with policy limitations, credit ratings and collateral pledging. Credit-risk-related Contingent Features The Corporation has agreements with certain of its derivative counterparties that contain a provision where if the Corporation fails to maintain its status as a well or adequately capitalized institution, then the Corporation could be required to terminate or fully collateralize all outstanding derivative contracts. Additionally, the Corporation has agreements with certain of its derivative counterparties that contain a provision where if the Corporation defaults on any of its indebtedness, including default where repayment of the indebtedness has not been accelerated by the lender, then the Corporation could also be declared in default on its derivative obligations. As of June 30, 2020 , the termination value of derivatives in a net liability position related to these agreements was $87,754,000 . As of June 30, 2020 , the Corporation has minimum collateral posting thresholds with certain of its derivative counterparties and has posted collateral of $80,855,000 . While the Corporation did not breach any of these provisions as of June 30, 2020 , if it had, the Corporation could have been required to settle its obligations under the agreements at their termination value. |
Disclosures About Fair Value of
Disclosures About Fair Value of Assets and Liabilities | 6 Months Ended |
Jun. 30, 2020 | |
Fair Value Disclosures [Abstract] | |
Disclosures About Fair Value of Assets and Liabilities | DISCLOSURES ABOUT FAIR VALUE OF ASSETS AND LIABILITIES The Corporation used fair value measurements to record fair value adjustments to certain assets and liabilities and to determine fair value disclosures. The accounting guidance defines fair value, establishes a framework for measuring fair value and expands disclosures about fair value measurements. ASC 820 applies only when other guidance requires or permits assets or liabilities to be measured at fair value; it does not expand the use of fair value in any new circumstances. As defined in ASC 820, fair value is the price to sell an asset or transfer a liability in an orderly transaction between market participants. It represents an exit price at the measurement date. Market participants are buyers and sellers, who are independent, knowledgeable, and willing and able to transact in the principal (or most advantageous) market for the asset or liability being measured. Current market conditions, including imbalances between supply and demand, are considered in determining fair value. The Corporation values its assets and liabilities in the principal market where it sells the particular asset or transfers the liability with the greatest volume and level of activity. In the absence of a principal market, the valuation is based on the most advantageous market for the asset or liability (i.e., the market where the asset could be sold or the liability transferred at a price that maximizes the amount to be received for the asset or minimizes the amount to be paid to transfer the liability). Valuation inputs refer to the assumptions market participants would use in pricing a given asset or liability. Inputs can be observable or unobservable. Observable inputs are those assumptions which market participants would use in pricing the particular asset or liability. These inputs are based on market data and are obtained from a source independent of the Corporation. Unobservable inputs are assumptions based on the Corporation’s own information or estimate of assumptions used by market participants in pricing the asset or liability. Unobservable inputs are based on the best and most current information available on the measurement date. All inputs, whether observable or unobservable, are ranked in accordance with a prescribed fair value hierarchy which gives the highest ranking to quoted prices (unadjusted) in active markets for identical assets or liabilities (Level 1) and the lowest ranking to unobservable inputs for which there is little or no market activity (Level 3). Fair values for assets or liabilities classified as Level 2 are based on one or a combination of the following factors: (i) quoted prices for similar assets; (ii) observable inputs for the asset or liability, such as interest rates or yield curves; or (iii) inputs derived principally from or corroborated by observable market data. The level in the fair value hierarchy within which the fair value measurement in its entirety falls is determined based on the lowest level input that is significant to the fair value measurement in its entirety. The Corporation considers an input to be significant if it drives 10 percent or more of the total fair value of a particular asset or liability. RECURRING MEASUREMENTS Assets and liabilities are considered to be measured at fair value on a recurring basis if fair value is measured regularly (i.e., daily, weekly, monthly or quarterly). Recurring valuation occurs at a minimum on the measurement date. Assets and liabilities are considered to be measured at fair value on a nonrecurring basis if the fair value measurement of the instrument does not necessarily result in a change in the amount recorded on the balance sheet. Generally, nonrecurring valuation is the result of the application of other accounting pronouncements which require assets or liabilities to be assessed for impairment or recorded at the lower of cost or fair value. The fair value of assets or liabilities transferred in or out of Level 3 is measured on the transfer date, with any additional changes in fair value subsequent to the transfer considered to be realized or unrealized gains or losses. Following is a description of the valuation methodologies used for instruments measured at fair value on a recurring basis and recognized in the accompanying balance sheets, as well as the general classification of such instruments pursuant to the valuation hierarchy. Investment Securities Where quoted prices are available in an active market, securities are classified within Level 1 of the valuation hierarchy. The Corporation currently has no securities classified within Level 1 of the hierarchy. Where significant observable inputs, other than Level 1 quoted prices, are available, securities are classified within Level 2 of the valuation hierarchy. Level 2 securities include U.S. treasury securities, government-sponsored agency and mortgage-backed securities, state and municipal securities and corporate obligations securities. In certain cases where Level 1 or Level 2 inputs are not available, securities are classified within Level 3 of the hierarchy and include state and municipal securities, government-sponsored mortgage-backed securities and corporate obligations securities. Level 3 fair value for securities was determined using a discounted cash flow model that incorporated market estimates of interest rates and volatility in markets that have not been active. Third party vendors compile prices from various sources and may apply such techniques as matrix pricing to determine the value of identical or similar investment securities (Level 2). Matrix pricing is a mathematical technique widely used in the banking industry to value investment securities without relying exclusively on quoted prices for specific investment securities but rather relying on the investment securities’ relationship to other benchmark quoted investment securities. Any investment security not valued based upon the methods above are considered Level 3. Interest Rate Derivative Agreements See information regarding the Corporation’s interest rate derivative products in NOTE 8. DERIVATIVE FINANCIAL INSTRUMENTS of these Notes to Consolidated Condensed Financial Statements. The following table presents the fair value measurements of assets and liabilities recognized in the accompanying balance sheets measured at fair value on a recurring basis and the level within the ASC 820 fair value hierarchy in which the fair value measurements fall at June 30, 2020 , and December 31, 2019 . Fair Value Measurements Using: June 30, 2020 Fair Value Quoted Prices in Active Markets for Identical Assets Significant Other Significant Available for sale securities: U.S. Treasury $ 600 $ — $ 600 $ — U.S. Government-sponsored agency securities 2,453 — 2,453 — State and municipal 1,094,218 — 1,091,753 2,465 U.S. Government-sponsored mortgage-backed securities 790,234 — 790,230 4 Corporate obligations 3,088 — 3,057 31 Interest rate swap asset 84,658 — 84,658 — Interest rate swap liability 87,205 — 87,205 — Fair Value Measurements Using: December 31, 2019 Fair Value Quoted Prices in Significant Other Observable Inputs Significant Available for sale securities: U.S. Government-sponsored agency securities $ 38,875 $ — $ 38,875 $ — State and municipal 899,796 — 896,938 2,858 U.S. Government-sponsored mortgage-backed securities 851,323 — 851,319 4 Corporate obligations 31 — — 31 Interest rate swap asset 27,855 — 27,855 — Interest rate swap liability 29,299 — 29,299 — There were no gains or losses included in earnings that were attributable to the changes in unrealized gains or losses related to assets or liabilities held at June 30, 2020 or December 31, 2019 . Level 3 Reconciliation The following is a reconciliation of the beginning and ending balances of recurring fair value measurements recognized in the accompanying balance sheets using significant unobservable Level 3 inputs for the three and six months ended June 30, 2020 and 2019 . Available for Sale Securities Three Months Ended Six Months Ended June 30, 2020 June 30, 2019 June 30, 2020 June 30, 2019 Balance at beginning of the period $ 2,528 $ 2,936 $ 2,892 $ 3,328 Included in other comprehensive income (30 ) 37 (50 ) 80 Principal payments 2 2 (342 ) (433 ) Ending balance $ 2,500 $ 2,975 $ 2,500 $ 2,975 Transfers Between Levels There were no transfers in or out of Level 3 for the three and six months ended June 30, 2020 and 2019 . Nonrecurring Measurements Following is a description of valuation methodologies used for instruments measured at fair value on a non-recurring basis and recognized in the accompanying balance sheets, as well as the general classification of such instruments pursuant to the valuation hierarchy for June 30, 2020 , and December 31, 2019 . Fair Value Measurements Using June 30, 2020 Fair Value Quoted Prices in Significant Other Significant Unobservable Impaired loans (collateral dependent) $ 22,690 $ — $ — $ 22,690 Other real estate owned 464 — — 464 Fair Value Measurements Using December 31, 2019 Fair Value Quoted Prices in Significant Other Significant Unobservable Impaired loans (collateral dependent) $ 5,653 $ — $ — $ 5,653 Other real estate owned 194 — — 194 Impaired Loans (collateral dependent) Loans for which it is probable that the Corporation will not collect all principal and interest due according to contractual terms are measured for impairment. Allowable methods for determining the amount of impairment include estimating fair value of the collateral for collateral dependent loans. If the impaired loan is identified as collateral dependent, then the fair value method of measuring the amount of impairment is utilized. This method requires obtaining a current independent appraisal of the collateral and applying a discount factor to the value. A portion of the allowance for loan losses is allocated to impaired loans if the value of such loans is deemed to be less than the unpaid balance. If these allocations cause the allowance for loan losses to increase, such increase is reported as a component of the provision for loan losses. Loan losses are charged against the allowance when management believes the uncollectability of the loan is confirmed. During 2019 and 2020 , certain impaired loans were partially charged off or re-evaluated. Impaired loans that are collateral dependent are classified within Level 3 of the fair value hierarchy when impairment is determined using the fair value method. Other Real Estate Owned The fair value for impaired loans and other real estate owned is measured based on the value of the collateral securing those loans or real estate and is determined using several methods. The fair value of real estate is generally determined based on appraisals by qualified licensed appraisers. The appraisers typically determine the value of the real estate by utilizing an income or market valuation approach. If an appraisal is not available, the fair value may be determined by using a discounted cash flow analysis. Fair value on other collateral such as business assets is typically ascertained by assessing, either singularly or some combination of, asset appraisals, accounts receivable aging reports, inventory listings and or customer financial statements. Both appraised values and values based on borrower’s financial information are discounted as considered appropriate based on age and quality of the information and current market conditions. Unobservable (Level 3) Inputs The following table presents quantitative information about unobservable inputs used in recurring and nonrecurring Level 3 fair value measurements, other than goodwill, at June 30, 2020 and December 31, 2019 . June 30, 2020 Fair Value Valuation Technique Unobservable Inputs Range (Weighted-Average) State and municipal securities $ 2,465 Discounted cash flow Maturity/Call date 1 month to 15 yrs US Muni BQ curve A- to BBB- Discount rate 1.5% - 4% Weighted-average coupon 3.87 % Corporate obligations and U.S. Government-sponsored mortgage-backed securities $ 35 Discounted cash flow Risk free rate 3 month LIBOR plus premium for illiquidity plus 200bps Weighted-average coupon — % Impaired loans (collateral dependent) $ 22,690 Collateral based measurements Discount to reflect current market conditions and ultimate collectability 0% - 10% Weighted-average discount by loan balance 10 % Other real estate owned $ 464 Appraisals Discount to reflect current market conditions 0% - 72% Weighted-average discount of other real estate owned balance 32 % December 31, 2019 Fair Value Valuation Technique Unobservable Inputs Range (Weighted-Average) State and municipal securities $ 2,858 Discounted cash flow Maturity/Call date 1 month to 15 yrs US Muni BQ curve A- to BBB- Discount rate 2% - 5% Weighted-average coupon 3.92 % Corporate obligations and U.S Government-sponsored mortgage-backed securities $ 35 Discounted cash flow Risk free rate 3 month LIBOR plus premium for illiquidity plus 200bps Weighted-average coupon — % Impaired loans (collateral dependent) $ 5,653 Collateral based measurements Discount to reflect current market conditions and ultimate collectability 0% - 10% Weighted-average discount by loan balance 1 % Other real estate owned $ 194 Appraisals Discount to reflect current market conditions 0% - 37% Weighted-average discount of other real estate owned balance 37 % The following is a discussion of the sensitivity of significant unobservable inputs, the interrelationships between those inputs and other unobservable inputs used in recurring fair value measurement and how those inputs might magnify or mitigate the effect of changes in the unobservable inputs on the fair value measurement. State and Municipal Securities, Corporate Obligations and U.S. Government-sponsored Mortgage-Backed Securities The significant unobservable inputs used in the fair value measurement of the Corporation's state and municipal securities, corporate obligations and U.S. Government-sponsored mortgage-backed securities are premiums for unrated securities and marketability discounts. Significant increases or decreases in either of those inputs in isolation would result in a significantly lower or higher fair value measurement. Generally, changes in either of those inputs will not affect the other input. Fair Value of Financial Instruments The following table presents estimated fair values of the Corporation’s financial instruments and the level within the fair value hierarchy in which the fair value measurements fall at June 30, 2020 , and December 31, 2019 . June 30, 2020 Quoted Prices in Active Markets Significant Significant Unobservable Carrying Amount (Level 1) (Level 2) (Level 3) Assets: Cash and cash equivalents $ 229,759 $ 229,759 $ — $ — Interest-bearing time deposits 380,021 380,021 — — Investment securities available for sale 1,890,593 — 1,888,093 2,500 Investment securities held to maturity 898,786 — 920,146 21,280 Loans held for sale 901 — 901 — Loans 9,177,422 — — 9,253,762 Federal Home Loan Bank stock 28,736 — 28,736 — Interest rate swap asset 84,658 — 84,658 — Interest receivable 57,063 — 57,063 — Liabilities: Deposits $ 10,965,988 $ 9,566,516 $ 1,395,002 $ — Borrowings: Securities sold under repurchase agreements 181,150 — 181,150 — Federal Home Loan Bank advances 400,817 — 415,737 — Subordinated debentures and other borrowings 285,197 — 276,306 — Interest rate swap liability 87,205 — 87,205 — Interest payable 5,587 — 5,587 — December 31, 2019 Quoted Prices in Active Markets Significant Significant Unobservable Carrying Amount (Level 1) (Level 2) (Level 3) Assets: Cash and cash equivalents $ 177,201 $ 177,201 $ — $ — Interest-bearing time deposits 118,263 118,263 — — Investment securities available for sale 1,790,025 — 1,787,132 2,893 Investment securities held to maturity 806,038 — 799,884 27,682 Loans held for sale 9,037 — 9,037 — Loans 8,379,026 — — 8,335,340 Federal Home Loan Bank stock 28,736 — 28,736 — Interest rate swap asset 27,855 — 27,855 — Interest receivable 48,901 — 48,901 — Liabilities: Deposits $ 9,839,956 $ 8,146,745 $ 1,675,202 $ — Borrowings: Federal funds purchased 55,000 — 55,000 — Securities sold under repurchase agreements 187,946 — 187,801 — Federal Home Loan Bank advances 351,072 — 352,581 — Subordinated debentures and other borrowings 138,685 — 123,571 — Interest rate swap liability 29,299 — 29,299 — Interest payable 6,754 — 6,754 — |
Transfers Accounted for as Secu
Transfers Accounted for as Secured Borrowings | 6 Months Ended |
Jun. 30, 2020 | |
Transfers and Servicing [Abstract] | |
Transfers Accounted for as Secured Borrowings | TRANSFERS ACCOUNTED FOR AS SECURED BORROWINGS The collateral pledged for all repurchase agreements that are accounted for as secured borrowings as of June 30, 2020 and December 31, 2019 were: June 30, 2020 Remaining Contractual Maturity of the Agreements Overnight and Continuous Up to 30 Days 30-90 Days Greater Than 90 Days Total U.S. Government-sponsored mortgage-backed securities $ 178,749 $ 750 $ — $ 1,651 $ 181,150 December 31, 2019 Remaining Contractual Maturity of the Agreements Overnight and Continuous Up to 30 Days 30-90 Days Greater Than 90 Days Total U.S. Government-sponsored mortgage-backed securities $ 178,732 $ — $ 7,672 $ 1,542 $ 187,946 |
Accumulated Other Comprehensive
Accumulated Other Comprehensive Income (Loss) | 6 Months Ended |
Jun. 30, 2020 | |
Equity [Abstract] | |
Accumulated Other Comprehensive Income (Loss) | ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS) The following table summarizes the changes in the balances of each component of accumulated other comprehensive income (loss), net of tax, as of June 30, 2020 and 2019 : Accumulated Other Comprehensive Income (Loss) Unrealized Gains (Losses) on Securities Available for Sale Unrealized Gains (Losses) on Cash Flow Hedges Unrealized Gains (Losses) on Defined Benefit Plans Total Balance at December 31, 2019 $ 38,872 $ (1,141 ) $ (9,857 ) $ 27,874 Other comprehensive income before reclassifications 42,909 (1,153 ) — 41,756 Amounts reclassified from accumulated other comprehensive income (6,067 ) 282 — (5,785 ) Period change 36,842 (871 ) — 35,971 Balance at June 30, 2020 $ 75,714 $ (2,012 ) $ (9,857 ) $ 63,845 Balance at December 31, 2018 $ (6,343 ) $ (559 ) $ (14,520 ) $ (21,422 ) Other comprehensive income before reclassifications 39,130 (862 ) — 38,268 Amounts reclassified from accumulated other comprehensive income (2,357 ) 113 — (2,244 ) Period change 36,773 (749 ) — 36,024 Balance at June 30, 2019 $ 30,430 $ (1,308 ) $ (14,520 ) $ 14,602 The following tables present the reclassification adjustments out of accumulated other comprehensive income (loss) that were included in net income in the Consolidated Condensed Statements of Income for the three and six months ended June 30, 2020 and 2019 . Amount Reclassified from Accumulated Other Comprehensive Income (Loss) For the Three Months Ended June 30, Details about Accumulated Other Comprehensive Income (Loss) Components 2020 2019 Affected Line Item in the Statements of Income Unrealized gains (losses) on available for sale securities (1) Realized securities gains reclassified into income $ 3,068 $ 1,843 Other income - net realized gains on sales of available for sale securities Related income tax expense (644 ) (387 ) Income tax expense $ 2,424 $ 1,456 Unrealized gains (losses) on cash flow hedges (2) Interest rate contracts $ (231 ) $ (84 ) Interest expense - subordinated debentures and term loans Related income tax benefit 49 18 Income tax expense $ (182 ) $ (66 ) Total reclassifications for the period, net of tax $ 2,242 $ 1,390 Amount Reclassified from Accumulated Other Comprehensive Income (Loss) For the Six Months Ended June 30, Details about Accumulated Other Comprehensive Income (Loss) Components 2020 2019 Affected Line Item in the Statements of Income Unrealized gains (losses) on available for sale securities (1) Realized securities gains reclassified into income $ 7,680 $ 2,983 Other income - net realized gains on sales of available for sale securities Related income tax expense (1,613 ) (626 ) Income tax expense $ 6,067 $ 2,357 Unrealized gains (losses) on cash flow hedges (2) Interest rate contracts $ (357 ) $ (143 ) Interest expense - subordinated debentures and term loans Related income tax benefit 75 30 Income tax expense $ (282 ) $ (113 ) Total reclassifications for the period, net of tax $ 5,785 $ 2,244 (1) For additional detail related to unrealized gains (losses) on available for sale securities and related amounts reclassified from accumulated other comprehensive income see NOTE 3. INVESTMENT SECURITIES of these Notes to Consolidated Condensed Financial Statements. (2) For additional detail related to unrealized gains (losses) on cash flow hedges and related amounts reclassified from accumulated other comprehensive income see NOTE 8. DERIVATIVE FINANCIAL INSTRUMENTS of these Notes to Consolidated Condensed Financial Statements. |
Share-Based Compensation
Share-Based Compensation | 6 Months Ended |
Jun. 30, 2020 | |
Share-based Payment Arrangement [Abstract] | |
Share-Based Compensation | SHARE-BASED COMPENSATION Stock options and RSAs have been issued to directors, officers and other management employees under the Corporation's 2009 Long-term Equity Incentive Plan, the 2019 Long-term Equity Incentive Plan, and the Equity Compensation Plan for Non-Employee Directors. The stock options, which have a ten year life, become 100 percent vested based on time ranging from one year to two years and are fully exercisable when vested. Option exercise prices equal the Corporation's common stock closing price on NASDAQ on the date of grant. The RSAs issued to employees and non-employee directors provide for the issuance of shares of the Corporation's common stock at no cost to the holder and generally vest after 3 years . The RSAs vest only if the employee is actively employed by the Corporation on the vesting date and, therefore, any unvested shares are forfeited. For non-employee directors, the RSAs vest only if the non-employee director remains as an active board member on the vesting date and, therefore, any unvested shares are forfeited. The RSAs for employees and non-employee directors are either immediately vested at retirement, disability or death, or, continue to vest after retirement, disability or death, depending on the plan under which the shares were granted. The Corporation’s 2009 ESPP and 2019 ESPP provide eligible employees of the Corporation and its subsidiaries an opportunity to purchase shares of common stock of the Corporation through quarterly offerings financed by payroll deductions. The price of the stock to be paid by the employees shall be equal to 85 percent of the average of the closing price of the Corporation’s common stock on each trading day during the offering period. However, in no event shall such purchase price be less than the lesser of an amount equal to 85 percent of the market price of the Corporation’s stock on the offering date or an amount equal to 85 percent of the market value on the date of purchase. Common stock purchases are made quarterly and are paid through advance payroll deductions up to a calendar year maximum of $25,000 . The 2009 ESPP expired on June 30, 2019. Compensation expense related to unvested share-based awards is recorded by recognizing the unamortized grant date fair value of these awards over the remaining service periods of those awards, with no change in historical reported fair values and earnings. Awards are valued at fair value in accordance with provisions of share-based compensation guidance and are recognized on a straight-line basis over the service periods of each award. To complete the exercise of vested stock options, RSA’s and ESPP options, the Corporation generally issues new shares from its authorized but unissued share pool. Share-based compensation for the three and six months ended June 30, 2020 was $1,214,000 and $2,433,000 , respectively, compared to $844,000 and $1,825,000 , respectively, for the three and six months ended June 30, 2019 . Share-based compensation has been recognized as a component of salaries and benefits expense in the accompanying Consolidated Condensed Statements of Income. Share-based compensation expense recognized in the Consolidated Condensed Statements of Income is based on awards ultimately expected to vest and is reduced for estimated forfeitures. Share-based compensation guidance requires forfeitures to be estimated at the time of grant and revised, if necessary, in subsequent periods, if actual forfeitures differ from those estimates. Pre-vesting forfeitures were estimated to be approximately 0.4 percent for the six months ended June 30, 2020 , based on historical experience. The following table summarizes the components of the Corporation's share-based compensation awards recorded as an expense and the income tax benefit of such awards. Three Months Ended Six Months Ended 2020 2019 2020 2019 Stock and ESPP Options Pre-tax compensation expense $ 12 $ 25 $ 53 $ 36 Income tax benefit (29 ) (41 ) (29 ) (57 ) Stock and ESPP option expense, net of income taxes $ (17 ) $ (16 ) $ 24 $ (21 ) Restricted Stock Awards Pre-tax compensation expense $ 1,202 $ 819 $ 2,380 $ 1,789 Income tax benefit (236 ) (186 ) (493 ) (726 ) Restricted stock awards expense, net of income taxes $ 966 $ 633 $ 1,887 $ 1,063 Total Share-Based Compensation Pre-tax compensation expense $ 1,214 $ 844 $ 2,433 $ 1,825 Income tax benefit (265 ) (227 ) (522 ) (783 ) Total share-based compensation expense, net of income taxes $ 949 $ 617 $ 1,911 $ 1,042 As of June 30, 2020 , unrecognized compensation expense related to RSAs was $5,595,000 and is expected to be recognized over a weighted-average period of 1.21 years . The Corporation did no t have any unrecognized compensation expense related to stock options as of June 30, 2020 . Stock option activity under the Corporation's stock option plans as of June 30, 2020 and changes during the six months ended June 30, 2020 , were as follows: Number of Weighted-Average Exercise Price Weighted Average Remaining Aggregate Outstanding at January 1, 2020 59,350 $ 13.51 Exercised (10,050 ) $ 8.29 Outstanding June 30, 2020 49,300 $ 14.57 2.32 $ 640,876 Vested and Expected to Vest at June 30,2020 49,300 $ 14.57 2.32 $ 640,876 Exercisable at June 30, 2020 49,300 $ 14.57 2.32 $ 640,876 The aggregate intrinsic value in the table above represents the total pre-tax intrinsic value (the difference between the Corporation's closing stock price on the last trading day of the first six months of 2020 and the exercise price, multiplied by the number of in-the-money options) that would have been received by the option holders had all option holders exercised their stock options on June 30, 2020 . The amount of aggregate intrinsic value will change based on the fair market value of the Corporation's common stock. The aggregate intrinsic value of stock options exercised during the six months ended June 30, 2020 and 2019 was $197,000 and $308,000 , respectively. Cash receipts of stock options exercised during this same period were $83,000 and $105,000 , respectively. The following table summarizes information on unvested RSAs outstanding as of June 30, 2020 : Number of Shares Weighted-Average Unvested RSAs at January 1, 2020 351,048 $ 40.67 Granted 14,657 $ 27.00 Vested (8,591 ) $ 40.09 Forfeited (525 ) $ 40.44 Unvested RSAs at June 30, 2020 356,589 $ 40.62 The grant date fair value of ESPP options was estimated to be approximately $12,000 at the beginning of the April 1, 2020 quarterly offering period. The ESPP options vested during the three months ending June 30, 2020 , leaving no unrecognized compensation expense related to unvested ESPP options at June 30, 2020 . |
Income Tax
Income Tax | 6 Months Ended |
Jun. 30, 2020 | |
Income Tax Disclosure [Abstract] | |
Income Tax | INCOME TAX The following table summarizes the major components creating differences between income taxes at the federal statutory and the effective tax rate recorded in the consolidated statements of income for the three and six months ended June 30, 2020 and 2019 : Three Months Ended Six Months Ended 2020 2019 2020 2019 Reconciliation of Federal Statutory to Actual Tax Expense: Federal statutory income tax at 21% $ 7,899 $ 10,249 $ 15,827 $ 19,858 Tax-exempt interest income (3,199 ) (2,403 ) (6,221 ) (4,670 ) Share-based compensation (6 ) (41 ) (6 ) (391 ) Tax-exempt earnings and gains on life insurance (278 ) (199 ) (564 ) (406 ) Tax credits (89 ) (63 ) (150 ) (141 ) CARES Act - NOL carryback rate differential — — (1,178 ) — Other 296 206 405 440 Actual Tax Expense $ 4,623 $ 7,749 $ 8,113 $ 14,690 Effective Tax Rate 12.3 % 15.9 % 10.8 % 15.5 % |
Net Income Per Share
Net Income Per Share | 6 Months Ended |
Jun. 30, 2020 | |
Earnings Per Share [Abstract] | |
Net Income Per Share | NET INCOME PER SHARE Basic net income per share is computed by dividing net income by the weighted-average shares outstanding during the reporting period. Diluted net income per share is computed by dividing net income by the combination of the weighted-average shares outstanding during the reporting period and all potentially dilutive common shares. Potentially dilutive common shares include stock options and RSAs issued under the Corporation's share-based compensation plans. Potentially dilutive common shares are excluded from the computation of diluted earnings per share in the periods where the effect would be antidilutive. The following table reconciles basic and diluted net income per share for the three and six months ended June 30, 2020 and 2019 . Three Months Ended June 30, 2020 2019 Net Income Weighted-Average Shares Per Share Net Income Weighted-Average Shares Per Share Net income available to common stockholders $ 32,992 53,762,913 $ 0.62 $ 41,056 49,432,167 $ 0.83 Effect of potentially dilutive stock options and restricted stock awards 179,654 117,720 Diluted net income per share $ 32,992 53,942,567 $ 0.62 $ 41,056 49,549,887 $ 0.83 Six Months Ended June 30, 2020 2019 Net Income Weighted-Average Shares Per Share Net Income Weighted-Average Shares Per Share Net income available to common stockholders $ 67,255 54,247,493 $ 1.24 $ 79,873 49,400,770 $ 1.62 Effect of potentially dilutive stock options and restricted stock awards 182,026 144,382 Diluted net income per share $ 67,255 54,429,519 $ 1.24 $ 79,873 49,545,152 $ 1.61 For the three and six months ended June 30, 2020 and 2019 , there were no |
General Litigation and Regulato
General Litigation and Regulatory Examinations | 6 Months Ended |
Jun. 30, 2020 | |
Commitments and Contingencies Disclosure [Abstract] | |
General Litigation and Regulatory Examinations | GENERAL LITIGATION AND REGULATORY EXAMINATIONS The Corporation is subject to claims and lawsuits that arise primarily in the ordinary course of business. Additionally, the Corporation is subject to periodic examinations by various regulatory agencies. It is the general opinion of management that the disposition or ultimate resolution of such claims, lawsuits, and examinations will not have a material adverse effect on the consolidated financial position, results of operations and cash flow of the Corporation. A discussion of the Bank’s Settlement Agreement and Agreed Order with the United States Department of Justice is contained in the "REGULATORY DEVELOPMENTS" section of Part I, Item 2. Management’s Discussion & Analysis of this Quarterly Report on Form 10-Q. |
General (Policies)
General (Policies) | 6 Months Ended |
Jun. 30, 2020 | |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |
Recent Accounting Changes Adopted in 2020 and New Accounting Pronouncements Not Yet Adopted | Recent Accounting Changes Adopted in 2020 FASB Accounting Standards Updates No. 2018-15 - Intangibles - Goodwill and Other - Internal-Use Software (Subtopic 350-40): Customer's Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That Is a Service Contract Summary - The FASB issued Accounting Standards Update (ASU) No. 2018-15, Intangibles-Goodwill and Other-Internal-Use Software (Subtopic 350-40): Customer’s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That Is a Service Contract, which reduces complexity for the accounting for costs of implementing a cloud computing service arrangement. This standard aligns the accounting for implementation costs of hosting arrangements, regardless of whether they convey a license to the hosted software. The ASU aligns the following requirements for capitalizing implementation costs: • Those incurred in a hosting arrangement that is a service contract, and • Those incurred to develop or obtain internal-use software (and hosting arrangements that include an internal-use software license). For calendar-year public companies, the changes were effective for fiscal years ending after December 15, 2019. The Corporation adopted the standard in the first quarter of 2020 and adoption of the standard did not have a significant effect on the Corporation’s consolidated financial statements. FASB Accounting Standards Updates No. 2018-14 - Compensation - Retirement Benefits - Defined Benefit Plans - General (Subtopic 715-20): Disclosure Framework - Changes to the Disclosure Requirements for Defined Benefit Plans Summary - The FASB issued ASU No. 2018-14, Compensation - Retirement Benefits - Defined Benefit Plans - General (Subtopic 715-20): Disclosure Framework - Changes to the Disclosure Requirements for Defined Benefit Plans, that applies to all employers that sponsor defined benefit pension or other postretirement plans. The amendments modify the disclosure requirements for employers that sponsor defined benefit pension or other postretirement plans. Disclosure Requirements Deleted • The amounts in accumulated other comprehensive income expected to be recognized as components of net periodic benefit cost over the next fiscal year. • The amount and timing of plan assets expected to be returned to the employer. • Related party disclosures about the amount of future annual benefits covered by insurance and annuity contracts and significant transactions between the employer or related parties and the plan. • For public entities, the effects of a one-percentage-point change in assumed health care cost trend rates on the (a) aggregate of the service and interest cost components of net periodic benefit costs and (b) benefit obligation for postretirement health care benefits. Disclosure Requirements Added • An explanation of the reasons for significant gains and losses related to changes in the benefit obligation for the period. The amendments also clarify the disclosure requirements in paragraph 715-20-50-3, which state that the following information for defined benefit pension plans should be disclosed: • The projected benefit obligation (PBO) and fair value of plan assets for plans with PBOs in excess of plan assets, and • The accumulated benefit obligation (ABO) and fair value of plan assets for plans with ABOs in excess of plan assets. ASU No. 2018-14 is effective for fiscal years ending after December 15, 2020, for public business entities and for fiscal years ending after December 15, 2021, for all other entities. Early adoption is permitted for all entities. The Corporation adopted the standard in the first quarter of 2020 and adoption of the standard did not have a significant effect on the Corporation’s disclosures. FASB Accounting Standards Updates No. 2018-13 - Fair Value Measurement (Topic 820): Disclosure Framework - Changes to the Disclosure Requirements for Fair Value Measurement Summary - The FASB issued ASU No. 2018-13, Fair Value Measurement (Topic 820): Disclosure Framework - Changes to the Disclosure Requirements for Fair Value Measurement. ASU No. 2018-13 modifies the disclosure requirements on fair value measurements in Topic 820. Certain disclosure requirements related to transfers between Level 1 and Level 2 of the fair value hierarchy and Level 3 valuation process were removed from Topic 820. Disclosures were also added to Topic 820 for changes in unrealized gains and losses for the period included in other comprehensive income for recurring Level 3 fair value measurements held at the end of the reporting period and the range and weighted average of significant unobservable inputs used to develop Level 3 fair value measurements. In addition, the amendments eliminate "at a minimum" from the phrase “an entity shall disclose at a minimum” to promote the appropriate exercise of discretion by entities when considering fair value measurement disclosures and to clarify that materiality is an appropriate consideration of entities and their auditors when evaluating disclosure requirements. The amendments in ASU No. 2018-13 were effective for all entities for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2019. The amendments on changes in unrealized gains and losses, the range and weighted average of significant unobservable inputs used to develop Level 3 fair value measurements, and the narrative description of measurement uncertainty were applied prospectively for only the most recent interim or annual period presented in the initial fiscal year of adoption. All other amendments were applied retrospectively to all periods presented upon their effective date. Early adoption was permitted. An entity was permitted to early adopt any removed or modified disclosures upon issuance of ASU No. 2018-13 and delay adoption of the additional disclosures until their effective date. The Corporation adopted the standard in the first quarter of 2020 and adoption of the standard did not have a significant effect on the Corporation’s disclosures. FASB Accounting Standards Updates No. 2017-04 - Intangibles - Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment. Summary - The FASB issued ASU No. 2017-04, Intangibles-Goodwill and Other (Topic 350): Simplifying the Test for Goodwill, which simplifies how an entity is required to test goodwill for impairment. To simplify the subsequent measurement of goodwill, the ASU eliminates Step 2 from the goodwill impairment test. The annual, or interim, goodwill impairment test is performed by comparing the fair value of a reporting unit with its carrying amount. An impairment charge should be recognized for the amount by which the carrying amount exceeds the reporting unit's fair value; however, the loss recognized should not exceed the total amount of goodwill allocated to that reporting unit. In addition, the income tax effects of tax deductible goodwill on the carrying amount of the reporting unit should be considered when measuring the goodwill impairment loss, if applicable. The amendments also eliminate the requirements for any reporting unit with a zero or negative carrying amount to perform Step 2 of the goodwill impairment test. An entity still has the option to perform the qualitative assessment for a reporting unit to determine if the qualitative impairment test is necessary. The amendments were applied on a prospective basis. The Corporation adopted ASU No. 2017-04, Intangibles-Goodwill and Other (Topic 350): Simplifying the Test for Goodwill, January 1, 2020 and assessed the recent economic impact and market conditions from the COVID-19 pandemic. Based upon factors considered in the assessment and the general uncertainty as to the full extent of the COVID-19 pandemic and its effect on economic recovery, the Corporation has determined that it is not more likely than not that the fair value of the Corporation is less than the carrying value. Therefore, the Corporation concluded goodwill was not impaired at June 30, 2020, the details of which are included in NOTE 6. GOODWILL of these Notes to Consolidated Condensed Financial Statements. Guidance on Non-TDR Loan Modifications due to COVID-19 On March 22, 2020, a statement was issued by the Bank's banking regulators and titled the “Interagency Statement on Loan Modifications and Reporting for Financial Institutions Working with Customers Affected by the Coronavirus” (the "Interagency Statement") that encourages financial institutions to work prudently with borrowers who are or may be unable to meet their contractual payment obligations due to the effects of COVID-19. Additionally, Section 4013 of the CARES Act further provides that a qualified loan modification is exempt by law from classification as a TDR as defined by GAAP, from the period beginning March 1, 2020 until the earlier of December 31, 2020 or the date that is 60 days after the date on which the national emergency concerning the COVID-19 outbreak under the National Emergencies Act (50 U.S.C. 1601 et seq.) terminates. The Interagency Statement was subsequently revised on April 7, 2020 to clarify the interaction of the original guidance with Section 4013 of the CARES Act, as well as setting forth the banking regulators’ views on consumer protection considerations. In accordance with such guidance, the Bank is offering short-term modifications made in response to COVID-19 to borrowers who are current and otherwise not past due. These include short-term, 180 days or less, modifications in the form of payment deferrals, fee waivers, extensions of repayment terms, or other delays in payment that are insignificant. During the six months ended June 30, 2020, modifications were completed on loans having a total aggregate balance of approximately $1.1 billion , or 12.1 percent of the loan portfolio. Details of the modifications are included in NOTE 4. LOANS AND ALLOWANCE of these Notes to Consolidated Condensed Financial Statements. New Accounting Pronouncements Not Yet Adopted The Corporation continually monitors potential accounting changes and pronouncements. The following pronouncements have been deemed to have the most applicability to the Corporation's financial statements: FASB Accounting Standards Update No. 2016-13, Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments Summary - The FASB issued Accounting Standards Update (ASU) No. 2016-13, Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments . This new guidance was issued to address concerns that current generally accepted accounting principles (GAAP) restricts the ability to record credit losses that are expected, but do not yet meet the “probable” threshold by replacing the current “incurred loss” model for recognizing credit losses with an “expected life of loan loss” model referred to as the Current Expected Credit Loss (CECL) model. Under the CECL model, certain financial assets carried at amortized cost, such as loans held for investment and held-to-maturity debt securities, are required to be presented at the net amount expected to be collected. The measurement of expected credit losses is to be based on information about past events, including historical experience, current conditions, and reasonable and supportable forecasts that affect the collectability of the reported amount. This measurement will take place at the time the financial asset is first added to the balance sheet and periodically thereafter. This differs significantly from the “incurred loss” model required under current GAAP, which delays recognition until it is probable a loss has been incurred. The change could materially affect how the allowance for loan losses is determined and cause a charge/credit to earnings through the provision for loan losses. Such could create volatility in earnings and could adversely affect the financial condition of the Corporation. The ASU is effective for SEC filers for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2019. Pursuant to the CARES Act and the related joint statement of federal banking regulators (which also became effective as of March 27, 2020), and consistent with guidance from the SEC and FASB, the Corporation has elected to delay implementation of ASU No. 2016-13, which would have become effective for the Corporation as of January 1, 2020. As discussed above, ASU No. 2016-13 provides for the replacement of the incurred loss model for recording the allowance for loan losses with CECL. However, as a result of the Corporation’s election, its second quarter 2020 financial statements have been prepared under the existing incurred loss model. The temporary relief applicable to the Corporation’s compliance with CECL ends on the earlier of: (1) the termination date of the national emergency concerning the COVID-19 outbreak, declared by the President of the United States on March 13, 2020, under the National Emergencies Act; or (2) December 31, 2020. The Corporation has developed models that satisfy the requirements of the new standard which will be governed by a system of internal controls and a cross-functional working group consisting of accounting, finance, and credit administration personnel. The loan portfolio was pooled into ten loan segments with similar risk characteristics for which the probability of default/loss given default methodology will be applied. The Corporation intends to utilize a one-year economic forecast period then revert to historical macroeconomic levels for the remaining life of the portfolio. A baseline macroeconomic scenario, along with other scenarios, will be used to develop a range of estimated credit losses for which to determine the best estimate within. The Corporation will record a one-time cumulative-effect adjustment to retained earnings, net of income taxes, on the consolidated balance sheet as of the beginning of the adoption period. If adopted with retrospective measurement to January 1, 2020, the allowance will increase by 55 - 65 percent from December 31, 2019 because it will cover expected credit losses over the life of the loan portfolio, which approximates four years , and it includes all purchased loans that were previously excluded from the allowance for loan losses calculation. CECL also requires the establishment of a reserve for potential losses from unfunded commitments that is recorded in other liabilities, separate from allowance for credit losses, which is estimated to be approximately $18 million . FASB Accounting Standards Update No. 2019-11 - Codification Improvements to (Topic 326): Financial Instruments - Credit Losses Summary - The FASB issued ASU No. 2019-11, Codification Improvements to Topic 326, Financial Instruments - Credit Losses in order to address issues raised by stakeholders during the implementation of ASU No. 2016-13 , Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses of Financial Instruments. Among other narrow-scope improvements, the new ASU clarifies guidance around how to report expected recoveries. “Expected recoveries” describes a situation in which an organization recognizes a full or partial write-off of the amortized cost basis of a financial asset, but then later determines that the amount written off, or a portion of that amount, will in fact be recovered. While applying the credit losses standard, stakeholders questioned whether expected recoveries were permitted on assets that had already shown credit deterioration at the time of purchase (also known as PCD assets). In response to this question, the ASU permits organizations to record expected recoveries on PCD assets. In addition to other narrow technical improvements, the ASU also reinforces existing guidance that prohibits organizations from recording negative allowances for available-for-sale debt securities. The ASU includes effective dates and transition requirements that vary depending on whether or not an entity has already adopted ASU No. 2016-13. As discussed above, pursuant to the CARES Act, the Corporation elected to defer the adoption of CECL. The temporary relief applicable to the Corporation’s compliance with CECL ends on the earlier of: (1) the termination date of the national emergency concerning the COVID-19 outbreak, declared by the President of the United States on March 13, 2020, under the National Emergencies Act; or (2) December 31, 2020. FASB Accounting Standards Updates - No. 2020-04 - Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting Summary - The FASB issued ASU No. 2020-04 to provide temporary optional guidance to ease the potential burden in accounting for reference rate reform. LIBOR and other interbank offered rates are widely used benchmarks or reference rates in the United States and globally. Trillions of dollars in loans, derivatives, and other financial contracts reference LIBOR, the benchmark interest rate banks use to make short-term loans to each other. With global capital markets expected to move away from LIBOR and other interbank offered rates toward rates that are more observable or transaction based and less susceptible to manipulation, the FASB launched a broad project in late 2018 to address potential accounting challenges expected to arise from the transition. The new guidance provides optional expedients and exceptions for applying generally accepted accounting principles to contract modifications and hedging relationships, subject to meeting certain criteria, that reference LIBOR or another reference rate expected to be discontinued. The ASU is intended to help stakeholders during the global market-wide reference rate transition period. Entities may apply this ASU as of the beginning of an interim period that includes the March 12, 2020 issuance date of the ASU, through December 31, 2022. The Corporation expects to adopt the practical expedients included in the ASU prior to December 31, 2022. The Corporation is implementing a transition plan to identify and modify its loans and other financial instruments with attributes that are either directly or indirectly influenced by LIBOR. The Corporation is assessing ASU 2020-04 and its impact on the Corporation's transition away from LIBOR for its loans and other financial instruments. |
Acquisition (Tables)
Acquisition (Tables) | 6 Months Ended |
Jun. 30, 2020 | |
Business Combinations [Abstract] | |
Schedule of preliminary valuations of the fair value of assets acquired and liabilities assumed | Based on preliminary valuations of the fair value of tangible and intangible assets acquired and liabilities assumed, which are based on assumptions that are subject to change based on the timing of the transaction, the purchase price for the MBT acquisition is detailed in the following table. If, prior to the end of the one-year measurement period for finalizing the purchase price allocation, information becomes available about facts and circumstances that existed as of the acquisition date, which would indicate adjustments are required to the purchase price allocation, such adjustments will be included in the purchase price allocation retrospectively. Fair Value Cash and cash equivalents $ 10,222 Interest-bearing time deposits 281,228 Investment securities 212,235 Loans 732,578 Premises and equipment 21,664 Federal Home Loan Bank stock 4,148 Interest receivable 3,361 Cash surrender value of life insurance 59,545 Tax asset, deferred and receivable 5,205 Other assets 6,011 Deposits (1,105,926 ) Securities sold under repurchase agreements (94,760 ) Federal Home Loan Bank advances (10,853 ) Other liabilities (9,807 ) Net tangible assets acquired 114,851 Core deposit intangible 16,527 Goodwill 98,563 Purchase price $ 229,941 |
Schedule of acquired loan data | Acquired loan data for MBT is included in the following table: Fair Value of Acquired Loans at Acquisition Date Gross Contractual Amounts Receivable at Acquisition Date Best Estimate at Acquisition Date of Contractual Cash Flows Not Expected to be Collected Acquired receivables subject to ASC 310-30 $ 3,531 $ 6,840 $ 2,733 Acquired receivables not subject to ASC 310-30 $ 729,047 $ 907,210 $ 14,722 |
Schedule of pro forma financial information | The results of operations of MBT have been included in the Corporation's consolidated financial statements since the acquisition date. The following table includes pro forma results for the year ended December 31, 2019 as if the MBT acquisition occurred as of the beginning of the period presented. 2019 Total revenue (net interest income plus other income) $ 474,891 Net income available to common shareholders $ 161,228 Earnings per share: Basic $ 2.89 Diluted $ 2.88 |
Investment Securities (Tables)
Investment Securities (Tables) | 6 Months Ended |
Jun. 30, 2020 | |
Investments, Debt and Equity Securities [Abstract] | |
Schedule of amortized cost, gross unrealized gains, gross unrealized losses and approximate fair value of investment securities | The amortized cost, gross unrealized gains, gross unrealized losses and approximate market value of the Corporation's investment securities at the dates indicated were: Amortized Gross Gross Fair Available for sale at June 30, 2020 U.S. Treasury $ 598 $ 2 $ — $ 600 U.S. Government-sponsored agency securities 2,385 68 — 2,453 State and municipal 1,026,917 67,439 138 1,094,218 U.S. Government-sponsored mortgage-backed securities 761,391 28,870 27 790,234 Corporate obligations 3,031 57 — 3,088 Total available for sale 1,794,322 96,436 165 1,890,593 Held to maturity at June 30, 2020 U.S. Government-sponsored agency securities 10,100 3 — 10,103 State and municipal 374,214 23,779 43 397,950 U.S. Government-sponsored mortgage-backed securities 512,972 18,932 31 531,873 Foreign investment 1,500 — — 1,500 Total held to maturity 898,786 42,714 74 941,426 Total Investment Securities $ 2,693,108 $ 139,150 $ 239 $ 2,832,019 Amortized Gross Gross Fair Available for sale at December 31, 2019 U.S. Government-sponsored agency securities $ 38,529 $ 346 $ — $ 38,875 State and municipal 859,511 41,092 807 899,796 U.S. Government-sponsored mortgage-backed securities 842,349 10,378 1,404 851,323 Corporate obligations 31 — — 31 Total available for sale 1,740,420 51,816 2,211 1,790,025 Held to maturity at December 31, 2019 U.S. Government-sponsored agency securities 15,619 1 37 15,583 State and municipal 354,115 15,151 107 369,159 U.S. Government-sponsored mortgage-backed securities 434,804 6,921 401 441,324 Foreign investment 1,500 — — 1,500 Total held to maturity 806,038 22,073 545 827,566 Total Investment Securities $ 2,546,458 $ 73,889 $ 2,756 $ 2,617,591 |
Schedule of amortized cost and fair value of available for sale securities and held to maturity securities | The amortized cost and fair value of available for sale and held to maturity securities at June 30, 2020 and December 31, 2019 , by contractual maturity, are shown below. Expected maturities will differ from contractual maturities because issuers may have the right to call or prepay obligations with or without call or prepayment penalties. Available for Sale Held to Maturity Amortized Cost Fair Value Amortized Cost Fair Value Maturity Distribution at June 30,2020: Due in one year or less $ 1,947 $ 1,961 $ 12,191 $ 12,217 Due after one through five years 4,589 4,718 23,639 24,224 Due after five through ten years 49,425 52,485 95,694 101,354 Due after ten years 976,970 1,041,195 254,290 271,758 1,032,931 1,100,359 385,814 409,553 U.S. Government-sponsored mortgage-backed securities 761,391 790,234 512,972 531,873 Total Investment Securities $ 1,794,322 $ 1,890,593 $ 898,786 $ 941,426 Available for Sale Held to Maturity Amortized Cost Fair Value Amortized Cost Fair Value Maturity Distribution at December 31, 2019 Due in one year or less $ 1,134 $ 1,136 $ 9,920 $ 10,105 Due after one through five years 5,031 5,141 45,197 45,654 Due after five through ten years 74,745 76,920 84,153 88,844 Due after ten years 817,161 855,505 231,964 241,639 898,071 938,702 371,234 386,242 U.S. Government-sponsored mortgage-backed securities 842,349 851,323 434,804 441,324 Total Investment Securities $ 1,740,420 $ 1,790,025 $ 806,038 $ 827,566 |
Schedule of gross gains on sales and redemptions of available for sale securities | Gross gains on the sales and redemptions of available for sale securities for the three and six months ended June 30, 2020 and 2019 are shown below. Three Months Ended Six Months Ended 2020 2019 2020 2019 Sales and Redemptions of Available for Sale Securities: Gross gains $ 3,068 $ 1,843 $ 7,680 $ 2,983 Gross losses — — — — |
Schedule of investment securities with unrealized losses, aggregated by investment category and length of time that individual securities have been in a continuous unrealized loss position | The following tables show the Corporation’s gross unrealized losses and fair value, aggregated by investment category and length of time the individual securities have been in a continuous unrealized loss position at June 30, 2020 , and December 31, 2019 : Less than 12 Months Total Fair Gross Fair Gross Fair Gross Temporarily Impaired Available for Sale Securities at June 30, 2020 State and municipal $ 23,745 $ 138 $ — $ — $ 23,745 $ 138 U.S. Government-sponsored mortgage-backed securities 15,239 27 — — 15,239 27 Total Temporarily Impaired Available for Sale Securities 38,984 165 — — 38,984 165 Temporarily Impaired Held to Maturity Securities at June 30,2020 State and municipal 2,633 43 — — 2,633 43 U.S. Government-sponsored mortgage-backed securities 10,198 31 — — 10,198 31 Total Temporarily Impaired Held to Maturity Securities 12,831 74 — — 12,831 74 Total Temporarily Impaired Investment Securities $ 51,815 $ 239 $ — $ — $ 51,815 $ 239 Less than 12 Months Total Fair Gross Fair Gross Fair Gross Temporarily Impaired Available for Sale Securities at December 31, 2019 State and municipal $ 76,273 $ 807 $ — $ — $ 76,273 $ 807 U.S. Government-sponsored mortgage-backed securities 127,673 1,326 20,796 78 148,469 1,404 Total Temporarily Impaired Available for Sale Securities 203,946 2,133 20,796 78 224,742 2,211 Temporarily Impaired Held to Maturity Securities at December 31, 2019 U.S. Government-sponsored agency securities 3,016 4 12,467 33 15,483 37 State and municipal 22,947 107 — — 22,947 107 U.S. Government-sponsored mortgage-backed securities 124,253 364 7,991 37 132,244 401 Total Temporarily Impaired Held to Maturity Securities 150,216 475 20,458 70 170,674 545 Total Temporarily Impaired Investment Securities $ 354,162 $ 2,608 $ 41,254 $ 148 $ 395,416 $ 2,756 |
Schedule of investments in debt and equity securities reported in the financial statements at an amount less than their historical cost | Certain investments in debt and equity securities are reported in the financial statements at an amount less than their historical cost as indicated in the table below. June 30, 2020 December 31, 2019 Investments reported at less than historical cost: Historical cost $ 52,054 $ 398,172 Fair value 51,815 395,416 Gross unrealized losses $ 239 $ 2,756 Percent of the Corporation's investment portfolio 1.9 % 15.2 % |
Loans and Allowance (Tables)
Loans and Allowance (Tables) | 6 Months Ended |
Jun. 30, 2020 | |
Receivables [Abstract] | |
Schedule of composition of loan portfolio by loan class | The following table illustrates the composition of the Corporation’s loan portfolio by loan class for the periods indicated: June 30, 2020 December 31, 2019 Commercial and industrial loans $ 2,898,329 $ 2,109,879 Agricultural production financing and other loans to farmers 93,838 93,861 Real estate loans: Construction 640,560 787,568 Commercial and farmland 3,239,998 3,052,698 Residential 1,145,187 1,143,217 Home equity 532,314 588,984 Individuals' loans for household and other personal expenditures 123,611 135,989 Public finance and other commercial loans 624,704 547,114 Loans 9,298,541 8,459,310 Allowance for loan losses (121,119 ) (80,284 ) Net Loans $ 9,177,422 $ 8,379,026 |
Schedule of changes in allowance for loan losses | The following tables summarize changes in the allowance for loan losses by loan segment for the three and six months ended June 30, 2020 and June 30, 2019 : Three Months Ended June 30, 2020 Commercial Commercial Consumer Residential Total Allowance for loan losses: Balances, March 31, 2020 $ 38,431 $ 37,907 $ 5,752 $ 17,364 $ 99,454 Provision for losses 6,240 8,945 2,783 3,927 21,895 Recoveries on loans 106 107 56 48 317 Loans charged off (99 ) (41 ) (146 ) (261 ) (547 ) Balances, June 30, 2020 $ 44,678 $ 46,918 $ 8,445 $ 21,078 $ 121,119 Six Months Ended June 30, 2020 Commercial Commercial Consumer Residential Total Allowance for loan losses: Balances, December 31, 2019 $ 32,902 $ 28,778 $ 4,035 $ 14,569 $ 80,284 Provision for losses 11,941 18,139 4,707 6,860 41,647 Recoveries on loans 549 225 98 118 990 Loans charged off (714 ) (224 ) (395 ) (469 ) (1,802 ) Balances, June 30, 2020 $ 44,678 $ 46,918 $ 8,445 $ 21,078 $ 121,119 Three Months Ended June 30, 2019 Commercial Commercial Consumer Residential Total Allowance for loan losses: Balances, March 31, 2019 $ 33,069 $ 29,434 $ 4,026 $ 14,373 $ 80,902 Provision for losses 100 320 36 44 500 Recoveries on loans 344 778 100 212 1,434 Loans charged off (311 ) (1,001 ) (92 ) (158 ) (1,562 ) Balances, June 30, 2019 $ 33,202 $ 29,531 $ 4,070 $ 14,471 $ 81,274 Six Months Ended June 30, 2019 Commercial Commercial Consumer Residential Total Allowance for loan losses: Balances, December 31, 2018 $ 32,657 $ 29,609 $ 3,964 $ 14,322 $ 80,552 Provision for losses 336 1,089 141 134 1,700 Recoveries on loans 886 1,023 218 312 2,439 Loans charged off (677 ) (2,190 ) (253 ) (297 ) (3,417 ) Balances, June 30, 2019 $ 33,202 $ 29,531 $ 4,070 $ 14,471 $ 81,274 |
Schedule of allowance for credit losses and loan portfolio by loan segment | The tables below show the Corporation’s allowance for loan losses and loan portfolio by loan segment as of the periods indicated. June 30, 2020 Commercial Commercial Consumer Residential Total Allowance Balances: Individually evaluated for impairment $ 7,466 $ 4,943 $ — $ 590 $ 12,999 Collectively evaluated for impairment 37,212 41,975 8,445 20,488 108,120 Total Allowance for Loan Losses $ 44,678 $ 46,918 $ 8,445 $ 21,078 $ 121,119 Loan Balances: Individually evaluated for impairment $ 15,312 $ 26,512 $ 3 $ 3,453 $ 45,280 Collectively evaluated for impairment 3,600,395 3,847,884 123,608 1,673,093 9,244,980 Loans acquired with deteriorated credit quality 1,164 6,162 — 955 8,281 Loans $ 3,616,871 $ 3,880,558 $ 123,611 $ 1,677,501 $ 9,298,541 December 31, 2019 Commercial Commercial Consumer Residential Total Allowance Balances: Individually evaluated for impairment $ — $ 231 $ — $ 458 $ 689 Collectively evaluated for impairment 32,902 28,547 4,035 14,111 79,595 Total Allowance for Loan Losses $ 32,902 $ 28,778 $ 4,035 $ 14,569 $ 80,284 Loan Balances: Individually evaluated for impairment $ 457 $ 8,728 $ 4 $ 2,520 $ 11,709 Collectively evaluated for impairment 2,748,681 3,821,660 135,985 1,727,966 8,434,292 Loans acquired with deteriorated credit quality 1,716 9,878 — 1,715 13,309 Loans $ 2,750,854 $ 3,840,266 $ 135,989 $ 1,732,201 $ 8,459,310 |
Schedule of non-accrual loans by loan class | The following table summarizes the Corporation’s non-accrual loans by loan class as of the periods indicated: June 30, 2020 December 31, 2019 Commercial and industrial loans $ 16,354 $ 1,255 Agriculture production financing and other loans to farmers — 183 Real estate loans: Construction 119 977 Commercial and farmland 25,405 7,007 Residential 5,773 5,062 Home equity 2,376 1,421 Individuals' loans for household and other personal expenditures 75 44 Total $ 50,102 $ 15,949 |
Schedule of composition of impaired loans by loan class | The following tables show the composition of the Corporation’s impaired loans, related allowance and interest income recognized while impaired by loan class as of the periods indicated: June 30, 2020 Unpaid Recorded Related Impaired loans with no related allowance: Commercial and industrial loans $ 5,024 $ 5,008 $ — Real estate Loans: Commercial and farmland 9,675 7,602 — Residential 75 59 — Individuals' loans for household and other personal expenditures 3 3 — Total $ 14,777 $ 12,672 $ — Impaired loans with related allowance: Commercial and industrial loans $ 10,342 $ 10,304 $ 7,466 Real estate Loans: Commercial and farmland 19,650 18,910 4,943 Residential 3,134 3,009 520 Home equity 401 385 70 Total $ 33,527 $ 32,608 $ 12,999 Total Impaired Loans $ 48,304 $ 45,280 $ 12,999 December 31, 2019 Unpaid Recorded Related Impaired loans with no related allowance: Commercial and industrial loans $ 320 $ 320 $ — Agriculture production financing and other loans to farmers 299 137 — Real estate Loans: Construction 1,206 970 — Commercial and farmland 8,037 5,849 — Residential 93 76 — Total $ 9,955 $ 7,352 $ — Impaired loans with related allowance: Real estate Loans: Commercial and farmland $ 2,648 $ 1,909 $ 231 Residential 2,070 2,044 383 Home equity 417 400 75 Individuals' loans for household and other personal expenditures 4 4 — Total $ 5,139 $ 4,357 $ 689 Total Impaired Loans $ 15,094 $ 11,709 $ 689 Three Months Ended June 30, 2020 Six Months Ended June 30, 2020 Average Interest Average Interest Impaired loans with no related allowance: Commercial and industrial loans $ 5,008 $ — $ 5,008 $ — Real estate Loans: Commercial and farmland 7,637 37 7,910 75 Residential 59 1 59 2 Individuals' loans for household and other personal expenditures 3 — 3 — Total $ 12,707 $ 38 $ 12,980 $ 77 Impaired loans with related allowance: Commercial and industrial loans $ 10,304 $ — $ 10,304 $ — Real estate Loans: Commercial and farmland 18,910 — 19,156 — Residential 3,020 19 3,032 38 Home equity 387 3 390 6 Total $ 32,621 $ 22 $ 32,882 $ 44 Total Impaired Loans $ 45,328 $ 60 $ 45,862 $ 121 Three Months Ended June 30, 2019 Six Months Ended June 30, 2019 Average Interest Average Interest Impaired loans with no related allowance: Commercial and industrial loans $ 1,013 $ — $ 1,021 $ — Agriculture production financing and other loans to farmers 668 — 672 — Real estate Loans: Construction 7,314 — 7,792 — Commercial and farmland 7,998 39 8,187 78 Residential 38 1 38 2 Home equity 49 — 49 — Public finance and other commercial loans 353 — 353 — Total $ 17,433 $ 40 $ 18,112 $ 80 Impaired loans with related allowance: Commercial and industrial loans $ 940 $ — $ 940 $ — Agriculture production financing and other loans to farmers 2,117 — 2,134 — Real estate Loans: Commercial and farmland 157 — 164 — Residential 2,021 16 2,029 32 Home equity 351 3 352 6 Individuals' loans for household and other personal expenditures 14 — 15 — Total $ 5,600 $ 19 $ 5,634 $ 38 Total Impaired Loans $ 23,033 $ 59 $ 23,746 $ 118 |
Schedule of credit quality of loan portfolio by loan class | The following tables summarize the credit quality of the Corporation’s loan portfolio, by loan class for the periods indicated. Consumer non-performing loans include accruing consumer loans 90-days or more delinquent and consumer non-accrual loans. The entire balance of a loan is considered delinquent if the minimum payment contractually required to be made is not received by the specified date. Loans that evidenced deterioration of credit quality since origination and it was probable, at acquisition, that all contractually required payments would not be collected are included in the applicable categories below. June 30, 2020 Commercial Commercial Commercial Substandard Commercial Commercial Loss Consumer Performing Consumer Total Commercial and industrial loans $ 2,722,071 $ 87,069 $ 89,189 $ — $ — $ — $ — $ 2,898,329 Agriculture production financing and other loans to farmers 78,645 6,082 9,111 — — — — 93,838 Real estate Loans: Construction 590,889 791 20,229 — — 28,536 115 640,560 Commercial and farmland 3,035,363 103,921 99,330 — — 1,384 — 3,239,998 Residential 189,053 1,637 6,684 — — 943,222 4,591 1,145,187 Home equity 20,214 — 1,342 — — 508,457 2,301 532,314 Individuals' loans for household and other personal expenditures — — — — — 123,524 87 123,611 Public finance and other commercial loans 624,655 49 — — — — — 624,704 Loans $ 7,260,890 $ 199,549 $ 225,885 $ — $ — $ 1,605,123 $ 7,094 $ 9,298,541 December 31, 2019 Commercial Commercial Commercial Substandard Commercial Commercial Loss Consumer Performing Consumer Total Commercial and industrial loans $ 1,956,985 $ 81,179 $ 71,715 $ — $ — $ — $ — $ 2,109,879 Agriculture production financing and other loans to farmers 78,558 5,626 9,677 — — — — 93,861 Real estate Loans: Construction 749,249 1,613 1,634 — — 35,072 — 787,568 Commercial and farmland 2,894,366 57,776 98,575 — — 1,981 — 3,052,698 Residential 196,710 877 8,075 — — 932,743 4,812 1,143,217 Home equity 24,211 257 682 — — 562,507 1,327 588,984 Individuals' loans for household and other personal expenditures — — — — — 135,944 45 135,989 Public finance and other commercial loans 547,114 — — — — — — 547,114 Loans $ 6,447,193 $ 147,328 $ 190,358 $ — $ — $ 1,668,247 $ 6,184 $ 8,459,310 |
Schedule of past due aging of loan portfolio by loan class | The tables below show a past due aging of the Corporation’s loan portfolio, by loan class, as of June 30, 2020 , and December 31, 2019 : June 30, 2020 Current 30-59 Days 60-89 Days Loans 90 Days or More Past Due And Accruing Non-Accrual Total Past Due Total Commercial and industrial loans $ 2,871,366 $ 9,435 $ 1,038 $ 136 $ 16,354 $ 26,963 $ 2,898,329 Agriculture production financing and other loans to farmers 92,735 1,103 — — — 1,103 93,838 Real estate loans: Construction 634,706 5,235 500 — 119 5,854 640,560 Commercial and farmland 3,172,688 18,948 18,458 4,499 25,405 67,310 3,239,998 Residential 1,136,131 2,679 329 275 5,773 9,056 1,145,187 Home equity 526,096 2,110 1,673 59 2,376 6,218 532,314 Individuals' loans for household and other personal expenditures 123,126 227 171 12 75 485 123,611 Public finance and other commercial loans 624,704 — — — — — 624,704 Loans $ 9,181,552 $ 39,737 $ 22,169 $ 4,981 $ 50,102 $ 116,989 $ 9,298,541 December 31, 2019 Current 30-59 Days 60-89 Days Loans 90 Days or More Past Due And Accruing Non-Accrual Total Past Due Total Commercial and industrial loans $ 2,105,445 $ 3,039 $ 136 $ 4 $ 1,255 $ 4,434 $ 2,109,879 Agriculture production financing and other loans to farmers 93,678 — — — 183 183 93,861 Real estate loans: Construction 784,961 1,630 — — 977 2,607 787,568 Commercial and farmland 3,043,318 2,324 49 — 7,007 9,380 3,052,698 Residential 1,133,476 4,290 367 22 5,062 9,741 1,143,217 Home equity 584,023 2,960 538 42 1,421 4,961 588,984 Individuals' loans for household and other personal expenditures 135,399 440 105 1 44 590 135,989 Public finance and other commercial loans 547,114 — — — — — 547,114 Loans $ 8,427,414 $ 14,683 $ 1,195 $ 69 $ 15,949 $ 31,896 $ 8,459,310 |
Schedules of troubled debt restructurings | The following tables summarize troubled debt restructures at the time of modification that occurred during the periods indicated: Three Months Ended June 30, 2020 Six Months Ended June 30, 2020 Pre-Modification Post-Modification Number Pre-Modification Post-Modification Number Commercial and industrial loans $ 654 $ 654 3 $ 654 $ 654 3 Real estate loans: Commercial and farmland 565 565 2 565 565 2 Residential 300 337 6 300 337 6 Total $ 1,519 $ 1,556 11 $ 1,519 $ 1,556 11 Three Months Ended June 30, 2019 Six Months Ended June 30, 2019 Pre-Modification Post-Modification Number Pre-Modification Post-Modification Number Real estate loans: Residential $ 171 $ 164 4 $ 261 $ 254 5 Total $ 171 $ 164 4 $ 261 $ 254 5 The following tables summarize by modification type, the recorded investment of troubled debt restructures as of June 30, 2020 and 2019, that occurred during the periods indicated: Three Months Ended June 30, 2020 Term Rate Combination Total Commercial and industrial loans $ 652 $ — $ — $ 652 Real estate loans: Commercial and farmland 565 — — 565 Residential — 111 223 334 Total $ 1,217 $ 111 $ 223 $ 1,551 Six Months Ended June 30, 2020 Term Rate Combination Total Commercial and industrial loans $ 652 $ — $ — $ 652 Real estate loans: Commercial and farmland 565 — — 565 Residential — 111 223 334 Total $ 1,217 $ 111 $ 223 $ 1,551 Three Months Ended June 30, 2019 Term Rate Combination Total Real estate loans: Residential $ — $ — $ 164 $ 164 Total $ — $ — $ 164 $ 164 Six Months Ended June 30, 2019 Term Rate Combination Total Real estate loans: Residential $ — $ 89 $ 164 $ 253 Total $ — $ 89 $ 164 $ 253 |
Schedule of troubled debt restructurings that subsequently defaulted | A loan is considered in default if it is 30-days or more past due. Three Months Ended June 30, 2020 Six Months Ended June 30, 2020 Number of Loans Recorded Balance Number of Loans Recorded Balance Commercial and industrial loans 1 $ 268 1 $ 268 Total 1 $ 268 1 $ 268 Three Months Ended June 30, 2019 Six Months Ended June 30, 2019 Number of Loans Recorded Balance Number of Loans Recorded Balance Real estate loans: Residential 1 $ 62 1 $ 62 Total 1 $ 62 1 $ 62 |
Purchased Credit Impaired Loa_2
Purchased Credit Impaired Loans (Tables) | 6 Months Ended |
Jun. 30, 2020 | |
Receivables [Abstract] | |
Schedule of accretable yield, or income expected to be collected, and reclassifications from nonaccretable yield | The accretable yield, or income expected to be collected, and reclassifications from nonaccretable, are identified in the table below. Three Months Ended June 30, 2020 Six Months Ended June 30, 2020 Accretable yield beginning balance $ 1,926 $ 2,132 Additions — $ — Accretion (1,033 ) (1,418 ) Reclassification from nonaccretable 653 839 Disposals — (7 ) Accretable yield ending balance $ 1,546 $ 1,546 Three Months Ended June 30, 2019 Six Months Ended June 30, 2019 Accretable yield beginning balance $ 2,064 $ 2,143 Additions — — Accretion (638 ) (1,218 ) Reclassification from nonaccretable 488 989 Disposals — — Accretable yield ending balance $ 1,914 $ 1,914 |
Goodwill (Tables)
Goodwill (Tables) | 6 Months Ended |
Jun. 30, 2020 | |
Goodwill and Intangible Assets Disclosure [Abstract] | |
Schedule of goodwill | 2019 Balance, January 1 $ 445,355 Goodwill acquired 97,844 Measurement period adjustment 719 Balance, December 31 $ 543,918 |
Core Deposit Intangibles (Table
Core Deposit Intangibles (Tables) | 6 Months Ended |
Jun. 30, 2020 | |
Goodwill and Intangible Assets Disclosure [Abstract] | |
Schedule of core deposit | The carrying basis and accumulated amortization of recognized core deposit intangibles are noted below. June 30, 2020 December 31, 2019 Gross carrying amount $ 102,396 $ 85,869 Core deposit intangibles acquired — 16,527 Accumulated amortization (70,459 ) (67,434 ) Total core deposit intangibles $ 31,937 $ 34,962 |
Schedule of estimated future amortization expense | Estimated future amortization expense is summarized as follows: Amortization Expense 2020 $ 2,962 2021 5,429 2022 5,027 2023 4,827 2024 4,241 After 2024 9,451 $ 31,937 |
Derivative Financial Instrume_2
Derivative Financial Instruments (Tables) | 6 Months Ended |
Jun. 30, 2020 | |
Derivative Instruments and Hedging Activities Disclosure [Abstract] | |
Schedule of fair value of derivative financial instruments and their classification on Balance Sheet | The table below presents the fair value of the Corporation’s derivative financial instruments, as well as their classification on the Balance Sheet, as of June 30, 2020 , and December 31, 2019 . Asset Derivatives Liability Derivatives June 30, 2020 December 31, 2019 June 30, 2020 December 31, 2019 Balance Fair Balance Fair Balance Fair Balance Fair Derivatives designated as hedging instruments: Interest rate contracts Other Assets $ — Other Assets $ — Other Liabilities $ 2,547 Other Liabilities $ 1,444 Derivatives not designated as hedging instruments: Interest rate contracts Other Assets $ 84,658 Other Assets $ 27,855 Other Liabilities $ 84,658 Other Liabilities $ 27,855 |
Schedule of amount of gain (loss) recognized in other comprehensive income | The amount of gain (loss) recognized in other comprehensive income is included in the table below for the periods indicated. Derivatives in Cash Flow Hedging Relationships Amount of Gain (Loss) Recognized in Other Comprehensive Income on Derivative Three Months Ended Six Months Ended June 30, 2020 June 30, 2019 June 30, 2020 June 30, 2019 Interest Rate Products $ (145 ) $ (701 ) $ (1,459 ) $ (1,092 ) |
Schedule of derivative instruments, gain (loss) in Income Statement | The amount of gain (loss) reclassified from other comprehensive income into income is included in the table below for the periods indicated. Derivatives Designated as Location of Gain (Loss) Amount of Gain (Loss) Reclassed from Other Comprehensive Income into Income (Effective Portion) Three Months Ended Three Months Ended Interest rate contracts Interest Expense $ (231 ) $ (84 ) Derivatives Designated as Location of Gain (Loss) Amount of Gain (Loss) Reclassed from Other Comprehensive Income into Income (Effective Portion) Six Months Ended Six Months Ended Interest rate contracts Interest Expense $ (357 ) $ (143 ) |
Disclosures About Fair Value _2
Disclosures About Fair Value of Assets and Liabilities (Tables) | 6 Months Ended |
Jun. 30, 2020 | |
Fair Value Disclosures [Abstract] | |
Schedule of fair value measurements of assets and liabilities recognized in Consolidated Condensed Balance Sheets measured at fair value | The following table presents the fair value measurements of assets and liabilities recognized in the accompanying balance sheets measured at fair value on a recurring basis and the level within the ASC 820 fair value hierarchy in which the fair value measurements fall at June 30, 2020 , and December 31, 2019 . Fair Value Measurements Using: June 30, 2020 Fair Value Quoted Prices in Active Markets for Identical Assets Significant Other Significant Available for sale securities: U.S. Treasury $ 600 $ — $ 600 $ — U.S. Government-sponsored agency securities 2,453 — 2,453 — State and municipal 1,094,218 — 1,091,753 2,465 U.S. Government-sponsored mortgage-backed securities 790,234 — 790,230 4 Corporate obligations 3,088 — 3,057 31 Interest rate swap asset 84,658 — 84,658 — Interest rate swap liability 87,205 — 87,205 — Fair Value Measurements Using: December 31, 2019 Fair Value Quoted Prices in Significant Other Observable Inputs Significant Available for sale securities: U.S. Government-sponsored agency securities $ 38,875 $ — $ 38,875 $ — State and municipal 899,796 — 896,938 2,858 U.S. Government-sponsored mortgage-backed securities 851,323 — 851,319 4 Corporate obligations 31 — — 31 Interest rate swap asset 27,855 — 27,855 — Interest rate swap liability 29,299 — 29,299 — |
Schedule of reconciliation of beginning and ending balances of recurring fair value measurements recognized in Consolidated Condensed Balance Sheets using significant unobservable Level 3 inputs | The following is a reconciliation of the beginning and ending balances of recurring fair value measurements recognized in the accompanying balance sheets using significant unobservable Level 3 inputs for the three and six months ended June 30, 2020 and 2019 . Available for Sale Securities Three Months Ended Six Months Ended June 30, 2020 June 30, 2019 June 30, 2020 June 30, 2019 Balance at beginning of the period $ 2,528 $ 2,936 $ 2,892 $ 3,328 Included in other comprehensive income (30 ) 37 (50 ) 80 Principal payments 2 2 (342 ) (433 ) Ending balance $ 2,500 $ 2,975 $ 2,500 $ 2,975 |
Schedule of description of valuation methodologies used for instruments measured at fair value on a non-recurring basis and recognized in Consolidated Condensed Balance Sheets | Following is a description of valuation methodologies used for instruments measured at fair value on a non-recurring basis and recognized in the accompanying balance sheets, as well as the general classification of such instruments pursuant to the valuation hierarchy for June 30, 2020 , and December 31, 2019 . Fair Value Measurements Using June 30, 2020 Fair Value Quoted Prices in Significant Other Significant Unobservable Impaired loans (collateral dependent) $ 22,690 $ — $ — $ 22,690 Other real estate owned 464 — — 464 Fair Value Measurements Using December 31, 2019 Fair Value Quoted Prices in Significant Other Significant Unobservable Impaired loans (collateral dependent) $ 5,653 $ — $ — $ 5,653 Other real estate owned 194 — — 194 |
Schedule of unobservable inputs used in recurring and nonrecurring Level 3 fair value measurements other than goodwill | The following table presents quantitative information about unobservable inputs used in recurring and nonrecurring Level 3 fair value measurements, other than goodwill, at June 30, 2020 and December 31, 2019 . June 30, 2020 Fair Value Valuation Technique Unobservable Inputs Range (Weighted-Average) State and municipal securities $ 2,465 Discounted cash flow Maturity/Call date 1 month to 15 yrs US Muni BQ curve A- to BBB- Discount rate 1.5% - 4% Weighted-average coupon 3.87 % Corporate obligations and U.S. Government-sponsored mortgage-backed securities $ 35 Discounted cash flow Risk free rate 3 month LIBOR plus premium for illiquidity plus 200bps Weighted-average coupon — % Impaired loans (collateral dependent) $ 22,690 Collateral based measurements Discount to reflect current market conditions and ultimate collectability 0% - 10% Weighted-average discount by loan balance 10 % Other real estate owned $ 464 Appraisals Discount to reflect current market conditions 0% - 72% Weighted-average discount of other real estate owned balance 32 % December 31, 2019 Fair Value Valuation Technique Unobservable Inputs Range (Weighted-Average) State and municipal securities $ 2,858 Discounted cash flow Maturity/Call date 1 month to 15 yrs US Muni BQ curve A- to BBB- Discount rate 2% - 5% Weighted-average coupon 3.92 % Corporate obligations and U.S Government-sponsored mortgage-backed securities $ 35 Discounted cash flow Risk free rate 3 month LIBOR plus premium for illiquidity plus 200bps Weighted-average coupon — % Impaired loans (collateral dependent) $ 5,653 Collateral based measurements Discount to reflect current market conditions and ultimate collectability 0% - 10% Weighted-average discount by loan balance 1 % Other real estate owned $ 194 Appraisals Discount to reflect current market conditions 0% - 37% Weighted-average discount of other real estate owned balance 37 % |
Schedule of estimated fair values of financial instruments | The following table presents estimated fair values of the Corporation’s financial instruments and the level within the fair value hierarchy in which the fair value measurements fall at June 30, 2020 , and December 31, 2019 . June 30, 2020 Quoted Prices in Active Markets Significant Significant Unobservable Carrying Amount (Level 1) (Level 2) (Level 3) Assets: Cash and cash equivalents $ 229,759 $ 229,759 $ — $ — Interest-bearing time deposits 380,021 380,021 — — Investment securities available for sale 1,890,593 — 1,888,093 2,500 Investment securities held to maturity 898,786 — 920,146 21,280 Loans held for sale 901 — 901 — Loans 9,177,422 — — 9,253,762 Federal Home Loan Bank stock 28,736 — 28,736 — Interest rate swap asset 84,658 — 84,658 — Interest receivable 57,063 — 57,063 — Liabilities: Deposits $ 10,965,988 $ 9,566,516 $ 1,395,002 $ — Borrowings: Securities sold under repurchase agreements 181,150 — 181,150 — Federal Home Loan Bank advances 400,817 — 415,737 — Subordinated debentures and other borrowings 285,197 — 276,306 — Interest rate swap liability 87,205 — 87,205 — Interest payable 5,587 — 5,587 — December 31, 2019 Quoted Prices in Active Markets Significant Significant Unobservable Carrying Amount (Level 1) (Level 2) (Level 3) Assets: Cash and cash equivalents $ 177,201 $ 177,201 $ — $ — Interest-bearing time deposits 118,263 118,263 — — Investment securities available for sale 1,790,025 — 1,787,132 2,893 Investment securities held to maturity 806,038 — 799,884 27,682 Loans held for sale 9,037 — 9,037 — Loans 8,379,026 — — 8,335,340 Federal Home Loan Bank stock 28,736 — 28,736 — Interest rate swap asset 27,855 — 27,855 — Interest receivable 48,901 — 48,901 — Liabilities: Deposits $ 9,839,956 $ 8,146,745 $ 1,675,202 $ — Borrowings: Federal funds purchased 55,000 — 55,000 — Securities sold under repurchase agreements 187,946 — 187,801 — Federal Home Loan Bank advances 351,072 — 352,581 — Subordinated debentures and other borrowings 138,685 — 123,571 — Interest rate swap liability 29,299 — 29,299 — Interest payable 6,754 — 6,754 — |
Transfers Accounted for as Se_2
Transfers Accounted for as Secured Borrowings (Tables) | 6 Months Ended |
Jun. 30, 2020 | |
Transfers and Servicing [Abstract] | |
Schedule of collateral pledged for all repurchase agreements accounted for as secured borrowings | The collateral pledged for all repurchase agreements that are accounted for as secured borrowings as of June 30, 2020 and December 31, 2019 were: June 30, 2020 Remaining Contractual Maturity of the Agreements Overnight and Continuous Up to 30 Days 30-90 Days Greater Than 90 Days Total U.S. Government-sponsored mortgage-backed securities $ 178,749 $ 750 $ — $ 1,651 $ 181,150 December 31, 2019 Remaining Contractual Maturity of the Agreements Overnight and Continuous Up to 30 Days 30-90 Days Greater Than 90 Days Total U.S. Government-sponsored mortgage-backed securities $ 178,732 $ — $ 7,672 $ 1,542 $ 187,946 |
Accumulated Other Comprehensi_2
Accumulated Other Comprehensive Income (Loss) (Tables) | 6 Months Ended |
Jun. 30, 2020 | |
Equity [Abstract] | |
Schedule of accumulated other comprehensive income (loss) | The following table summarizes the changes in the balances of each component of accumulated other comprehensive income (loss), net of tax, as of June 30, 2020 and 2019 : Accumulated Other Comprehensive Income (Loss) Unrealized Gains (Losses) on Securities Available for Sale Unrealized Gains (Losses) on Cash Flow Hedges Unrealized Gains (Losses) on Defined Benefit Plans Total Balance at December 31, 2019 $ 38,872 $ (1,141 ) $ (9,857 ) $ 27,874 Other comprehensive income before reclassifications 42,909 (1,153 ) — 41,756 Amounts reclassified from accumulated other comprehensive income (6,067 ) 282 — (5,785 ) Period change 36,842 (871 ) — 35,971 Balance at June 30, 2020 $ 75,714 $ (2,012 ) $ (9,857 ) $ 63,845 Balance at December 31, 2018 $ (6,343 ) $ (559 ) $ (14,520 ) $ (21,422 ) Other comprehensive income before reclassifications 39,130 (862 ) — 38,268 Amounts reclassified from accumulated other comprehensive income (2,357 ) 113 — (2,244 ) Period change 36,773 (749 ) — 36,024 Balance at June 30, 2019 $ 30,430 $ (1,308 ) $ (14,520 ) $ 14,602 |
Schedule of reclassification out of accumulated other comprehensive income (loss) | The following tables present the reclassification adjustments out of accumulated other comprehensive income (loss) that were included in net income in the Consolidated Condensed Statements of Income for the three and six months ended June 30, 2020 and 2019 . Amount Reclassified from Accumulated Other Comprehensive Income (Loss) For the Three Months Ended June 30, Details about Accumulated Other Comprehensive Income (Loss) Components 2020 2019 Affected Line Item in the Statements of Income Unrealized gains (losses) on available for sale securities (1) Realized securities gains reclassified into income $ 3,068 $ 1,843 Other income - net realized gains on sales of available for sale securities Related income tax expense (644 ) (387 ) Income tax expense $ 2,424 $ 1,456 Unrealized gains (losses) on cash flow hedges (2) Interest rate contracts $ (231 ) $ (84 ) Interest expense - subordinated debentures and term loans Related income tax benefit 49 18 Income tax expense $ (182 ) $ (66 ) Total reclassifications for the period, net of tax $ 2,242 $ 1,390 Amount Reclassified from Accumulated Other Comprehensive Income (Loss) For the Six Months Ended June 30, Details about Accumulated Other Comprehensive Income (Loss) Components 2020 2019 Affected Line Item in the Statements of Income Unrealized gains (losses) on available for sale securities (1) Realized securities gains reclassified into income $ 7,680 $ 2,983 Other income - net realized gains on sales of available for sale securities Related income tax expense (1,613 ) (626 ) Income tax expense $ 6,067 $ 2,357 Unrealized gains (losses) on cash flow hedges (2) Interest rate contracts $ (357 ) $ (143 ) Interest expense - subordinated debentures and term loans Related income tax benefit 75 30 Income tax expense $ (282 ) $ (113 ) Total reclassifications for the period, net of tax $ 5,785 $ 2,244 (1) For additional detail related to unrealized gains (losses) on available for sale securities and related amounts reclassified from accumulated other comprehensive income see NOTE 3. INVESTMENT SECURITIES of these Notes to Consolidated Condensed Financial Statements. (2) For additional detail related to unrealized gains (losses) on cash flow hedges and related amounts reclassified from accumulated other comprehensive income see NOTE 8. DERIVATIVE FINANCIAL INSTRUMENTS of these Notes to Consolidated Condensed Financial Statements. |
Share-Based Compensation (Table
Share-Based Compensation (Tables) | 6 Months Ended |
Jun. 30, 2020 | |
Share-based Payment Arrangement [Abstract] | |
Schedule of components of share-based compensation awards | The following table summarizes the components of the Corporation's share-based compensation awards recorded as an expense and the income tax benefit of such awards. Three Months Ended Six Months Ended 2020 2019 2020 2019 Stock and ESPP Options Pre-tax compensation expense $ 12 $ 25 $ 53 $ 36 Income tax benefit (29 ) (41 ) (29 ) (57 ) Stock and ESPP option expense, net of income taxes $ (17 ) $ (16 ) $ 24 $ (21 ) Restricted Stock Awards Pre-tax compensation expense $ 1,202 $ 819 $ 2,380 $ 1,789 Income tax benefit (236 ) (186 ) (493 ) (726 ) Restricted stock awards expense, net of income taxes $ 966 $ 633 $ 1,887 $ 1,063 Total Share-Based Compensation Pre-tax compensation expense $ 1,214 $ 844 $ 2,433 $ 1,825 Income tax benefit (265 ) (227 ) (522 ) (783 ) Total share-based compensation expense, net of income taxes $ 949 $ 617 $ 1,911 $ 1,042 |
Schedule of stock option activity under stock option plans | Stock option activity under the Corporation's stock option plans as of June 30, 2020 and changes during the six months ended June 30, 2020 , were as follows: Number of Weighted-Average Exercise Price Weighted Average Remaining Aggregate Outstanding at January 1, 2020 59,350 $ 13.51 Exercised (10,050 ) $ 8.29 Outstanding June 30, 2020 49,300 $ 14.57 2.32 $ 640,876 Vested and Expected to Vest at June 30,2020 49,300 $ 14.57 2.32 $ 640,876 Exercisable at June 30, 2020 49,300 $ 14.57 2.32 $ 640,876 |
Schedule of Unvested RSAs outstanding | The following table summarizes information on unvested RSAs outstanding as of June 30, 2020 : Number of Shares Weighted-Average Unvested RSAs at January 1, 2020 351,048 $ 40.67 Granted 14,657 $ 27.00 Vested (8,591 ) $ 40.09 Forfeited (525 ) $ 40.44 Unvested RSAs at June 30, 2020 356,589 $ 40.62 |
Income Tax (Tables)
Income Tax (Tables) | 6 Months Ended |
Jun. 30, 2020 | |
Income Tax Disclosure [Abstract] | |
Schedule of differences between income taxes at federal statutory tax rate and effective tax rate | The following table summarizes the major components creating differences between income taxes at the federal statutory and the effective tax rate recorded in the consolidated statements of income for the three and six months ended June 30, 2020 and 2019 : Three Months Ended Six Months Ended 2020 2019 2020 2019 Reconciliation of Federal Statutory to Actual Tax Expense: Federal statutory income tax at 21% $ 7,899 $ 10,249 $ 15,827 $ 19,858 Tax-exempt interest income (3,199 ) (2,403 ) (6,221 ) (4,670 ) Share-based compensation (6 ) (41 ) (6 ) (391 ) Tax-exempt earnings and gains on life insurance (278 ) (199 ) (564 ) (406 ) Tax credits (89 ) (63 ) (150 ) (141 ) CARES Act - NOL carryback rate differential — — (1,178 ) — Other 296 206 405 440 Actual Tax Expense $ 4,623 $ 7,749 $ 8,113 $ 14,690 Effective Tax Rate 12.3 % 15.9 % 10.8 % 15.5 % |
Net Income Per Share (Tables)
Net Income Per Share (Tables) | 6 Months Ended |
Jun. 30, 2020 | |
Earnings Per Share [Abstract] | |
Schedule of basic and diluted net income per share | The following table reconciles basic and diluted net income per share for the three and six months ended June 30, 2020 and 2019 . Three Months Ended June 30, 2020 2019 Net Income Weighted-Average Shares Per Share Net Income Weighted-Average Shares Per Share Net income available to common stockholders $ 32,992 53,762,913 $ 0.62 $ 41,056 49,432,167 $ 0.83 Effect of potentially dilutive stock options and restricted stock awards 179,654 117,720 Diluted net income per share $ 32,992 53,942,567 $ 0.62 $ 41,056 49,549,887 $ 0.83 Six Months Ended June 30, 2020 2019 Net Income Weighted-Average Shares Per Share Net Income Weighted-Average Shares Per Share Net income available to common stockholders $ 67,255 54,247,493 $ 1.24 $ 79,873 49,400,770 $ 1.62 Effect of potentially dilutive stock options and restricted stock awards 182,026 144,382 Diluted net income per share $ 67,255 54,429,519 $ 1.24 $ 79,873 49,545,152 $ 1.61 |
General (Details)
General (Details) - USD ($) $ in Thousands | Jan. 01, 2020 | Jun. 30, 2020 | Dec. 31, 2019 |
New Accounting Pronouncements or Change in Accounting Principle [Line Items] | |||
Loans | $ 9,298,541 | $ 8,459,310 | |
Estimated | One-time cumulative-effect adjustment | |||
New Accounting Pronouncements or Change in Accounting Principle [Line Items] | |||
Life of loan portfolio | 4 years | ||
Reserve for potential losses from unfunded commitments | $ 18,000 | ||
Estimated | One-time cumulative-effect adjustment | Minimum | |||
New Accounting Pronouncements or Change in Accounting Principle [Line Items] | |||
Increase in allowance | 55.00% | ||
Estimated | One-time cumulative-effect adjustment | Maximum | |||
New Accounting Pronouncements or Change in Accounting Principle [Line Items] | |||
Increase in allowance | 65.00% | ||
Payment deferrals, fee waivers, extensions of repayment terms, or other | |||
New Accounting Pronouncements or Change in Accounting Principle [Line Items] | |||
Loans | $ 1,100,000 | ||
Percent of loan portfolio modified | 12.10% |
Acquisition - Narrative (Detail
Acquisition - Narrative (Details) - MBT $ in Thousands, shares in Millions | Sep. 01, 2019USD ($)bank_branchshares | Dec. 31, 2019USD ($) |
Business Acquisition [Line Items] | ||
Percentage of interest acquired | 100.00% | |
Number of banking centers acquired | bank_branch | 20 | |
Stock issued as part of acquisition, value | $ 229,900 | |
Core deposit intangible | 16,527 | |
Operating revenue | $ 19,700 | |
Non-recurring expenses | $ 19,700 | |
Core deposit intangibles acquired | ||
Business Acquisition [Line Items] | ||
Core deposit intangible | $ 16,527 | |
Acquired intangible asset, expected useful life | 10 years | |
Common Stock | ||
Business Acquisition [Line Items] | ||
Number of shares of common stock | 0.275 | |
Stock issued as a part of acquisition (in shares) | shares | 6.4 |
Acquisition - Assets Acquired a
Acquisition - Assets Acquired and Liabilities Assumed (Details) - USD ($) $ in Thousands | Jun. 30, 2020 | Dec. 31, 2019 | Sep. 01, 2019 | Dec. 31, 2018 |
Business Acquisition [Line Items] | ||||
Goodwill | $ 543,918 | $ 543,918 | $ 445,355 | |
MBT | ||||
Business Acquisition [Line Items] | ||||
Cash and cash equivalents | $ 10,222 | |||
Interest-bearing time deposits | 281,228 | |||
Investment securities | 212,235 | |||
Loans | 732,578 | |||
Premises and equipment | 21,664 | |||
Federal Home Loan Bank stock | 4,148 | |||
Interest receivable | 3,361 | |||
Cash surrender value of life insurance | 59,545 | |||
Tax asset, deferred and receivable | 5,205 | |||
Other assets | 6,011 | |||
Deposits | (1,105,926) | |||
Securities sold under repurchase agreements | (94,760) | |||
Federal Home Loan Bank advances | (10,853) | |||
Other liabilities | (9,807) | |||
Net tangible assets acquired | 114,851 | |||
Core deposit intangible | 16,527 | |||
Goodwill | 98,563 | |||
Purchase price | $ 229,941 |
Acquisition - Schedule of Acqui
Acquisition - Schedule of Acquired Loan Data (Details) - MBT $ in Thousands | Sep. 01, 2019USD ($) |
Business Acquisition [Line Items] | |
Fair Value of Acquired Loans at Acquisition Date, Acquired receivables subject to ASC 310-30 | $ 3,531 |
Gross Contractual Amounts Receivable at Acquisition Date, Acquired receivables subject to ASC 310-30 | 6,840 |
Best Estimate at Acquisition Date of Contractual Cash Flows Not Expected to be Collected, Acquired receivables subject to ASC 310-30 | 2,733 |
Fair Value of Acquired Loans at Acquisition Date, Acquired receivables not subject to ASC 310-30 | 729,047 |
Gross Contractual Amounts Receivable at Acquisition Date, Acquired receivables not subject to ASC 310-30 | 907,210 |
Best Estimate at Acquisition Date of Contractual Cash Flows Not Expected to be Collected, Acquired receivables not subject to ASC 310-30 | $ 14,722 |
Acquisition - Pro Forma Financi
Acquisition - Pro Forma Financial Information (Details) - MBT $ / shares in Units, $ in Thousands | 12 Months Ended |
Dec. 31, 2019USD ($)$ / shares | |
Business Acquisition [Line Items] | |
Total revenue (net interest income plus other income) | $ | $ 474,891 |
Net income | $ | $ 161,228 |
Earnings per share: Basic (in dollars per share) | $ / shares | $ 2.89 |
Earnings per share: Diluted (in dollars per share) | $ / shares | $ 2.88 |
Investment Securities - Amortiz
Investment Securities - Amortized Cost and Approximate Fair Value of Securities (Details) - USD ($) $ in Thousands | Jun. 30, 2020 | Dec. 31, 2019 |
Available for sale securities | ||
Total Investment Securities | $ 1,794,322 | $ 1,740,420 |
Gross Unrealized Gains | 96,436 | 51,816 |
Gross Unrealized Losses | 165 | 2,211 |
Fair Value | 1,890,593 | 1,790,025 |
Held to maturity securities | ||
Total Investment Securities | 898,786 | 806,038 |
Gross Unrealized Gains | 42,714 | 22,073 |
Gross Unrealized Losses | 74 | 545 |
Fair Value | 941,426 | 827,566 |
Amortized Cost | 2,693,108 | 2,546,458 |
Gross Unrealized Gains | 139,150 | 73,889 |
Gross Unrealized Losses | 239 | 2,756 |
Fair Value | 2,832,019 | 2,617,591 |
U.S. Treasury | ||
Available for sale securities | ||
Total Investment Securities | 598 | |
Gross Unrealized Gains | 2 | |
Gross Unrealized Losses | 0 | |
Fair Value | 600 | |
U.S. Government-sponsored agency securities | ||
Available for sale securities | ||
Total Investment Securities | 2,385 | 38,529 |
Gross Unrealized Gains | 68 | 346 |
Gross Unrealized Losses | 0 | 0 |
Fair Value | 2,453 | 38,875 |
Held to maturity securities | ||
Total Investment Securities | 10,100 | 15,619 |
Gross Unrealized Gains | 3 | 1 |
Gross Unrealized Losses | 0 | 37 |
Fair Value | 10,103 | 15,583 |
State and municipal | ||
Available for sale securities | ||
Total Investment Securities | 1,026,917 | 859,511 |
Gross Unrealized Gains | 67,439 | 41,092 |
Gross Unrealized Losses | 138 | 807 |
Fair Value | 1,094,218 | 899,796 |
Held to maturity securities | ||
Total Investment Securities | 374,214 | 354,115 |
Gross Unrealized Gains | 23,779 | 15,151 |
Gross Unrealized Losses | 43 | 107 |
Fair Value | 397,950 | 369,159 |
U.S. Government-sponsored mortgage-backed securities | ||
Available for sale securities | ||
Total Investment Securities | 761,391 | 842,349 |
Gross Unrealized Gains | 28,870 | 10,378 |
Gross Unrealized Losses | 27 | 1,404 |
Fair Value | 790,234 | 851,323 |
Held to maturity securities | ||
Total Investment Securities | 512,972 | 434,804 |
Gross Unrealized Gains | 18,932 | 6,921 |
Gross Unrealized Losses | 31 | 401 |
Fair Value | 531,873 | 441,324 |
Corporate obligations | ||
Available for sale securities | ||
Total Investment Securities | 3,031 | 31 |
Gross Unrealized Gains | 57 | 0 |
Gross Unrealized Losses | 0 | 0 |
Fair Value | 3,088 | 31 |
Foreign investment | ||
Held to maturity securities | ||
Total Investment Securities | 1,500 | 1,500 |
Gross Unrealized Gains | 0 | 0 |
Gross Unrealized Losses | 0 | 0 |
Fair Value | $ 1,500 | $ 1,500 |
Investment Securities - Amort_2
Investment Securities - Amortized Cost and Fair Value of Available for Sale Securities and Held to Maturity Securities by Contractual Maturity (Details) - USD ($) $ in Thousands | Jun. 30, 2020 | Dec. 31, 2019 |
Amortized Cost | ||
Due in one year or less | $ 1,947 | $ 1,134 |
Due after one through five years | 4,589 | 5,031 |
Due after five through ten years | 49,425 | 74,745 |
Due after ten years | 976,970 | 817,161 |
Total debt securities with a single maturity date | 1,032,931 | 898,071 |
Total Investment Securities | 1,794,322 | 1,740,420 |
Fair Value | ||
Due in one year or less | 1,961 | 1,136 |
Due after one through five years | 4,718 | 5,141 |
Due after five through ten years | 52,485 | 76,920 |
Due after ten years | 1,041,195 | 855,505 |
Total debt securities with a single maturity date | 1,100,359 | 938,702 |
Total Investment Securities | 1,890,593 | 1,790,025 |
Amortized Cost | ||
Due in one year or less | 12,191 | 9,920 |
Due after one through five years | 23,639 | 45,197 |
Due after five through ten years | 95,694 | 84,153 |
Due after ten years | 254,290 | 231,964 |
Total debt securities with a single maturity date | 385,814 | 371,234 |
Total Investment Securities | 898,786 | 806,038 |
Fair Value | ||
Due in one year or less | 12,217 | 10,105 |
Due after one through five years | 24,224 | 45,654 |
Due after five through ten years | 101,354 | 88,844 |
Due after ten years | 271,758 | 241,639 |
Total debt securities with a single maturity date | 409,553 | 386,242 |
Investment securities held to maturity | 941,426 | 827,566 |
U.S. Government-sponsored mortgage-backed securities | ||
Amortized Cost | ||
Without single maturity date | 761,391 | 842,349 |
Total Investment Securities | 761,391 | 842,349 |
Fair Value | ||
Without single maturity date | 790,234 | 851,323 |
Total Investment Securities | 790,234 | 851,323 |
Amortized Cost | ||
Without single maturity date | 512,972 | 434,804 |
Total Investment Securities | 512,972 | 434,804 |
Fair Value | ||
Without single maturity date | 531,873 | 441,324 |
Investment securities held to maturity | $ 531,873 | $ 441,324 |
Investment Securities - Narrati
Investment Securities - Narrative (Details) $ in Thousands | Jun. 30, 2020USD ($)security | Dec. 31, 2019USD ($) |
Investments, Debt and Equity Securities [Abstract] | ||
Carrying value of securities pledged as collateral | $ 1,100,278 | $ 503,427 |
Book value of securities sold under agreements to repurchase | 171,346 | 182,856 |
Schedule of Available for sale Securities and Held to maturity Securities [Line Items] | ||
Gross unrealized losses | 165 | 2,211 |
Held-to-maturity unrealized losses | 74 | 545 |
State and municipal | ||
Schedule of Available for sale Securities and Held to maturity Securities [Line Items] | ||
Gross unrealized losses | $ 138 | 807 |
Number of securities in unrealized loss positions | security | 13 | |
Held-to-maturity unrealized losses | $ 43 | 107 |
Held-to-maturity, number of securities in unrealized loss positions | security | 2 | |
U.S. Government-sponsored mortgage-backed securities | ||
Schedule of Available for sale Securities and Held to maturity Securities [Line Items] | ||
Gross unrealized losses | $ 27 | 1,404 |
Number of securities in unrealized loss positions | security | 1 | |
Held-to-maturity unrealized losses | $ 31 | $ 401 |
Held-to-maturity, number of securities in unrealized loss positions | security | 3 |
Investment Securities - Gross G
Investment Securities - Gross Gains on Sales and Redemptions of Available for Sale Securities (Details) - USD ($) $ in Thousands | 3 Months Ended | 6 Months Ended | ||
Jun. 30, 2020 | Jun. 30, 2019 | Jun. 30, 2020 | Jun. 30, 2019 | |
Sales and Redemptions of Available for Sale Securities: | ||||
Gross gains | $ 3,068 | $ 1,843 | $ 7,680 | $ 2,983 |
Gross losses | $ 0 | $ 0 | $ 0 | $ 0 |
Investment Securities - Investm
Investment Securities - Investments' Gross Unrealized Losses and Fair Value Aggregated by Investment Category and Length of Time in Continuous Unrealized Loss Position (Details) - USD ($) $ in Thousands | Jun. 30, 2020 | Dec. 31, 2019 |
Fair Value | ||
Less than 12 Months | $ 38,984 | $ 203,946 |
12 Months or Longer | 0 | 20,796 |
Total | 38,984 | 224,742 |
Gross Unrealized Losses | ||
Less than 12 Months | 165 | 2,133 |
12 Months or Longer | 0 | 78 |
Total | 165 | 2,211 |
Fair Value | ||
Less than 12 Months | 12,831 | 150,216 |
12 Months or Longer | 0 | 20,458 |
Total | 12,831 | 170,674 |
Gross Unrealized Losses | ||
Less than 12 Months | 74 | 475 |
12 Months or Longer | 0 | 70 |
Total | 74 | 545 |
Less than 12 Months, Fair Value | 51,815 | 354,162 |
12 Months or Longer, Fair Value | 0 | 41,254 |
Total, Fair Value | 51,815 | 395,416 |
Less than 12 Months, Gross Unrealized Losses | 239 | 2,608 |
12 Months or Longer, Gross Unrealized Losses | 0 | 148 |
Total, Gross Unrealized Losses | 239 | 2,756 |
U.S. Government-sponsored agency securities | ||
Fair Value | ||
Less than 12 Months | 3,016 | |
12 Months or Longer | 12,467 | |
Total | 15,483 | |
Gross Unrealized Losses | ||
Less than 12 Months | 4 | |
12 Months or Longer | 33 | |
Total | 37 | |
State and municipal | ||
Fair Value | ||
Less than 12 Months | 23,745 | 76,273 |
12 Months or Longer | 0 | 0 |
Total | 23,745 | 76,273 |
Gross Unrealized Losses | ||
Less than 12 Months | 138 | 807 |
12 Months or Longer | 0 | 0 |
Total | 138 | 807 |
Fair Value | ||
Less than 12 Months | 2,633 | 22,947 |
12 Months or Longer | 0 | 0 |
Total | 2,633 | 22,947 |
Gross Unrealized Losses | ||
Less than 12 Months | 43 | 107 |
12 Months or Longer | 0 | 0 |
Total | 43 | 107 |
U.S. Government-sponsored mortgage-backed securities | ||
Fair Value | ||
Less than 12 Months | 15,239 | 127,673 |
12 Months or Longer | 0 | 20,796 |
Total | 15,239 | 148,469 |
Gross Unrealized Losses | ||
Less than 12 Months | 27 | 1,326 |
12 Months or Longer | 0 | 78 |
Total | 27 | 1,404 |
Fair Value | ||
Less than 12 Months | 10,198 | 124,253 |
12 Months or Longer | 0 | 7,991 |
Total | 10,198 | 132,244 |
Gross Unrealized Losses | ||
Less than 12 Months | 31 | 364 |
12 Months or Longer | 0 | 37 |
Total | $ 31 | $ 401 |
Investment Securities - Inves_2
Investment Securities - Investments in Debt and Equity Securities Reported Less than Historical Cost (Details) - USD ($) $ in Thousands | Jun. 30, 2020 | Dec. 31, 2019 |
Schedule of Investments [Line Items] | ||
Fair value | $ 51,815 | $ 395,416 |
Investments reported at less than historical cost | ||
Schedule of Investments [Line Items] | ||
Historical cost | 52,054 | 398,172 |
Fair value | 51,815 | 395,416 |
Gross unrealized losses | $ 239 | $ 2,756 |
Percent of the Corporation's investment portfolio | 1.90% | 15.20% |
Loans and Allowance - Narrative
Loans and Allowance - Narrative (Details) loan in Thousands, $ in Thousands | 3 Months Ended | 6 Months Ended | ||||||
Jun. 30, 2020USD ($) | Jun. 30, 2019USD ($) | Jun. 30, 2020USD ($)loan | Jun. 30, 2019USD ($) | Mar. 31, 2020USD ($) | Dec. 31, 2019USD ($) | Mar. 31, 2019USD ($) | Dec. 31, 2018USD ($) | |
Receivables [Abstract] | ||||||||
Loans held for sale | $ 901 | $ 901 | $ 9,037 | |||||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||||||||
Number of funded loans | loan | 5 | |||||||
Loans | 9,298,541 | $ 9,298,541 | 8,459,310 | |||||
Loans - allowance for loan losses | 121,119 | $ 81,274 | 121,119 | $ 81,274 | $ 99,454 | 80,284 | $ 80,902 | $ 80,552 |
Increase in past due loans | 25,100 | |||||||
PPP, CARES Act | ||||||||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||||||||
Loans net of deferred fees | 882,900 | 882,900 | ||||||
Deferred fees | 24,600 | 24,600 | ||||||
Residential | ||||||||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||||||||
Loans | 1,677,501 | 1,677,501 | 1,732,201 | |||||
Loans - allowance for loan losses | $ 21,078 | $ 14,471 | $ 21,078 | $ 14,471 | $ 17,364 | 14,569 | $ 14,373 | $ 14,322 |
Percentage of troubled debt restructured loans | 42.00% | 100.00% | 42.00% | 100.00% | ||||
Mortgage loans with formal foreclosure proceedings | $ 492 | $ 492 | 1,033 | |||||
Loans acquired with deteriorated credit quality | ||||||||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||||||||
Loans | 8,281 | 8,281 | 13,309 | |||||
Loans acquired with deteriorated credit quality | Commercial and consumer loan | ||||||||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||||||||
Loans | 3,783 | 3,783 | 2,819 | |||||
Loans - allowance for loan losses | 192 | 192 | 124 | |||||
Loans acquired with deteriorated credit quality | Residential | ||||||||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||||||||
Loans | 955 | 955 | $ 1,715 | |||||
Four relationships | ||||||||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||||||||
Increase in past due loans | 28,600 | |||||||
Three relationships | ||||||||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||||||||
Increase in non-accrual loans | 34,200 | |||||||
Three relationships | Real estate secured loan | ||||||||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||||||||
Increase in past due loans | $ 17,800 | |||||||
Increase in non-accrual loans, percent of total | 69.00% | |||||||
Two relationships | Senior living sector | ||||||||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||||||||
Increase in non-accrual loans | $ 17,000 | |||||||
One relationships | University logo apparel sports | ||||||||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||||||||
Increase in non-accrual loans | 14,400 | |||||||
PPPL Facility | ||||||||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||||||||
Outstanding balance | $ 166,900 | $ 166,900 |
Loans and Allowance - Compositi
Loans and Allowance - Composition of Loan Portfolio by Loan Class (Details) - USD ($) $ in Thousands | Jun. 30, 2020 | Mar. 31, 2020 | Dec. 31, 2019 | Jun. 30, 2019 | Mar. 31, 2019 | Dec. 31, 2018 |
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||||||
Loans | $ 9,298,541 | $ 8,459,310 | ||||
Allowance for loan losses | (121,119) | $ (99,454) | (80,284) | $ (81,274) | $ (80,902) | $ (80,552) |
Net Loans | 9,177,422 | 8,379,026 | ||||
Commercial and industrial loans | ||||||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||||||
Loans | 2,898,329 | 2,109,879 | ||||
Agricultural production financing and other loans to farmers | ||||||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||||||
Loans | 93,838 | 93,861 | ||||
Construction | ||||||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||||||
Loans | 640,560 | 787,568 | ||||
Commercial and farmland | ||||||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||||||
Loans | 3,239,998 | 3,052,698 | ||||
Residential | ||||||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||||||
Loans | 1,145,187 | 1,143,217 | ||||
Allowance for loan losses | (21,078) | (17,364) | (14,569) | (14,471) | (14,373) | (14,322) |
Home equity | ||||||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||||||
Loans | 532,314 | 588,984 | ||||
Individuals' loans for household and other personal expenditures | ||||||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||||||
Loans | 123,611 | 135,989 | ||||
Allowance for loan losses | (8,445) | $ (5,752) | (4,035) | $ (4,070) | $ (4,026) | $ (3,964) |
Public finance and other commercial loans | ||||||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||||||
Loans | $ 624,704 | $ 547,114 |
Loans and Allowance - Changes i
Loans and Allowance - Changes in Allowance for Loan Losses by Loan Segment (Details) - USD ($) $ in Thousands | 3 Months Ended | 6 Months Ended | ||
Jun. 30, 2020 | Jun. 30, 2019 | Jun. 30, 2020 | Jun. 30, 2019 | |
Allowance for loan losses: | ||||
Beginning balance | $ 99,454 | $ 80,902 | $ 80,284 | $ 80,552 |
Provision for losses | 21,895 | 500 | 41,647 | 1,700 |
Recoveries on loans | 317 | 1,434 | 990 | 2,439 |
Loans charged off | (547) | (1,562) | (1,802) | (3,417) |
Ending balance | 121,119 | 81,274 | 121,119 | 81,274 |
Commercial | ||||
Allowance for loan losses: | ||||
Beginning balance | 38,431 | 33,069 | 32,902 | 32,657 |
Provision for losses | 6,240 | 100 | 11,941 | 336 |
Recoveries on loans | 106 | 344 | 549 | 886 |
Loans charged off | (99) | (311) | (714) | (677) |
Ending balance | 44,678 | 33,202 | 44,678 | 33,202 |
Commercial Real Estate | ||||
Allowance for loan losses: | ||||
Beginning balance | 37,907 | 29,434 | 28,778 | 29,609 |
Provision for losses | 8,945 | 320 | 18,139 | 1,089 |
Recoveries on loans | 107 | 778 | 225 | 1,023 |
Loans charged off | (41) | (1,001) | (224) | (2,190) |
Ending balance | 46,918 | 29,531 | 46,918 | 29,531 |
Consumer | ||||
Allowance for loan losses: | ||||
Beginning balance | 5,752 | 4,026 | 4,035 | 3,964 |
Provision for losses | 2,783 | 36 | 4,707 | 141 |
Recoveries on loans | 56 | 100 | 98 | 218 |
Loans charged off | (146) | (92) | (395) | (253) |
Ending balance | 8,445 | 4,070 | 8,445 | 4,070 |
Residential | ||||
Allowance for loan losses: | ||||
Beginning balance | 17,364 | 14,373 | 14,569 | 14,322 |
Provision for losses | 3,927 | 44 | 6,860 | 134 |
Recoveries on loans | 48 | 212 | 118 | 312 |
Loans charged off | (261) | (158) | (469) | (297) |
Ending balance | $ 21,078 | $ 14,471 | $ 21,078 | $ 14,471 |
Loans and Allowance - Allowance
Loans and Allowance - Allowance for Credit Losses and Loan Portfolio by Loan Segment (Details) - USD ($) $ in Thousands | Jun. 30, 2020 | Mar. 31, 2020 | Dec. 31, 2019 | Jun. 30, 2019 | Mar. 31, 2019 | Dec. 31, 2018 |
Allowance Balances: | ||||||
Individually evaluated for impairment | $ 12,999 | $ 689 | ||||
Collectively evaluated for impairment | 108,120 | 79,595 | ||||
Total Allowance for Loan Losses | 121,119 | $ 99,454 | 80,284 | $ 81,274 | $ 80,902 | $ 80,552 |
Loan Balance [Abstract] | ||||||
Individually evaluated for impairment | 45,280 | 11,709 | ||||
Collectively evaluated for impairment | 9,244,980 | 8,434,292 | ||||
Loans | 9,298,541 | 8,459,310 | ||||
Loans acquired with deteriorated credit quality | ||||||
Loan Balance [Abstract] | ||||||
Loans | 8,281 | 13,309 | ||||
Commercial | ||||||
Allowance Balances: | ||||||
Individually evaluated for impairment | 7,466 | 0 | ||||
Collectively evaluated for impairment | 37,212 | 32,902 | ||||
Total Allowance for Loan Losses | 44,678 | 38,431 | 32,902 | 33,202 | 33,069 | 32,657 |
Loan Balance [Abstract] | ||||||
Individually evaluated for impairment | 15,312 | 457 | ||||
Collectively evaluated for impairment | 3,600,395 | 2,748,681 | ||||
Loans | 3,616,871 | 2,750,854 | ||||
Commercial | Loans acquired with deteriorated credit quality | ||||||
Loan Balance [Abstract] | ||||||
Loans | 1,164 | 1,716 | ||||
Commercial Real Estate | ||||||
Allowance Balances: | ||||||
Individually evaluated for impairment | 4,943 | 231 | ||||
Collectively evaluated for impairment | 41,975 | 28,547 | ||||
Total Allowance for Loan Losses | 46,918 | 37,907 | 28,778 | 29,531 | 29,434 | 29,609 |
Loan Balance [Abstract] | ||||||
Individually evaluated for impairment | 26,512 | 8,728 | ||||
Collectively evaluated for impairment | 3,847,884 | 3,821,660 | ||||
Loans | 3,880,558 | 3,840,266 | ||||
Commercial Real Estate | Loans acquired with deteriorated credit quality | ||||||
Loan Balance [Abstract] | ||||||
Loans | 6,162 | 9,878 | ||||
Consumer | ||||||
Allowance Balances: | ||||||
Individually evaluated for impairment | 0 | 0 | ||||
Collectively evaluated for impairment | 8,445 | 4,035 | ||||
Total Allowance for Loan Losses | 8,445 | 5,752 | 4,035 | 4,070 | 4,026 | 3,964 |
Loan Balance [Abstract] | ||||||
Individually evaluated for impairment | 3 | 4 | ||||
Collectively evaluated for impairment | 123,608 | 135,985 | ||||
Loans | 123,611 | 135,989 | ||||
Residential | ||||||
Allowance Balances: | ||||||
Individually evaluated for impairment | 590 | 458 | ||||
Collectively evaluated for impairment | 20,488 | 14,111 | ||||
Total Allowance for Loan Losses | 21,078 | $ 17,364 | 14,569 | $ 14,471 | $ 14,373 | $ 14,322 |
Loan Balance [Abstract] | ||||||
Individually evaluated for impairment | 3,453 | 2,520 | ||||
Collectively evaluated for impairment | 1,673,093 | 1,727,966 | ||||
Loans | 1,677,501 | 1,732,201 | ||||
Residential | Loans acquired with deteriorated credit quality | ||||||
Loan Balance [Abstract] | ||||||
Loans | $ 955 | $ 1,715 |
Loans and Allowance - Summary o
Loans and Allowance - Summary of Non-Accrual Loans by Loan Class (Details) - USD ($) $ in Thousands | Jun. 30, 2020 | Dec. 31, 2019 |
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||
Non-accrual loans | $ 50,102 | $ 15,949 |
Commercial and industrial loans | ||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||
Non-accrual loans | 16,354 | 1,255 |
Agricultural production financing and other loans to farmers | ||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||
Non-accrual loans | 0 | 183 |
Construction | ||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||
Non-accrual loans | 119 | 977 |
Commercial and farmland | ||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||
Non-accrual loans | 25,405 | 7,007 |
Residential | ||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||
Non-accrual loans | 5,773 | 5,062 |
Home equity | ||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||
Non-accrual loans | 2,376 | 1,421 |
Individuals' loans for household and other personal expenditures | ||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||
Non-accrual loans | $ 75 | $ 44 |
Loans and Allowance - Composi_2
Loans and Allowance - Composition of Impaired Loans by Loan Class (Details) - USD ($) $ in Thousands | 3 Months Ended | 6 Months Ended | |||
Jun. 30, 2020 | Jun. 30, 2019 | Jun. 30, 2020 | Jun. 30, 2019 | Dec. 31, 2019 | |
Unpaid Principal Balance | |||||
Impaired loans with no related allowance | $ 14,777 | $ 14,777 | $ 9,955 | ||
Impaired loans with related allowance | 33,527 | 33,527 | 5,139 | ||
Total Impaired Loans | 48,304 | 48,304 | 15,094 | ||
Recorded Investment | |||||
Impaired loans with no related allowance | 12,672 | 12,672 | 7,352 | ||
Impaired loans with related allowance | 32,608 | 32,608 | 4,357 | ||
Total Impaired Loans | 45,280 | 45,280 | 11,709 | ||
Related Allowance | 12,999 | 12,999 | 689 | ||
Average Recorded Investment | |||||
Impaired loans with no related allowance | 12,707 | $ 17,433 | 12,980 | $ 18,112 | |
Impaired loans with related allowance | 32,621 | 5,600 | 32,882 | 5,634 | |
Total Impaired Loans | 45,328 | 23,033 | 45,862 | 23,746 | |
Interest Income Recognized | |||||
Impaired loans with no related allowance | 38 | 40 | 77 | 80 | |
Impaired loans with related allowance | 22 | 19 | 44 | 38 | |
Total Impaired Loans | 60 | 59 | 121 | 118 | |
Commercial and industrial loans | |||||
Unpaid Principal Balance | |||||
Impaired loans with no related allowance | 5,024 | 5,024 | 320 | ||
Impaired loans with related allowance | 10,342 | 10,342 | |||
Recorded Investment | |||||
Impaired loans with no related allowance | 5,008 | 5,008 | 320 | ||
Impaired loans with related allowance | 10,304 | 10,304 | |||
Related Allowance | 7,466 | 7,466 | |||
Average Recorded Investment | |||||
Impaired loans with no related allowance | 5,008 | 1,013 | 5,008 | 1,021 | |
Impaired loans with related allowance | 10,304 | 940 | 10,304 | 940 | |
Interest Income Recognized | |||||
Impaired loans with no related allowance | 0 | 0 | 0 | 0 | |
Impaired loans with related allowance | 0 | 0 | 0 | ||
Agricultural production financing and other loans to farmers | |||||
Unpaid Principal Balance | |||||
Impaired loans with no related allowance | 299 | ||||
Recorded Investment | |||||
Impaired loans with no related allowance | 137 | ||||
Average Recorded Investment | |||||
Impaired loans with no related allowance | 668 | 672 | |||
Impaired loans with related allowance | 2,117 | 2,134 | |||
Interest Income Recognized | |||||
Impaired loans with no related allowance | 0 | 0 | |||
Construction | |||||
Unpaid Principal Balance | |||||
Impaired loans with no related allowance | 1,206 | ||||
Recorded Investment | |||||
Impaired loans with no related allowance | 970 | ||||
Average Recorded Investment | |||||
Impaired loans with no related allowance | 7,314 | 7,792 | |||
Interest Income Recognized | |||||
Impaired loans with no related allowance | 0 | 0 | |||
Commercial and farmland | |||||
Unpaid Principal Balance | |||||
Impaired loans with no related allowance | 9,675 | 9,675 | 8,037 | ||
Impaired loans with related allowance | 19,650 | 19,650 | 2,648 | ||
Recorded Investment | |||||
Impaired loans with no related allowance | 7,602 | 7,602 | 5,849 | ||
Impaired loans with related allowance | 18,910 | 18,910 | 1,909 | ||
Related Allowance | 4,943 | 4,943 | 231 | ||
Average Recorded Investment | |||||
Impaired loans with no related allowance | 7,637 | 7,998 | 7,910 | 8,187 | |
Impaired loans with related allowance | 18,910 | 157 | 19,156 | 164 | |
Interest Income Recognized | |||||
Impaired loans with no related allowance | 37 | 39 | 75 | 78 | |
Impaired loans with related allowance | 0 | ||||
Residential | |||||
Unpaid Principal Balance | |||||
Impaired loans with no related allowance | 75 | 75 | 93 | ||
Impaired loans with related allowance | 3,134 | 3,134 | 2,070 | ||
Recorded Investment | |||||
Impaired loans with no related allowance | 59 | 59 | 76 | ||
Impaired loans with related allowance | 3,009 | 3,009 | 2,044 | ||
Related Allowance | 520 | 520 | 383 | ||
Average Recorded Investment | |||||
Impaired loans with no related allowance | 59 | 38 | 59 | 38 | |
Impaired loans with related allowance | 3,020 | 2,021 | 3,032 | 2,029 | |
Interest Income Recognized | |||||
Impaired loans with no related allowance | 1 | 1 | 2 | 2 | |
Impaired loans with related allowance | 19 | 16 | 38 | 32 | |
Home equity | |||||
Unpaid Principal Balance | |||||
Impaired loans with related allowance | 401 | 401 | 417 | ||
Recorded Investment | |||||
Impaired loans with related allowance | 385 | 385 | 400 | ||
Related Allowance | 70 | 70 | 75 | ||
Average Recorded Investment | |||||
Impaired loans with no related allowance | 49 | 49 | |||
Impaired loans with related allowance | 387 | 351 | 390 | 352 | |
Interest Income Recognized | |||||
Impaired loans with no related allowance | 0 | ||||
Impaired loans with related allowance | 3 | 3 | 6 | 6 | |
Individuals' loans for household and other personal expenditures | |||||
Unpaid Principal Balance | |||||
Impaired loans with no related allowance | 3 | 3 | |||
Impaired loans with related allowance | 4 | ||||
Recorded Investment | |||||
Impaired loans with no related allowance | 3 | 3 | |||
Impaired loans with related allowance | 4 | ||||
Related Allowance | $ 0 | ||||
Average Recorded Investment | |||||
Impaired loans with no related allowance | $ 3 | 3 | |||
Impaired loans with related allowance | 14 | 15 | |||
Interest Income Recognized | |||||
Impaired loans with no related allowance | $ 0 | ||||
Impaired loans with related allowance | 0 | ||||
Public finance and other commercial loans | |||||
Average Recorded Investment | |||||
Impaired loans with no related allowance | 353 | 353 | |||
Interest Income Recognized | |||||
Impaired loans with no related allowance | $ 0 | $ 0 |
Loans and Allowance - Credit Qu
Loans and Allowance - Credit Quality of Loan Portfolio by Loan Class (Details) - USD ($) $ in Thousands | Jun. 30, 2020 | Dec. 31, 2019 |
Financing Receivable, Credit Quality Indicator [Line Items] | ||
Loans | $ 9,298,541 | $ 8,459,310 |
Commercial and industrial loans | ||
Financing Receivable, Credit Quality Indicator [Line Items] | ||
Loans | 2,898,329 | 2,109,879 |
Agricultural production financing and other loans to farmers | ||
Financing Receivable, Credit Quality Indicator [Line Items] | ||
Loans | 93,838 | 93,861 |
Construction | ||
Financing Receivable, Credit Quality Indicator [Line Items] | ||
Loans | 640,560 | 787,568 |
Commercial and farmland | ||
Financing Receivable, Credit Quality Indicator [Line Items] | ||
Loans | 3,239,998 | 3,052,698 |
Residential | ||
Financing Receivable, Credit Quality Indicator [Line Items] | ||
Loans | 1,145,187 | 1,143,217 |
Home equity | ||
Financing Receivable, Credit Quality Indicator [Line Items] | ||
Loans | 532,314 | 588,984 |
Individuals' loans for household and other personal expenditures | ||
Financing Receivable, Credit Quality Indicator [Line Items] | ||
Loans | 123,611 | 135,989 |
Public finance and other commercial loans | ||
Financing Receivable, Credit Quality Indicator [Line Items] | ||
Loans | 624,704 | 547,114 |
Commercial Pass | ||
Financing Receivable, Credit Quality Indicator [Line Items] | ||
Loans | 7,260,890 | 6,447,193 |
Commercial Pass | Commercial and industrial loans | ||
Financing Receivable, Credit Quality Indicator [Line Items] | ||
Loans | 2,722,071 | 1,956,985 |
Commercial Pass | Agricultural production financing and other loans to farmers | ||
Financing Receivable, Credit Quality Indicator [Line Items] | ||
Loans | 78,645 | 78,558 |
Commercial Pass | Construction | ||
Financing Receivable, Credit Quality Indicator [Line Items] | ||
Loans | 590,889 | 749,249 |
Commercial Pass | Commercial and farmland | ||
Financing Receivable, Credit Quality Indicator [Line Items] | ||
Loans | 3,035,363 | 2,894,366 |
Commercial Pass | Residential | ||
Financing Receivable, Credit Quality Indicator [Line Items] | ||
Loans | 189,053 | 196,710 |
Commercial Pass | Home equity | ||
Financing Receivable, Credit Quality Indicator [Line Items] | ||
Loans | 20,214 | 24,211 |
Commercial Pass | Individuals' loans for household and other personal expenditures | ||
Financing Receivable, Credit Quality Indicator [Line Items] | ||
Loans | 0 | 0 |
Commercial Pass | Public finance and other commercial loans | ||
Financing Receivable, Credit Quality Indicator [Line Items] | ||
Loans | 624,655 | 547,114 |
Commercial Special Mention | ||
Financing Receivable, Credit Quality Indicator [Line Items] | ||
Loans | 199,549 | 147,328 |
Commercial Special Mention | Commercial and industrial loans | ||
Financing Receivable, Credit Quality Indicator [Line Items] | ||
Loans | 87,069 | 81,179 |
Commercial Special Mention | Agricultural production financing and other loans to farmers | ||
Financing Receivable, Credit Quality Indicator [Line Items] | ||
Loans | 6,082 | 5,626 |
Commercial Special Mention | Construction | ||
Financing Receivable, Credit Quality Indicator [Line Items] | ||
Loans | 791 | 1,613 |
Commercial Special Mention | Commercial and farmland | ||
Financing Receivable, Credit Quality Indicator [Line Items] | ||
Loans | 103,921 | 57,776 |
Commercial Special Mention | Residential | ||
Financing Receivable, Credit Quality Indicator [Line Items] | ||
Loans | 1,637 | 877 |
Commercial Special Mention | Home equity | ||
Financing Receivable, Credit Quality Indicator [Line Items] | ||
Loans | 0 | 257 |
Commercial Special Mention | Individuals' loans for household and other personal expenditures | ||
Financing Receivable, Credit Quality Indicator [Line Items] | ||
Loans | 0 | 0 |
Commercial Special Mention | Public finance and other commercial loans | ||
Financing Receivable, Credit Quality Indicator [Line Items] | ||
Loans | 49 | 0 |
Commercial Substandard | ||
Financing Receivable, Credit Quality Indicator [Line Items] | ||
Loans | 225,885 | 190,358 |
Commercial Substandard | Commercial and industrial loans | ||
Financing Receivable, Credit Quality Indicator [Line Items] | ||
Loans | 89,189 | 71,715 |
Commercial Substandard | Agricultural production financing and other loans to farmers | ||
Financing Receivable, Credit Quality Indicator [Line Items] | ||
Loans | 9,111 | 9,677 |
Commercial Substandard | Construction | ||
Financing Receivable, Credit Quality Indicator [Line Items] | ||
Loans | 20,229 | 1,634 |
Commercial Substandard | Commercial and farmland | ||
Financing Receivable, Credit Quality Indicator [Line Items] | ||
Loans | 99,330 | 98,575 |
Commercial Substandard | Residential | ||
Financing Receivable, Credit Quality Indicator [Line Items] | ||
Loans | 6,684 | 8,075 |
Commercial Substandard | Home equity | ||
Financing Receivable, Credit Quality Indicator [Line Items] | ||
Loans | 1,342 | 682 |
Commercial Substandard | Individuals' loans for household and other personal expenditures | ||
Financing Receivable, Credit Quality Indicator [Line Items] | ||
Loans | 0 | 0 |
Commercial Substandard | Public finance and other commercial loans | ||
Financing Receivable, Credit Quality Indicator [Line Items] | ||
Loans | 0 | 0 |
Commercial Doubtful | ||
Financing Receivable, Credit Quality Indicator [Line Items] | ||
Loans | 0 | 0 |
Commercial Doubtful | Commercial and industrial loans | ||
Financing Receivable, Credit Quality Indicator [Line Items] | ||
Loans | 0 | 0 |
Commercial Doubtful | Agricultural production financing and other loans to farmers | ||
Financing Receivable, Credit Quality Indicator [Line Items] | ||
Loans | 0 | 0 |
Commercial Doubtful | Construction | ||
Financing Receivable, Credit Quality Indicator [Line Items] | ||
Loans | 0 | 0 |
Commercial Doubtful | Commercial and farmland | ||
Financing Receivable, Credit Quality Indicator [Line Items] | ||
Loans | 0 | 0 |
Commercial Doubtful | Residential | ||
Financing Receivable, Credit Quality Indicator [Line Items] | ||
Loans | 0 | 0 |
Commercial Doubtful | Home equity | ||
Financing Receivable, Credit Quality Indicator [Line Items] | ||
Loans | 0 | 0 |
Commercial Doubtful | Individuals' loans for household and other personal expenditures | ||
Financing Receivable, Credit Quality Indicator [Line Items] | ||
Loans | 0 | 0 |
Commercial Doubtful | Public finance and other commercial loans | ||
Financing Receivable, Credit Quality Indicator [Line Items] | ||
Loans | 0 | 0 |
Commercial Loss | ||
Financing Receivable, Credit Quality Indicator [Line Items] | ||
Loans | 0 | 0 |
Commercial Loss | Commercial and industrial loans | ||
Financing Receivable, Credit Quality Indicator [Line Items] | ||
Loans | 0 | 0 |
Commercial Loss | Agricultural production financing and other loans to farmers | ||
Financing Receivable, Credit Quality Indicator [Line Items] | ||
Loans | 0 | 0 |
Commercial Loss | Construction | ||
Financing Receivable, Credit Quality Indicator [Line Items] | ||
Loans | 0 | 0 |
Commercial Loss | Commercial and farmland | ||
Financing Receivable, Credit Quality Indicator [Line Items] | ||
Loans | 0 | 0 |
Commercial Loss | Residential | ||
Financing Receivable, Credit Quality Indicator [Line Items] | ||
Loans | 0 | 0 |
Commercial Loss | Home equity | ||
Financing Receivable, Credit Quality Indicator [Line Items] | ||
Loans | 0 | 0 |
Commercial Loss | Individuals' loans for household and other personal expenditures | ||
Financing Receivable, Credit Quality Indicator [Line Items] | ||
Loans | 0 | 0 |
Commercial Loss | Public finance and other commercial loans | ||
Financing Receivable, Credit Quality Indicator [Line Items] | ||
Loans | 0 | 0 |
Consumer Performing | ||
Financing Receivable, Credit Quality Indicator [Line Items] | ||
Loans | 1,605,123 | 1,668,247 |
Consumer Performing | Commercial and industrial loans | ||
Financing Receivable, Credit Quality Indicator [Line Items] | ||
Loans | 0 | 0 |
Consumer Performing | Agricultural production financing and other loans to farmers | ||
Financing Receivable, Credit Quality Indicator [Line Items] | ||
Loans | 0 | 0 |
Consumer Performing | Construction | ||
Financing Receivable, Credit Quality Indicator [Line Items] | ||
Loans | 28,536 | 35,072 |
Consumer Performing | Commercial and farmland | ||
Financing Receivable, Credit Quality Indicator [Line Items] | ||
Loans | 1,384 | 1,981 |
Consumer Performing | Residential | ||
Financing Receivable, Credit Quality Indicator [Line Items] | ||
Loans | 943,222 | 932,743 |
Consumer Performing | Home equity | ||
Financing Receivable, Credit Quality Indicator [Line Items] | ||
Loans | 508,457 | 562,507 |
Consumer Performing | Individuals' loans for household and other personal expenditures | ||
Financing Receivable, Credit Quality Indicator [Line Items] | ||
Loans | 123,524 | 135,944 |
Consumer Performing | Public finance and other commercial loans | ||
Financing Receivable, Credit Quality Indicator [Line Items] | ||
Loans | 0 | 0 |
Consumer Non-Performing | ||
Financing Receivable, Credit Quality Indicator [Line Items] | ||
Loans | 7,094 | 6,184 |
Consumer Non-Performing | Commercial and industrial loans | ||
Financing Receivable, Credit Quality Indicator [Line Items] | ||
Loans | 0 | 0 |
Consumer Non-Performing | Agricultural production financing and other loans to farmers | ||
Financing Receivable, Credit Quality Indicator [Line Items] | ||
Loans | 0 | 0 |
Consumer Non-Performing | Construction | ||
Financing Receivable, Credit Quality Indicator [Line Items] | ||
Loans | 115 | 0 |
Consumer Non-Performing | Commercial and farmland | ||
Financing Receivable, Credit Quality Indicator [Line Items] | ||
Loans | 0 | 0 |
Consumer Non-Performing | Residential | ||
Financing Receivable, Credit Quality Indicator [Line Items] | ||
Loans | 4,591 | 4,812 |
Consumer Non-Performing | Home equity | ||
Financing Receivable, Credit Quality Indicator [Line Items] | ||
Loans | 2,301 | 1,327 |
Consumer Non-Performing | Individuals' loans for household and other personal expenditures | ||
Financing Receivable, Credit Quality Indicator [Line Items] | ||
Loans | 87 | 45 |
Consumer Non-Performing | Public finance and other commercial loans | ||
Financing Receivable, Credit Quality Indicator [Line Items] | ||
Loans | $ 0 | $ 0 |
Loans and Allowance - Past Due
Loans and Allowance - Past Due Aging of Loan Portfolio by Loan Class (Details) - USD ($) $ in Thousands | Jun. 30, 2020 | Dec. 31, 2019 |
Financing Receivable, Past Due [Line Items] | ||
Current | $ 9,181,552 | $ 8,427,414 |
Non-Accrual | 50,102 | 15,949 |
Total Past Due & Non-Accrual | 116,989 | 31,896 |
Total | 9,298,541 | 8,459,310 |
Commercial and industrial loans | ||
Financing Receivable, Past Due [Line Items] | ||
Current | 2,871,366 | 2,105,445 |
Non-Accrual | 16,354 | 1,255 |
Total Past Due & Non-Accrual | 26,963 | 4,434 |
Total | 2,898,329 | 2,109,879 |
Agricultural production financing and other loans to farmers | ||
Financing Receivable, Past Due [Line Items] | ||
Current | 92,735 | 93,678 |
Non-Accrual | 0 | 183 |
Total Past Due & Non-Accrual | 1,103 | 183 |
Total | 93,838 | 93,861 |
Construction | ||
Financing Receivable, Past Due [Line Items] | ||
Current | 634,706 | 784,961 |
Non-Accrual | 119 | 977 |
Total Past Due & Non-Accrual | 5,854 | 2,607 |
Total | 640,560 | 787,568 |
Commercial and farmland | ||
Financing Receivable, Past Due [Line Items] | ||
Current | 3,172,688 | 3,043,318 |
Non-Accrual | 25,405 | 7,007 |
Total Past Due & Non-Accrual | 67,310 | 9,380 |
Total | 3,239,998 | 3,052,698 |
Residential | ||
Financing Receivable, Past Due [Line Items] | ||
Current | 1,136,131 | 1,133,476 |
Non-Accrual | 5,773 | 5,062 |
Total Past Due & Non-Accrual | 9,056 | 9,741 |
Total | 1,145,187 | 1,143,217 |
Home equity | ||
Financing Receivable, Past Due [Line Items] | ||
Current | 526,096 | 584,023 |
Non-Accrual | 2,376 | 1,421 |
Total Past Due & Non-Accrual | 6,218 | 4,961 |
Total | 532,314 | 588,984 |
Individuals' loans for household and other personal expenditures | ||
Financing Receivable, Past Due [Line Items] | ||
Current | 123,126 | 135,399 |
Non-Accrual | 75 | 44 |
Total Past Due & Non-Accrual | 485 | 590 |
Total | 123,611 | 135,989 |
Public finance and other commercial loans | ||
Financing Receivable, Past Due [Line Items] | ||
Current | 624,704 | 547,114 |
Non-Accrual | 0 | 0 |
Total Past Due & Non-Accrual | 0 | |
Total | 624,704 | 547,114 |
30-59 Days Past Due | ||
Financing Receivable, Past Due [Line Items] | ||
Past Due | 39,737 | 14,683 |
30-59 Days Past Due | Commercial and industrial loans | ||
Financing Receivable, Past Due [Line Items] | ||
Past Due | 9,435 | 3,039 |
30-59 Days Past Due | Agricultural production financing and other loans to farmers | ||
Financing Receivable, Past Due [Line Items] | ||
Past Due | 1,103 | 0 |
30-59 Days Past Due | Construction | ||
Financing Receivable, Past Due [Line Items] | ||
Past Due | 5,235 | 1,630 |
30-59 Days Past Due | Commercial and farmland | ||
Financing Receivable, Past Due [Line Items] | ||
Past Due | 18,948 | 2,324 |
30-59 Days Past Due | Residential | ||
Financing Receivable, Past Due [Line Items] | ||
Past Due | 2,679 | 4,290 |
30-59 Days Past Due | Home equity | ||
Financing Receivable, Past Due [Line Items] | ||
Past Due | 2,110 | 2,960 |
30-59 Days Past Due | Individuals' loans for household and other personal expenditures | ||
Financing Receivable, Past Due [Line Items] | ||
Past Due | 227 | 440 |
30-59 Days Past Due | Public finance and other commercial loans | ||
Financing Receivable, Past Due [Line Items] | ||
Past Due | 0 | 0 |
60-89 Days Past Due | ||
Financing Receivable, Past Due [Line Items] | ||
Past Due | 22,169 | 1,195 |
60-89 Days Past Due | Commercial and industrial loans | ||
Financing Receivable, Past Due [Line Items] | ||
Past Due | 1,038 | 136 |
60-89 Days Past Due | Agricultural production financing and other loans to farmers | ||
Financing Receivable, Past Due [Line Items] | ||
Past Due | 0 | 0 |
60-89 Days Past Due | Construction | ||
Financing Receivable, Past Due [Line Items] | ||
Past Due | 500 | 0 |
60-89 Days Past Due | Commercial and farmland | ||
Financing Receivable, Past Due [Line Items] | ||
Past Due | 18,458 | 49 |
60-89 Days Past Due | Residential | ||
Financing Receivable, Past Due [Line Items] | ||
Past Due | 329 | 367 |
60-89 Days Past Due | Home equity | ||
Financing Receivable, Past Due [Line Items] | ||
Past Due | 1,673 | 538 |
60-89 Days Past Due | Individuals' loans for household and other personal expenditures | ||
Financing Receivable, Past Due [Line Items] | ||
Past Due | 171 | 105 |
60-89 Days Past Due | Public finance and other commercial loans | ||
Financing Receivable, Past Due [Line Items] | ||
Past Due | 0 | 0 |
Loans 90 Days or More Past Due And Accruing | ||
Financing Receivable, Past Due [Line Items] | ||
Past Due | 4,981 | 69 |
Loans 90 Days or More Past Due And Accruing | Commercial and industrial loans | ||
Financing Receivable, Past Due [Line Items] | ||
Past Due | 136 | 4 |
Loans 90 Days or More Past Due And Accruing | Agricultural production financing and other loans to farmers | ||
Financing Receivable, Past Due [Line Items] | ||
Past Due | 0 | 0 |
Loans 90 Days or More Past Due And Accruing | Construction | ||
Financing Receivable, Past Due [Line Items] | ||
Past Due | 0 | 0 |
Loans 90 Days or More Past Due And Accruing | Commercial and farmland | ||
Financing Receivable, Past Due [Line Items] | ||
Past Due | 4,499 | 0 |
Loans 90 Days or More Past Due And Accruing | Residential | ||
Financing Receivable, Past Due [Line Items] | ||
Past Due | 275 | 22 |
Loans 90 Days or More Past Due And Accruing | Home equity | ||
Financing Receivable, Past Due [Line Items] | ||
Past Due | 59 | 42 |
Loans 90 Days or More Past Due And Accruing | Individuals' loans for household and other personal expenditures | ||
Financing Receivable, Past Due [Line Items] | ||
Past Due | 12 | 1 |
Loans 90 Days or More Past Due And Accruing | Public finance and other commercial loans | ||
Financing Receivable, Past Due [Line Items] | ||
Past Due | $ 0 | $ 0 |
Loans and Allowance - Summary_2
Loans and Allowance - Summary of Troubled Debt Restructurings (Details) $ in Thousands | 3 Months Ended | 6 Months Ended | ||
Jun. 30, 2020USD ($)loan | Jun. 30, 2019USD ($)loan | Jun. 30, 2020USD ($)loan | Jun. 30, 2019USD ($)loan | |
Financing Receivable, Troubled Debt Restructuring [Line Items] | ||||
Pre-Modification Recorded Balance | $ 1,519 | $ 171 | $ 1,519 | $ 261 |
Post-Modification Recorded Balance | $ 1,556 | $ 164 | $ 1,556 | $ 254 |
Number of Loans | loan | 11 | 4 | 11 | 5 |
Commercial and industrial loans | ||||
Financing Receivable, Troubled Debt Restructuring [Line Items] | ||||
Pre-Modification Recorded Balance | $ 654 | $ 654 | ||
Post-Modification Recorded Balance | $ 654 | $ 654 | ||
Number of Loans | loan | 3 | 3 | ||
Commercial and farmland | ||||
Financing Receivable, Troubled Debt Restructuring [Line Items] | ||||
Pre-Modification Recorded Balance | $ 565 | $ 565 | ||
Post-Modification Recorded Balance | $ 565 | $ 565 | ||
Number of Loans | loan | 2 | 2 | ||
Residential | ||||
Financing Receivable, Troubled Debt Restructuring [Line Items] | ||||
Pre-Modification Recorded Balance | $ 300 | $ 171 | $ 300 | $ 261 |
Post-Modification Recorded Balance | $ 337 | $ 164 | $ 337 | $ 254 |
Number of Loans | loan | 6 | 4 | 6 | 5 |
Loans and Allowance - Summary_3
Loans and Allowance - Summary of Troubled Debt Restructurings by Modification Type (Details) - USD ($) $ in Thousands | 3 Months Ended | 6 Months Ended | ||
Jun. 30, 2020 | Jun. 30, 2019 | Jun. 30, 2020 | Jun. 30, 2019 | |
Financing Receivable, Troubled Debt Restructuring [Line Items] | ||||
Modification | $ 1,551 | $ 164 | $ 1,551 | $ 253 |
Term Modification | ||||
Financing Receivable, Troubled Debt Restructuring [Line Items] | ||||
Modification | 1,217 | 1,217 | 0 | |
Rate Modification | ||||
Financing Receivable, Troubled Debt Restructuring [Line Items] | ||||
Modification | 111 | 111 | 89 | |
Combination | ||||
Financing Receivable, Troubled Debt Restructuring [Line Items] | ||||
Modification | 223 | 164 | 223 | 164 |
Commercial and industrial loans | ||||
Financing Receivable, Troubled Debt Restructuring [Line Items] | ||||
Modification | 652 | 652 | ||
Commercial and industrial loans | Term Modification | ||||
Financing Receivable, Troubled Debt Restructuring [Line Items] | ||||
Modification | 652 | 652 | ||
Commercial and industrial loans | Rate Modification | ||||
Financing Receivable, Troubled Debt Restructuring [Line Items] | ||||
Modification | 0 | |||
Commercial and industrial loans | Combination | ||||
Financing Receivable, Troubled Debt Restructuring [Line Items] | ||||
Modification | 0 | 0 | ||
Commercial and farmland | ||||
Financing Receivable, Troubled Debt Restructuring [Line Items] | ||||
Modification | 565 | 565 | ||
Commercial and farmland | Term Modification | ||||
Financing Receivable, Troubled Debt Restructuring [Line Items] | ||||
Modification | 565 | 565 | ||
Commercial and farmland | Combination | ||||
Financing Receivable, Troubled Debt Restructuring [Line Items] | ||||
Modification | 0 | 0 | ||
Residential | ||||
Financing Receivable, Troubled Debt Restructuring [Line Items] | ||||
Modification | 334 | 164 | 334 | 253 |
Residential | Term Modification | ||||
Financing Receivable, Troubled Debt Restructuring [Line Items] | ||||
Modification | 0 | |||
Residential | Rate Modification | ||||
Financing Receivable, Troubled Debt Restructuring [Line Items] | ||||
Modification | 111 | 111 | 89 | |
Residential | Combination | ||||
Financing Receivable, Troubled Debt Restructuring [Line Items] | ||||
Modification | $ 223 | $ 164 | $ 223 | $ 164 |
Loans and Allowance - Subsequen
Loans and Allowance - Subsequent Default (Details) $ in Thousands | 3 Months Ended | 6 Months Ended | ||
Jun. 30, 2020USD ($)loan | Jun. 30, 2019USD ($)loan | Jun. 30, 2020USD ($)loan | Jun. 30, 2019USD ($)loan | |
Financing Receivable, Troubled Debt Restructuring [Line Items] | ||||
Number of Loans | loan | 1 | 1 | 1 | 1 |
Recorded Balance | $ | $ 268 | $ 62 | $ 268 | $ 62 |
Commercial and industrial loans | ||||
Financing Receivable, Troubled Debt Restructuring [Line Items] | ||||
Number of Loans | loan | 1 | 1 | ||
Recorded Balance | $ | $ 268 | $ 268 | ||
Residential | ||||
Financing Receivable, Troubled Debt Restructuring [Line Items] | ||||
Number of Loans | loan | 1 | 1 | ||
Recorded Balance | $ | $ 62 | $ 62 |
Purchased Credit Impaired Loa_3
Purchased Credit Impaired Loans - Accretable Yield or Income Expected to be Collected (Details) - USD ($) $ in Thousands | 3 Months Ended | 6 Months Ended | |||
Jun. 30, 2020 | Jun. 30, 2019 | Jun. 30, 2020 | Jun. 30, 2019 | Dec. 31, 2019 | |
Certain Loans Acquired in Transfer Not Accounted for as Debt Securities, Accretable Yield Movement Schedule [Roll Forward] | |||||
Accretable yield beginning balance | $ 1,926 | $ 2,064 | $ 2,132 | $ 2,143 | |
Additions | 0 | 0 | 0 | 0 | |
Accretion | (1,033) | (638) | (1,418) | (1,218) | |
Reclassification from nonaccretable | 653 | 488 | 839 | 989 | |
Disposals | 0 | 0 | (7) | 0 | |
Accretable yield ending balance | 1,546 | $ 1,914 | 1,546 | $ 1,914 | |
Loans acquired with deteriorated credit quality | |||||
Accounts, Notes, Loans and Financing Receivable [Line Items] | |||||
Loans acquired and accounted for under ASC 310-30, carrying amount | 12,100 | 12,100 | $ 16,100 | ||
Loans acquired and accounted for under ASC 310-30, allowance amount | $ 192 | $ 192 | $ 124 |
Goodwill - Narrative (Details)
Goodwill - Narrative (Details) - USD ($) $ in Thousands | 12 Months Ended | |||
Dec. 31, 2019 | Jun. 30, 2020 | Sep. 01, 2019 | Dec. 31, 2018 | |
Goodwill [Line Items] | ||||
Goodwill | $ 543,918 | $ 543,918 | $ 445,355 | |
Measurement period adjustment | 719 | |||
MBT | ||||
Goodwill [Line Items] | ||||
Goodwill | $ 98,563 | |||
Measurement period adjustment | $ 719 |
Goodwill - Schedule of Goodwill
Goodwill - Schedule of Goodwill (Details) $ in Thousands | 12 Months Ended |
Dec. 31, 2019USD ($) | |
Goodwill [Roll Forward] | |
Balance, January 1 | $ 445,355 |
Goodwill acquired | 97,844 |
Measurement period adjustment | 719 |
Balance, Period end | $ 543,918 |
Core Deposit Intangibles - Narr
Core Deposit Intangibles - Narrative (Details) - USD ($) $ in Thousands | 3 Months Ended | 6 Months Ended | |||
Jun. 30, 2020 | Jun. 30, 2019 | Jun. 30, 2020 | Jun. 30, 2019 | Sep. 01, 2019 | |
Finite-Lived Intangible Assets [Line Items] | |||||
Intangible asset amortization | $ 1,511 | $ 1,520 | $ 3,025 | $ 3,048 | |
Maximum | |||||
Finite-Lived Intangible Assets [Line Items] | |||||
Useful life of core deposit intangibles and other intangibles | 10 years | ||||
MBT | |||||
Finite-Lived Intangible Assets [Line Items] | |||||
Core deposit intangible | $ 16,527 |
Core Deposit Intangibles - Sche
Core Deposit Intangibles - Schedule of Core Deposit and Other Intangibles (Details) - USD ($) $ in Thousands | 6 Months Ended | 12 Months Ended |
Jun. 30, 2020 | Dec. 31, 2019 | |
Finite-Lived Intangible Assets [Line Items] | ||
Gross carrying amount | $ 102,396 | $ 85,869 |
Accumulated amortization | (70,459) | (67,434) |
Total core deposit intangibles | 31,937 | 34,962 |
Core deposit intangibles acquired | ||
Finite-Lived Intangible Assets [Line Items] | ||
Core deposit intangibles acquired | $ 0 | $ 16,527 |
Core Deposit Intangibles - Esti
Core Deposit Intangibles - Estimated Future Amortization Expense (Details) - USD ($) $ in Thousands | Jun. 30, 2020 | Dec. 31, 2019 |
Amortization Expense | ||
2020 | $ 2,962 | |
2021 | 5,429 | |
2022 | 5,027 | |
2023 | 4,827 | |
2024 | 4,241 | |
After 2024 | 9,451 | |
Total core deposit intangibles | $ 31,937 | $ 34,962 |
Derivative Financial Instrume_3
Derivative Financial Instruments - Narrative (Details) $ in Thousands | 6 Months Ended | |
Jun. 30, 2020USD ($)interest_rate_swapinstrument | Dec. 31, 2019USD ($)interest_rate_swap | |
Derivative [Line Items] | ||
Estimated amount to be transferred from accumulated other comprehensive income to earnings | $ 1,046 | |
Termination value of derivatives in a net liability position | 87,754 | |
Derivative collateral posted | 80,855 | |
Not Designated as Hedging Instrument | ||
Derivative [Line Items] | ||
Notional amount of interest rate derivatives | $ 817,463 | $ 692,287 |
Federal Home Loan Bank Advances | ||
Derivative [Line Items] | ||
Number of debt instruments held | instrument | 2 | |
Interest rate contracts | Not Designated as Hedging Instrument | ||
Derivative [Line Items] | ||
Increase in derivative assets | $ 56,800 | |
Increase in derivative liabilities | 57,900 | |
Increase in outstanding notional balance | $ 125,200 | |
Cash Flow Hedging | Interest Rate Swap | ||
Derivative [Line Items] | ||
Number of interest rate derivatives held | interest_rate_swap | 4 | 4 |
Notional amount of interest rate derivatives | $ 46,000 | $ 46,000 |
Cash Flow Hedging | Interest Rate Swap | Trust Preferred Debt | ||
Derivative [Line Items] | ||
Notional amount of interest rate derivatives | 26,000 | |
Cash Flow Hedging | Interest Rate Swap | Federal Home Loan Bank Advances | ||
Derivative [Line Items] | ||
Notional amount of interest rate derivatives | $ 20,000 |
Derivative Financial Instrume_4
Derivative Financial Instruments - Fair Value of Derivative Financial Instruments and Their Classification on Balance Sheet (Details) - Interest rate contracts - USD ($) $ in Thousands | Jun. 30, 2020 | Dec. 31, 2019 |
Derivatives designated as hedging instruments | Other Assets | ||
Derivatives, Fair Value [Line Items] | ||
Asset Derivatives | $ 0 | $ 0 |
Derivatives designated as hedging instruments | Other Liabilities | ||
Derivatives, Fair Value [Line Items] | ||
Liability Derivatives | 2,547 | 1,444 |
Derivatives not designated as hedging instruments | Other Assets | ||
Derivatives, Fair Value [Line Items] | ||
Asset Derivatives | 84,658 | 27,855 |
Derivatives not designated as hedging instruments | Other Liabilities | ||
Derivatives, Fair Value [Line Items] | ||
Liability Derivatives | $ 84,658 | $ 27,855 |
Derivative Financial Instrume_5
Derivative Financial Instruments - Effect of Derivative Financial Instruments on Other Comprehensive Income (Details) - USD ($) $ in Thousands | 3 Months Ended | 6 Months Ended | ||
Jun. 30, 2020 | Jun. 30, 2019 | Jun. 30, 2020 | Jun. 30, 2019 | |
Designated as Hedging Instrument | Cash Flow Hedging | Interest Rate Products | ||||
Derivative [Line Items] | ||||
Amount of Gain (Loss) Recognized in Other Comprehensive Income on Derivative (Effective Portion) | $ (145) | $ (701) | $ (1,459) | $ (1,092) |
Derivative Financial Instrume_6
Derivative Financial Instruments - Effect of Derivative Financial Instruments on Income Statement (Details) - USD ($) $ in Thousands | 3 Months Ended | 6 Months Ended | ||
Jun. 30, 2020 | Jun. 30, 2019 | Jun. 30, 2020 | Jun. 30, 2019 | |
Interest rate contracts | Derivatives designated as hedging instruments | Interest Expense | ||||
Derivative [Line Items] | ||||
Amount of Gain (Loss) Reclassified from Other Comprehensive Income into Income (Effective Portion) | $ (231) | $ (84) | $ (357) | $ (143) |
Disclosures About Fair Value _3
Disclosures About Fair Value of Assets and Liabilities - Fair Value Measurements of Assets and Liabilities Measured at Fair Value on Recurring Basis (Details) - USD ($) $ in Thousands | Jun. 30, 2020 | Dec. 31, 2019 |
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Investment securities available for sale | $ 1,890,593 | $ 1,790,025 |
Quoted Prices in Active Markets for Identical Assets (Level 1) | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Investment securities available for sale | 0 | 0 |
Significant Other Observable Inputs (Level 2) | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Investment securities available for sale | 1,888,093 | 1,787,132 |
Significant Unobservable Inputs (Level 3) | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Investment securities available for sale | 2,500 | 2,893 |
Fair Value, Measurements, Recurring | Interest rate swap liability | Quoted Prices in Active Markets for Identical Assets (Level 1) | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Interest rate swap liability | 0 | 0 |
Fair Value, Measurements, Recurring | Interest rate swap liability | Significant Other Observable Inputs (Level 2) | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Interest rate swap liability | 87,205 | 29,299 |
Fair Value, Measurements, Recurring | Interest rate swap liability | Significant Unobservable Inputs (Level 3) | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Interest rate swap liability | 0 | 0 |
Fair Value, Measurements, Recurring | Fair Value | Interest rate swap liability | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Interest rate swap liability | 87,205 | 29,299 |
U.S. Treasury | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Investment securities available for sale | 600 | |
U.S. Treasury | Fair Value, Measurements, Recurring | Quoted Prices in Active Markets for Identical Assets (Level 1) | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Investment securities available for sale | 0 | |
U.S. Treasury | Fair Value, Measurements, Recurring | Significant Other Observable Inputs (Level 2) | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Investment securities available for sale | 600 | |
U.S. Treasury | Fair Value, Measurements, Recurring | Significant Unobservable Inputs (Level 3) | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Investment securities available for sale | 0 | |
U.S. Treasury | Fair Value, Measurements, Recurring | Fair Value | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Investment securities available for sale | 600 | |
U.S. Government-sponsored agency securities | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Investment securities available for sale | 2,453 | 38,875 |
U.S. Government-sponsored agency securities | Fair Value, Measurements, Recurring | Quoted Prices in Active Markets for Identical Assets (Level 1) | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Investment securities available for sale | 0 | 0 |
U.S. Government-sponsored agency securities | Fair Value, Measurements, Recurring | Significant Other Observable Inputs (Level 2) | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Investment securities available for sale | 2,453 | 38,875 |
U.S. Government-sponsored agency securities | Fair Value, Measurements, Recurring | Significant Unobservable Inputs (Level 3) | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Investment securities available for sale | 0 | 0 |
U.S. Government-sponsored agency securities | Fair Value, Measurements, Recurring | Fair Value | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Investment securities available for sale | 2,453 | 38,875 |
State and municipal | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Investment securities available for sale | 1,094,218 | 899,796 |
State and municipal | Fair Value, Measurements, Recurring | Quoted Prices in Active Markets for Identical Assets (Level 1) | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Investment securities available for sale | 0 | 0 |
State and municipal | Fair Value, Measurements, Recurring | Significant Other Observable Inputs (Level 2) | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Investment securities available for sale | 1,091,753 | 896,938 |
State and municipal | Fair Value, Measurements, Recurring | Significant Unobservable Inputs (Level 3) | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Investment securities available for sale | 2,465 | 2,858 |
State and municipal | Fair Value, Measurements, Recurring | Fair Value | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Investment securities available for sale | 1,094,218 | 899,796 |
U.S. Government-sponsored mortgage-backed securities | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Investment securities available for sale | 790,234 | 851,323 |
U.S. Government-sponsored mortgage-backed securities | Fair Value, Measurements, Recurring | Quoted Prices in Active Markets for Identical Assets (Level 1) | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Investment securities available for sale | 0 | 0 |
U.S. Government-sponsored mortgage-backed securities | Fair Value, Measurements, Recurring | Significant Other Observable Inputs (Level 2) | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Investment securities available for sale | 790,230 | 851,319 |
U.S. Government-sponsored mortgage-backed securities | Fair Value, Measurements, Recurring | Significant Unobservable Inputs (Level 3) | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Investment securities available for sale | 4 | 4 |
U.S. Government-sponsored mortgage-backed securities | Fair Value, Measurements, Recurring | Fair Value | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Investment securities available for sale | 790,234 | 851,323 |
Corporate obligations | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Investment securities available for sale | 3,088 | 31 |
Corporate obligations | Fair Value, Measurements, Recurring | Quoted Prices in Active Markets for Identical Assets (Level 1) | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Investment securities available for sale | 0 | 0 |
Corporate obligations | Fair Value, Measurements, Recurring | Significant Other Observable Inputs (Level 2) | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Investment securities available for sale | 3,057 | 0 |
Corporate obligations | Fair Value, Measurements, Recurring | Significant Unobservable Inputs (Level 3) | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Investment securities available for sale | 31 | 31 |
Corporate obligations | Fair Value, Measurements, Recurring | Fair Value | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Investment securities available for sale | 3,088 | 31 |
Interest rate swap asset | Fair Value, Measurements, Recurring | Quoted Prices in Active Markets for Identical Assets (Level 1) | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Interest rate swap asset | 0 | 0 |
Interest rate swap asset | Fair Value, Measurements, Recurring | Significant Other Observable Inputs (Level 2) | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Interest rate swap asset | 84,658 | 27,855 |
Interest rate swap asset | Fair Value, Measurements, Recurring | Significant Unobservable Inputs (Level 3) | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Interest rate swap asset | 0 | 0 |
Interest rate swap asset | Fair Value, Measurements, Recurring | Fair Value | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Interest rate swap asset | $ 84,658 | $ 27,855 |
Disclosures About Fair Value _4
Disclosures About Fair Value of Assets and Liabilities - Reconciliation of Beginning and Ending Balances of Recurring Fair Value Measurements using Significant Unobservable Level 3 Inputs (Details) - Fair Value, Measurements, Recurring - Available for Sale Securities - USD ($) $ in Thousands | 3 Months Ended | 6 Months Ended | ||
Jun. 30, 2020 | Jun. 30, 2019 | Jun. 30, 2020 | Jun. 30, 2019 | |
Available for Sale Securities | ||||
Balance at beginning of the period | $ 2,528 | $ 2,936 | $ 2,892 | $ 3,328 |
Included in other comprehensive income | (30) | 37 | (50) | 80 |
Principal payments | 2 | 2 | (342) | (433) |
Ending balance | $ 2,500 | $ 2,975 | $ 2,500 | $ 2,975 |
Disclosures About Fair Value _5
Disclosures About Fair Value of Assets and Liabilities - Transfers Between Levels (Details) - USD ($) | 3 Months Ended | |
Jun. 30, 2020 | Jun. 30, 2019 | |
Fair Value Disclosures [Abstract] | ||
Transfers in or out of Level 3 | $ 0 | $ 0 |
Disclosures About Fair Value _6
Disclosures About Fair Value of Assets and Liabilities - Valuation Methodologies Used for Instruments Measured at Fair Value on Non-Recurring Basis (Details) - Fair Value, Measurements, Nonrecurring - USD ($) $ in Thousands | Jun. 30, 2020 | Dec. 31, 2019 |
Impaired loans (collateral dependent) | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Fair Value | $ 22,690 | $ 5,653 |
Impaired loans (collateral dependent) | Quoted Prices in Active Markets for Identical Assets (Level 1) | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Fair Value | 0 | 0 |
Impaired loans (collateral dependent) | Significant Other Observable Inputs (Level 2) | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Fair Value | 0 | 0 |
Impaired loans (collateral dependent) | Significant Unobservable Inputs (Level 3) | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Fair Value | 22,690 | 5,653 |
Other real estate owned | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Fair Value | 464 | 194 |
Other real estate owned | Quoted Prices in Active Markets for Identical Assets (Level 1) | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Fair Value | 0 | 0 |
Other real estate owned | Significant Other Observable Inputs (Level 2) | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Fair Value | 0 | 0 |
Other real estate owned | Significant Unobservable Inputs (Level 3) | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Fair Value | $ 464 | $ 194 |
Disclosures About Fair Value _7
Disclosures About Fair Value of Assets and Liabilities - Unobservable Inputs Used in Recurring and Nonrecurring Level 3 Fair Value Measurements Other Than Goodwill (Details) - Significant Unobservable Inputs (Level 3) $ in Thousands | 6 Months Ended | 12 Months Ended |
Jun. 30, 2020USD ($) | Dec. 31, 2019USD ($) | |
State and municipal securities | Discounted cash flow | ||
Fair Value Measurement Inputs and Valuation Techniques [Line Items] | ||
Fair Value | $ 2,465 | $ 2,858 |
State and municipal securities | Discounted cash flow | Minimum | ||
Fair Value Measurement Inputs and Valuation Techniques [Line Items] | ||
Maturity/Call date | 1 month | 1 month |
US Muni BQ curve | A- | A- |
State and municipal securities | Discounted cash flow | Maximum | ||
Fair Value Measurement Inputs and Valuation Techniques [Line Items] | ||
Maturity/Call date | 15 years | 15 years |
US Muni BQ curve | BBB- | BBB- |
Corporate obligations and U.S. Government-sponsored mortgage-backed securities | Discounted cash flow | ||
Fair Value Measurement Inputs and Valuation Techniques [Line Items] | ||
Fair Value | $ 35 | $ 35 |
Impaired loans (collateral dependent) | Collateral based measurements | ||
Fair Value Measurement Inputs and Valuation Techniques [Line Items] | ||
Fair Value | 22,690 | 5,653 |
Other real estate owned | Appraisals | ||
Fair Value Measurement Inputs and Valuation Techniques [Line Items] | ||
Fair Value | $ 464 | $ 194 |
Discount rate | State and municipal securities | Discounted cash flow | Minimum | ||
Fair Value Measurement Inputs and Valuation Techniques [Line Items] | ||
Discount rate | 0.015 | 0.0200 |
Discount rate | State and municipal securities | Discounted cash flow | Maximum | ||
Fair Value Measurement Inputs and Valuation Techniques [Line Items] | ||
Discount rate | 0.04 | 0.05 |
Weighted-average coupon | State and municipal securities | Discounted cash flow | Weighted Average | ||
Fair Value Measurement Inputs and Valuation Techniques [Line Items] | ||
Discount rate | 0.0387 | 0.0392 |
Weighted-average coupon | Corporate obligations and U.S. Government-sponsored mortgage-backed securities | Discounted cash flow | Weighted Average | ||
Fair Value Measurement Inputs and Valuation Techniques [Line Items] | ||
Discount rate | 0 | 0 |
Risk free rate | Corporate obligations and U.S. Government-sponsored mortgage-backed securities | Discounted cash flow | ||
Fair Value Measurement Inputs and Valuation Techniques [Line Items] | ||
Risk free rate | 3 month LIBOR | 3 month LIBOR |
Plus premium for illiquidity | Corporate obligations and U.S. Government-sponsored mortgage-backed securities | Discounted cash flow | ||
Fair Value Measurement Inputs and Valuation Techniques [Line Items] | ||
Discount rate | 0.0200 | 0.0200 |
Discount to reflect current market conditions and ultimate collectability | Impaired loans (collateral dependent) | Collateral based measurements | Minimum | ||
Fair Value Measurement Inputs and Valuation Techniques [Line Items] | ||
Discount to reflect current market conditions and ultimate collectability | 0 | 0 |
Discount to reflect current market conditions and ultimate collectability | Impaired loans (collateral dependent) | Collateral based measurements | Maximum | ||
Fair Value Measurement Inputs and Valuation Techniques [Line Items] | ||
Discount to reflect current market conditions and ultimate collectability | 0.10 | 0.10 |
Discount to reflect current market conditions and ultimate collectability | Impaired loans (collateral dependent) | Collateral based measurements | Weighted Average | ||
Fair Value Measurement Inputs and Valuation Techniques [Line Items] | ||
Discount to reflect current market conditions and ultimate collectability | 0.10 | 0.01 |
Discount to reflect current market conditions | Other real estate owned | Appraisals | Minimum | ||
Fair Value Measurement Inputs and Valuation Techniques [Line Items] | ||
Other real estate owned | 0 | 0 |
Discount to reflect current market conditions | Other real estate owned | Appraisals | Maximum | ||
Fair Value Measurement Inputs and Valuation Techniques [Line Items] | ||
Other real estate owned | 0.72 | 0.37 |
Discount to reflect current market conditions | Other real estate owned | Appraisals | Weighted Average | ||
Fair Value Measurement Inputs and Valuation Techniques [Line Items] | ||
Other real estate owned | 0.32 | 0.37 |
Disclosures About Fair Value _8
Disclosures About Fair Value of Assets and Liabilities - Estimated Fair Values of Financial Instruments (Details) - USD ($) $ in Thousands | Jun. 30, 2020 | Dec. 31, 2019 |
Assets: | ||
Investment securities available for sale | $ 1,890,593 | $ 1,790,025 |
Investment securities held to maturity | 941,426 | 827,566 |
Loans held for sale | 901 | 9,037 |
Quoted Prices in Active Markets for Identical Assets (Level 1) | ||
Assets: | ||
Cash and cash equivalents | 229,759 | 177,201 |
Interest-bearing time deposits | 380,021 | 118,263 |
Investment securities available for sale | 0 | 0 |
Investment securities held to maturity | 0 | 0 |
Loans held for sale | 0 | 0 |
Loans | 0 | 0 |
Federal Home Loan Bank stock | 0 | 0 |
Interest rate swap asset | 0 | 0 |
Interest receivable | 0 | 0 |
Liabilities: | ||
Deposits | 9,566,516 | 8,146,745 |
Borrowings: | ||
Federal funds purchased | 0 | |
Securities sold under repurchase agreements | 0 | 0 |
Federal Home Loan Bank advances | 0 | 0 |
Subordinated debentures and other borrowings | 0 | 0 |
Interest rate swap liability | 0 | 0 |
Interest payable | 0 | 0 |
Significant Other Observable Inputs (Level 2) | ||
Assets: | ||
Cash and cash equivalents | 0 | 0 |
Interest-bearing time deposits | 0 | 0 |
Investment securities available for sale | 1,888,093 | 1,787,132 |
Investment securities held to maturity | 920,146 | 799,884 |
Loans held for sale | 901 | 9,037 |
Loans | 0 | 0 |
Federal Home Loan Bank stock | 28,736 | 28,736 |
Interest rate swap asset | 84,658 | 27,855 |
Interest receivable | 57,063 | 48,901 |
Liabilities: | ||
Deposits | 1,395,002 | 1,675,202 |
Borrowings: | ||
Federal funds purchased | 55,000 | |
Securities sold under repurchase agreements | 181,150 | 187,801 |
Federal Home Loan Bank advances | 415,737 | 352,581 |
Subordinated debentures and other borrowings | 276,306 | 123,571 |
Interest rate swap liability | 87,205 | 29,299 |
Interest payable | 5,587 | 6,754 |
Significant Unobservable Inputs (Level 3) | ||
Assets: | ||
Cash and cash equivalents | 0 | 0 |
Interest-bearing time deposits | 0 | 0 |
Investment securities available for sale | 2,500 | 2,893 |
Investment securities held to maturity | 21,280 | 27,682 |
Loans held for sale | 0 | 0 |
Loans | 9,253,762 | 8,335,340 |
Federal Home Loan Bank stock | 0 | 0 |
Interest rate swap asset | 0 | 0 |
Interest receivable | 0 | 0 |
Liabilities: | ||
Deposits | 0 | 0 |
Borrowings: | ||
Federal funds purchased | 0 | |
Securities sold under repurchase agreements | 0 | 0 |
Federal Home Loan Bank advances | 0 | 0 |
Subordinated debentures and other borrowings | 0 | 0 |
Interest rate swap liability | 0 | 0 |
Interest payable | 0 | 0 |
Carrying Amount | ||
Assets: | ||
Cash and cash equivalents | 229,759 | 177,201 |
Interest-bearing time deposits | 380,021 | 118,263 |
Investment securities available for sale | 1,890,593 | 1,790,025 |
Investment securities held to maturity | 898,786 | 806,038 |
Loans held for sale | 901 | 9,037 |
Loans | 9,177,422 | 8,379,026 |
Federal Home Loan Bank stock | 28,736 | 28,736 |
Interest rate swap asset | 84,658 | 27,855 |
Interest receivable | 57,063 | 48,901 |
Liabilities: | ||
Deposits | 10,965,988 | 9,839,956 |
Borrowings: | ||
Federal funds purchased | 55,000 | |
Securities sold under repurchase agreements | 181,150 | 187,946 |
Federal Home Loan Bank advances | 400,817 | 351,072 |
Subordinated debentures and other borrowings | 285,197 | 138,685 |
Interest rate swap liability | 87,205 | 29,299 |
Interest payable | $ 5,587 | $ 6,754 |
Transfers Accounted for as Se_3
Transfers Accounted for as Secured Borrowings (Details) - U.S. Government-sponsored mortgage-backed securities - USD ($) $ in Thousands | Jun. 30, 2020 | Dec. 31, 2019 |
Assets Sold under Agreements to Repurchase [Line Items] | ||
Collateral pledged for all repurchase agreements accounted for as secured borrowings | $ 181,150 | $ 187,946 |
Overnight and Continuous | ||
Assets Sold under Agreements to Repurchase [Line Items] | ||
Collateral pledged for all repurchase agreements accounted for as secured borrowings | 178,749 | 178,732 |
Up to 30 Days | ||
Assets Sold under Agreements to Repurchase [Line Items] | ||
Collateral pledged for all repurchase agreements accounted for as secured borrowings | 750 | 0 |
30-90 Days | ||
Assets Sold under Agreements to Repurchase [Line Items] | ||
Collateral pledged for all repurchase agreements accounted for as secured borrowings | 0 | 7,672 |
Greater Than 90 Days | ||
Assets Sold under Agreements to Repurchase [Line Items] | ||
Collateral pledged for all repurchase agreements accounted for as secured borrowings | $ 1,651 | $ 1,542 |
Accumulated Other Comprehensi_3
Accumulated Other Comprehensive Income (Loss) - Changes in Balances of Each Component (Details) - USD ($) $ in Thousands | 3 Months Ended | 6 Months Ended | ||
Jun. 30, 2020 | Jun. 30, 2019 | Jun. 30, 2020 | Jun. 30, 2019 | |
Accumulated Other Comprehensive Income (Loss) | ||||
Beginning balance | $ 1,777,960 | $ 1,455,848 | $ 1,786,437 | $ 1,408,260 |
Other comprehensive income before reclassifications | 41,756 | 38,268 | ||
Amounts reclassified from accumulated other comprehensive income | (2,242) | (1,390) | (5,785) | (2,244) |
Total other comprehensive income (loss), net of tax | 35,971 | 36,024 | ||
Ending balance | 1,809,095 | 1,501,636 | 1,809,095 | 1,501,636 |
Total | ||||
Accumulated Other Comprehensive Income (Loss) | ||||
Beginning balance | 53,656 | (1,595) | 27,874 | (21,422) |
Ending balance | 63,845 | 14,602 | 63,845 | 14,602 |
Unrealized Gains (Losses) on Securities Available for Sale | ||||
Accumulated Other Comprehensive Income (Loss) | ||||
Beginning balance | 38,872 | (6,343) | ||
Other comprehensive income before reclassifications | 42,909 | 39,130 | ||
Amounts reclassified from accumulated other comprehensive income | (6,067) | (2,357) | ||
Total other comprehensive income (loss), net of tax | 36,842 | 36,773 | ||
Ending balance | 75,714 | 30,430 | 75,714 | 30,430 |
Unrealized Gains (Losses) on Cash Flow Hedges | ||||
Accumulated Other Comprehensive Income (Loss) | ||||
Beginning balance | (1,141) | (559) | ||
Other comprehensive income before reclassifications | (1,153) | (862) | ||
Amounts reclassified from accumulated other comprehensive income | 282 | 113 | ||
Total other comprehensive income (loss), net of tax | (871) | (749) | ||
Ending balance | (2,012) | (1,308) | (2,012) | (1,308) |
Unrealized Gains (Losses) on Defined Benefit Plans | ||||
Accumulated Other Comprehensive Income (Loss) | ||||
Beginning balance | (9,857) | (14,520) | ||
Other comprehensive income before reclassifications | 0 | 0 | ||
Amounts reclassified from accumulated other comprehensive income | 0 | 0 | ||
Total other comprehensive income (loss), net of tax | 0 | 0 | ||
Ending balance | $ (9,857) | $ (14,520) | $ (9,857) | $ (14,520) |
Accumulated Other Comprehensi_4
Accumulated Other Comprehensive Income (Loss) - Reclassifications (Details) - USD ($) $ in Thousands | 3 Months Ended | 6 Months Ended | ||
Jun. 30, 2020 | Jun. 30, 2019 | Jun. 30, 2020 | Jun. 30, 2019 | |
Reclassification Adjustments out of Accumulated Other Comprehensive Income [Line Items] | ||||
Net realized gains on sales of available for sale securities | $ 3,068 | $ 1,843 | $ 7,680 | $ 2,983 |
Interest expense - subordinated debentures and term loans | 1,639 | 2,123 | 3,584 | 4,239 |
Income tax expense | (4,623) | (7,749) | (8,113) | (14,690) |
Total reclassifications for the period, net of tax | 2,242 | 1,390 | 5,785 | 2,244 |
Unrealized gains (losses) on available for sale securities | ||||
Reclassification Adjustments out of Accumulated Other Comprehensive Income [Line Items] | ||||
Total reclassifications for the period, net of tax | 2,424 | 1,456 | 6,067 | 2,357 |
Unrealized gains (losses) on cash flow hedges | ||||
Reclassification Adjustments out of Accumulated Other Comprehensive Income [Line Items] | ||||
Total reclassifications for the period, net of tax | (182) | (66) | (282) | (113) |
Amount Reclassified from Accumulated Other Comprehensive Income (Loss) for the Period | Unrealized gains (losses) on available for sale securities | ||||
Reclassification Adjustments out of Accumulated Other Comprehensive Income [Line Items] | ||||
Net realized gains on sales of available for sale securities | 3,068 | 1,843 | 7,680 | 2,983 |
Income tax expense | (644) | (387) | (1,613) | (626) |
Amount Reclassified from Accumulated Other Comprehensive Income (Loss) for the Period | Unrealized gains (losses) on cash flow hedges | ||||
Reclassification Adjustments out of Accumulated Other Comprehensive Income [Line Items] | ||||
Income tax expense | 49 | 18 | 75 | 30 |
Amount Reclassified from Accumulated Other Comprehensive Income (Loss) for the Period | Unrealized gains (losses) on cash flow hedges | Interest rate contracts | ||||
Reclassification Adjustments out of Accumulated Other Comprehensive Income [Line Items] | ||||
Interest expense - subordinated debentures and term loans | $ (231) | $ (84) | $ (357) | $ (143) |
Share-Based Compensation - Narr
Share-Based Compensation - Narrative (Details) - USD ($) | 3 Months Ended | 6 Months Ended | ||
Jun. 30, 2020 | Jun. 30, 2019 | Jun. 30, 2020 | Jun. 30, 2019 | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||
Percentage of average closing price to be paid by employees | 85.00% | |||
Maximum common stock purchases through advance payroll deductions in a calendar year | $ 25,000 | |||
Share-based compensation | $ 1,214,000 | $ 844,000 | $ 2,433,000 | $ 1,825,000 |
Forfeiture rate | 0.40% | |||
Unrecognized compensation expense related to stock options | 0 | $ 0 | ||
Aggregate intrinsic value of stock options exercised | 197,000 | 308,000 | ||
Cash receipts of stock options exercised | $ 83,000 | $ 105,000 | ||
Stock Options | ||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||
Stock option term | 10 years | |||
Stock options vesting percentage | 100.00% | |||
Stock Options | Minimum | ||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||
Vested period | 1 year | |||
Stock Options | Maximum | ||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||
Vested period | 2 years | |||
RSAs | ||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||
Vested period | 3 years | |||
Unrecognized compensation expense related to RSAs | 5,595,000 | $ 5,595,000 | ||
Unrecognized compensation expense expected recognition period | 1 year 2 months 15 days | |||
ESPP | ||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||
Unrecognized compensation expense related to stock options | 0 | $ 0 | ||
Grant date fair value of ESPP options | $ 12,000 |
Share-Based Compensation - Comp
Share-Based Compensation - Components of Share-Based Compensation Awards (Details) - USD ($) $ in Thousands | 3 Months Ended | 6 Months Ended | ||
Jun. 30, 2020 | Jun. 30, 2019 | Jun. 30, 2020 | Jun. 30, 2019 | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||
Pre-tax compensation expense | $ 1,214 | $ 844 | $ 2,433 | $ 1,825 |
Income tax benefit | (265) | (227) | (522) | (783) |
Total share-based compensation expense, net of income taxes | 949 | 617 | 1,911 | 1,042 |
Stock and ESPP Options | ||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||
Pre-tax compensation expense | 12 | 25 | 53 | 36 |
Income tax benefit | (29) | (41) | (29) | (57) |
Total share-based compensation expense, net of income taxes | (17) | (16) | 24 | (21) |
Restricted Stock Awards | ||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||
Pre-tax compensation expense | 1,202 | 819 | 2,380 | 1,789 |
Income tax benefit | (236) | (186) | (493) | (726) |
Total share-based compensation expense, net of income taxes | $ 966 | $ 633 | $ 1,887 | $ 1,063 |
Share-Based Compensation - Stoc
Share-Based Compensation - Stock Option Activity under Stock Option Plans (Details) - USD ($) | 6 Months Ended |
Jun. 30, 2020 | |
Number of Shares | |
Beginning balance (in shares) | 59,350 |
Exercised (in shares) | (10,050) |
Ending balance (in shares) | 49,300 |
Vested and Expected to Vest (in shares) | 49,300 |
Exercisable (in shares) | 49,300 |
Weighted-Average Exercise Price | |
Beginning balance (in dollars per share) | $ 13.51 |
Exercised (in dollars per share) | 8.29 |
Ending balance (in dollars per share) | 14.57 |
Vested and Expected to Vest (in dollars per share) | 14.57 |
Exercisable (in dollars per share) | $ 14.57 |
Weighted Average Remaining Contractual Term (in Years) | |
Outstanding (term) | 2 years 3 months 25 days |
Vested and Expected to Vest (term) | 2 years 3 months 25 days |
Exercisable (term) | 2 years 3 months 25 days |
Aggregate Intrinsic Value | |
Outstanding | $ 640,876 |
Vested and Expected to Vest | 640,876 |
Exercisable | $ 640,876 |
Share-Based Compensation - Unve
Share-Based Compensation - Unvested RSAs Outstanding (Details) - RSAs | 6 Months Ended |
Jun. 30, 2020$ / sharesshares | |
Number of Shares | |
Unvested RSAs, Beginning Balance (in shares) | shares | 351,048 |
Granted (in shares) | shares | 14,657 |
Vested (in shares) | shares | (8,591) |
Forfeited (in shares) | shares | (525) |
Unvested RSAs, Ending Balance (in shares) | shares | 356,589 |
Weighted-Average Grant Date Fair Value | |
Unvested RSAs, Beginning Balance (in dollars per share) | $ / shares | $ 40.67 |
Granted (in dollars per share) | $ / shares | 27 |
Vested (in dollars per share) | $ / shares | 40.09 |
Forfeited (in dollars per share) | $ / shares | 40.44 |
Unvested RSAs, Ending Balance (in dollars per share) | $ / shares | $ 40.62 |
Income Tax (Details)
Income Tax (Details) - USD ($) $ in Thousands | 3 Months Ended | 6 Months Ended | ||
Jun. 30, 2020 | Jun. 30, 2019 | Jun. 30, 2020 | Jun. 30, 2019 | |
Reconciliation of Federal Statutory to Actual Tax Expense: | ||||
Federal statutory income tax at 21% | $ 7,899 | $ 10,249 | $ 15,827 | $ 19,858 |
Tax-exempt interest income | (3,199) | (2,403) | (6,221) | (4,670) |
Share-based compensation | (6) | (41) | (6) | (391) |
Tax-exempt earnings and gains on life insurance | (278) | (199) | (564) | (406) |
Tax credits | (89) | (63) | (150) | (141) |
CARES Act - NOL carryback rate differential | 0 | 0 | (1,178) | 0 |
Other | 296 | 206 | 405 | 440 |
Actual Tax Expense | $ 4,623 | $ 7,749 | $ 8,113 | $ 14,690 |
Effective Tax Rate | 12.30% | 15.90% | 10.80% | 15.50% |
Net Income Per Share - Reconcil
Net Income Per Share - Reconciliation of Basic and Diluted Net Income Per Share (Details) - USD ($) $ / shares in Units, $ in Thousands | 3 Months Ended | 6 Months Ended | ||
Jun. 30, 2020 | Jun. 30, 2019 | Jun. 30, 2020 | Jun. 30, 2019 | |
Net Income | ||||
Net income available to common stockholders | $ 32,992 | $ 41,056 | $ 67,255 | $ 79,873 |
Diluted net income per share | $ 32,992 | $ 41,056 | $ 67,255 | $ 79,873 |
Weighted-Average Shares | ||||
Net income available to common stockholders (in shares) | 53,762,913 | 49,432,167 | 54,247,493 | 49,400,770 |
Effect of potentially dilutive stock options and restricted stock awards (in shares) | 179,654 | 117,720 | 182,026 | 144,382 |
Diluted net income per share (in shares) | 53,942,567 | 49,549,887 | 54,429,519 | 49,545,152 |
Per Share Amount | ||||
Net income available to common stockholders (in dollars per share) | $ 0.62 | $ 0.83 | $ 1.24 | $ 1.62 |
Diluted net income per share (in dollars per share) | $ 0.62 | $ 0.83 | $ 1.24 | $ 1.61 |
Net Income Per Share - Narrativ
Net Income Per Share - Narrative (Details) - shares | 3 Months Ended | 6 Months Ended | ||
Jun. 30, 2020 | Jun. 30, 2019 | Jun. 30, 2020 | Jun. 30, 2019 | |
Stock Options | ||||
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | ||||
Stock options not included in the earnings per share calculation (in shares) | 0 | 0 | 0 | 0 |